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Abstract 
The average age of the HIV population is increasing, due primarily to advances in antiretroviral 
treatment. Adults over the age of 50 will soon make up the majority of adults with HIV in 
resource rich settings. However, research into their well-being is lagging behind. An initial 
systematic review into the well-being of older persons with HIV (PWH), conducted as part of 
this thesis, revealed little comprehensive research. Even fewer studies were identified 
exploring the effects of ‘time diagnosed with HIV’ on well-being, which is increasingly a 
significant variable in HIV care. This makes designing effective health-care interventions for 
older adults with HIV in the UK problematic. 
This thesis aims to identify differences in physical, social, and mental well-being in PWH in 
relation to age, and time diagnosed with HIV. Using one multi-centre UK study (the ASTRA 
study; N=3,258), one smaller study (the Resilience study, N=327) and two systematic reviews. 
It reveals that physical symptom frequency and distress did not differ in prevalence with age, 
although the symptoms of concern did. Social support decreased with age and problems with 
activities of daily living increased, but mental health (assessed by depression and anxiety 
symptoms) improved. Time with diagnosed HIV, however, was found to be strongly related to 
worse physical, mental, and social well-being. This is novel data and would benefit from 
further research to identify the extent of its effect on well-being. A second study was designed 
and utilised to explore these conflicting findings, and 'resilience' (assessed via the RS-14 scale) 
was found to relate to the increase in mental health with age, as well as the reduction in well-
being identified in adults with long-term HIV. This data is the first of its kind. The results are 
used to suggest appropriate intervention content for adults ageing with HIV.   
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List of commonly used abbreviations and terms 
– ADLs - Activities of Daily Living (e.g. washing, getting dressed) 
– Autonomy - freedom from external control or influence; independence  
– Biopsychosocial health - physical, mental and social wellbeing 
– cART - Combination AntiRetroviral Therapy 
– CET - Coping Effectiveness Therapy 
– Frailty - a condition characterized by increased vulnerability to stressors and 
identified through decreased muscle mass, energy, weight, physical strength, 
and physical activity 
– GAD - Generalised Anxiety Disorder 
– HrQoL/QoL - Health-related/ Quality of Life 
– OPWH - Older Persons With HIV 
– PHE - Public Health England 
– PWH - Persons with HIV 
– Resilience - the ability to maintain wellbeing in the face of stressors 
– SEGT - Supportive-Expressive Group Therapy 
– Self-efficacy - an individual's belief in their own ability to complete tasks and 
achieve goals  
– Stressor - a biological, chemical, environmental or external event which causes 
physiological and/or psychological stress 
– Well-being – The level of happiness, comfort and satisfaction with an 
individual’s personal state 
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1 Introduction 
1.1 Age, ageing and HIV infection in the UK 
Human immunodeficiency virus (HIV) is a virus which attacks the immune system, resulting in a 
progressive depletion of CD4 cells (T cells)1;2. The CD4 cell count is, therefore, considered an 
important marker of the progression of HIV. If left untreated, the immune system becomes 
compromised to the point where the individual can no longer fight infection or disease and 
illnesses becomes more common and severe2;3. These 'opportunistic' infections can signal the 
transition to AIDS (Acquired Immune Deficiency Syndrome): the last stage of HIV infection.  
HIV is primarily spread through unprotected sex, but also through infected needle stick and 
blood transfusion4;5.  HIV/AIDS is considered a pandemic—a disease outbreak which is present 
over a large area and is actively spreading6;7.  HIV/AIDS was first identified in the early 
1980s6;8;9 and the HIV pandemic has changed markedly over its 35-year history. What was once 
a terminal illness is now considered to be a chronic, life-long condition which, with regular 
medication and care, can be controlled6;9;10.  
The medicine used to treat HIV is known as antiretroviral therapy (ART). It controls the 
replication of the virus and therefore the number of HIV copies present (the viral load)11. If 
adhered to appropriately, ART suppresses viral replication to undetectable levels and 
maintains this suppression, allowing recovery of CD4 count and normalisation of immune 
function12;13. This can prolong the lives of People With HIV14 (PWH), reduce the likelihood of 
opportunistic infections, and greatly lower their chance of transmitting the virus to others3;9. 
As such, an individual diagnosed with HIV in resource rich settings can now expect a life 
expectancy approaching that of the general population10;15-18.   
An estimated 103,700 people are living with HIV in the UK19. Over the past two decades 
combination antiretroviral therapy (cART) has become more effective, simpler, and easier to 
20 
 
tolerate in terms of side-effects14. Due to these advances in treatment, PWH have a greatly 
improved life expectancy16;20, with recent reports suggesting that more than 50% of PWH on 
cART in high-income countries will live beyond the age of 60. UNAIDS surmise that worldwide 
3.6 million HIV-diagnosed people (10.2%) are over 50 years old*1 and that in high income 
countries this proportion could be nearer 33.3%22. In the UK specifically the number of older 
adults with HIV has tripled in the past decade23, with newly diagnosed infections in older adults 
doubling in this population in the same time period24. Indeed, according to Public Health 
England (PHE)19, there were 6000 new diagnoses of HIV in the UK in 2013, of which 974 (16%) 
were in people over the age of fifty. The age at HIV diagnosis of PWH from the UK, along with 
the age distribution of the HIV population itself for the past ten years is shown in figure 1 and 
figure 2 respectively (adapted from PHE statistical reports19).  
 
Figure 1. Age at HIV diagnosis in PWH from the UK across time19. 
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Figure 2. The number of people with HIV in the UK by age group19. 
 
As can be seen from figure 1, while the number of new HIV diagnoses has been declining since 
2005, the number of new diagnoses over the age of 50 has been increasing: from 689 in 2005 
to 974 in 201319. Figure 2 shows that the number of people with HIV in the UK has also 
increased over time, specifically in relation to the 35-49 years and 50+ years age groups (from 
19,932 and 4,837 in 2004 respectively to 39,180 and 19,959 in 201319). In the same year there 
were only 530 reported deaths in the HIV-positive population: a decline in mortality rate from 
11 per 1,000 people in 2004 to 4.3 per 1,000 in 2013 (vs. 1.8 per 1,000 people in the general 
population)19. Taken together, this suggests that adults are increasingly being diagnosed with 
HIV at an older age, and HIV-positive adults are reaching older ages and living with HIV for 
longer. This creates two distinct, growing, groups in need of care: 1) older adults with HIV and 
2) adults who have lived with HIV for a long time (adults growing older with HIV).  
Although the number of older adults being diagnosed with HIV is increasing, many older 
people with HIV (OPWH) are still diagnosed at later stages of infection than younger adults23;25-
30. Indeed, the 2014 PHE report19shows that 58% of older PWH are likely to be diagnosed with 
a CD4 count lower than 350 cell/mm3 - the UK clinician guidelines for initiation of cART at the 
time24 (this guideline has since been altered to include all persons with HIV of any CD4 
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count11). This delay in diagnosis may in part be affected by health care worker's beliefs that 
older adults are not sexually active (and are therefore not at risk), their discomfort in exploring 
sexuality with older patients, and a misattribution of older adult’s symptoms (e.g., fatigue, 
weight loss, memory loss) to illnesses commonly associated with old age (e.g. Alzheimer's 
disease, Parkinson's disease, cancer, chronic obstructive pulmonary disease, and non-AIDS-
related pneumonia)31-36. This delay in diagnosis and treatment, in turn, is related to higher 
rates of mortality37-40, faster CD4 cell loss, and faster progression to AIDS25;41;42. This makes 
newly diagnosed OPWH a population at high risk of ill health, and of specific concern for the 
health-care system.  
Despite the increase in numbers of OPWH, there has been a lack of focused research into the 
interactions between HIV and ageing on physical, mental, and social ‘well-being’. That is, much 
is left unclear about the impact of ageing with HIV on older adult's 'level of happiness, comfort, 
and satisfaction with their current personal state’43. This has left much of the literature on 
ageing with HIV to extrapolate information from gerontological and general HIV-based 
evidence44. For example, a literature review (section 1.3) on HIV and ageing was only able to 
identify five published UK papers conducted in the past ten years which examined the patient-
reported experiences of physical health amongst older adults with HIV25;40;45-47, of which only 
one was a study, rather than a summary paper40. 
This burgeoning population represents a challenge for researchers and healthcare systems. 
Specifically, evidence-based planning must be undertaken to meet the health-care needs of 
OPWH. For this to occur, we need to be aware of their needs - in terms of physical, mental, 
and social health - as well as to identify any ‘positive’ effects of ageing which could be utilised 
as a coping resource. In 2012 the National Institute of Health's office of AIDS specified studies 
into mental health, social networks, and the possibility of 'successful ageing' in OPWH as 
priority research areas48. In order to meet this priority it is important to understand general 
age-specific issues in well-being, as well as those faced by adults ageing with HIV specifically.  
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In this thesis I discuss these issues in relation to the Biopsychosocial model of health49: a well-
established model developed in health psychology that depicts health as a result of interacting 
physical, mental, and social factors.  
In the following introductory sections, general age-related issues with well-being are 
discussed, followed by those specific to ageing with HIV. 
 
1.1.1 Ageing 
According to some researchers, ageing is ‘a natural process that culminates in physical decline, 
morbidity, and mortality’50;51. Certainly, ageing does bring challenges in relation to health, but 
also life roles, and social participation. Older adulthood marks a time of change in relation to 
friends and family, physical functioning, ﬁnancial productivity, physical appearance, and 
identity: all of which must be addressed and adapted to.  
With age comes an increase in morbidity and mortality rates due to cell death and reductions 
in the body's ability to maintain a balanced internal environment8 and to protect against 
illness25;52;53. This also results in greater fatigue, physical frailty, and problems with activities of 
daily living (ADLs), which in turn reduce the autonomy, physical activity, and social mobility of 
older adults26;54;55. However, should older adults remain free of chronic illness, good physical 
function appears to be possible54.  
Possibly in relation to these health-related limitations in activity, depression has been found to 
be high in older adults56-58. It is also possible that depression may be high in older adults due to 
disengagement with social roles and increased economic strain caused by retirement and 
bereavement57;59;60. For example, many adults define themselves by their occupation, hobbies, 
or ability to care for their spouse and children61;62. In these cases retiring, ill health, and/or 
children growing up and moving away could cause older adults to feel obsolete, or anxious, or 
feel a need to adapt their identity to reflect these situational changes. As such, where chronic 
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illness prevents these personality-defining activities, it is likely that disengagement with life 
may occur at an earlier age63.  
For the same reasons, social support is thought to decline with age64-66. It has been observed, 
for example, that many older adults maintain small, highly valued social groups in order to 
maximise emotional and physical resources while limiting the energy and mobility required to 
participate in social interactions64;67;68. Despite the tendency for smaller size of these social 
groups, the importance of social support is not diminished with age. Indeed, social support has 
been repeatedly found to be related to physical and mental well-being in older adults, 
including the promotion of health-preserving activities such as exercise and healthy diet69-74. As 
such, it is possible that spousal support becomes more salient75, in relation to overall well-
being, with age.  
It appears that older adults face challenges to physical, mental, and social health which are not 
present in younger adults. This strongly implies that their care needs must be explored and 
addressed separately from those of younger adults. 
 
1.1.2 Ageing with HIV 
As in the general population, it is likely that older PWH experience age-related co-morbidities 
and lead more sedentary life-styles than younger PWH. It is also likely that they experience 
fear and uncertainty in relation to both age-related illness and their ability to recover their 
health after acute illness76. While the improvements in treatment mean that achievement of a 
satisfactory CD4 count is possible across all age groups77-79, higher rates of illness and mortality 
are still reported in OPWH3;19;21 in comparison to younger PWH and to the general population. 
There is a recent train of thought, even, that HIV debilitates the immune system in adults in 
ways which are similar to- and even exacerbate- the ageing process80;81. In other words, 
physical decline in OPWH may be associated with primary ageing (biological ageing), secondary 
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ageing (lifestyle, e.g. high smoking rates82, sedentary behaviour83), and tertiary ageing (disease) 
causing cumulative detriments to health37. 
Compared to physical health, mental health is under-researched in OPWH, particularly among 
people with HIV in the UK and Europe. Information on anxiety and positive mental well-being 
is especially absent in the literature. However, studies from the US have shown that levels of 
depression are higher in PWH than the general population84;85 and depression has been related 
to several factors salient in older age groups, such as bereavement86, poorer physical 
function85;87;88, health-induced anxiety84;89;90, and social isolation85;91;92. As such it is not 
unreasonable to conclude that OPWH may be at an increased risk of mental distress when 
compared to younger PWH and the general population.  
In relation to social health, OPWH have been identified as showing low levels of disclosure of 
their HIV status to family and friends93-96. Indeed, some report feeling that their adult children 
are a source of HIV-related stress and stigma97. This may result in lower levels of social support 
and less inclusion in social activities. Furthermore, fear of HIV-related stigma may prevent 
OPWH from populating their social circles with people of a similar age96;98;99. This is likely to 
result in greater reliance upon a HIV-positive network for support94-96 which, in turn, may 
increase the burden of stress on other OPWH. It also increases the likelihood of a diminishing 
social circle through bereavement at a faster rate than experienced in older adults within the 
general population.  
Therefore it is possible that OPWH face unique physical, mental, and social health needs based 
on an accumulation of age- and HIV- related limitations. As informal physical and mental 
support diminishes and age-related ill health increases, OPWH may develop an increasing 
reliance on formal health-care100, which places a burden on the health-care system. In order to 
enable high levels of well-being in this population and ease the burden on health-care, these 
care needs need to be identified and addressed. 
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1.1.3 Time with diagnosed HIV 
An important factor related to the well-being of OPWH is the amount of time they have been 
diagnosed with HIV. Living with HIV for a long period of time may cause HIV-specific stressors 
(causes of stress) in older adults. For example, those who were diagnosed before the 
availability of effective cART - when HIV was a terminal illness - are likely to have experienced 
many of their friends and partners dying from AIDS. They may also have lived with the fear of 
their own potentially imminent death, and through the era of early and ineffective treatments 
(such as monotherapy), severe medication side-effects, and the fear of progression to AIDS. 
Indeed, these experiences may be unique enough that recently diagnosed- and 'previously-
diagnosed'- older PWH should be treated as separate treatment groups with separate 
histories, experiences, and well-being needs101;102.  
However, this sub-group has not been well-researched. A search of the key-words 'time', 
'length', 'long', 'long-term', 'diagnosis' and 'HIV' revealed six papers centring on the needs or 
issues faced by PWH who had been diagnosed for a long time. One Italian study (N=2,424) 
initiated in 2004 compared OPWH (over 45 years of age) to adults ageing with HIV (diagnosed 
for more than 20 years) and HIV negative adults101. They found higher morbidity rates 
(lipodystrophy, cardiovascular disease, hypertension, diabetes, chronic kidney disease) in both 
HIV positive populations when compared to HIV negative adults. Within the HIV positive 
group, worse comorbidities were found in relation to older age than longer time diagnosed 
with HIV101. An American study (N=4631) reported worse physical health (assessed via the 
Physical Health Component Summary) in adults with longer duration of HIV103. Another small 
qualitative study of 24 PWH diagnosed for ten or more years, reported that the primary 
concerns were in relation to interpersonal relationships, coping with stress, health-care issues, 
and a fear of progression to AIDS104. A second qualitative analysis also reported the importance 
of social support to long-term survivors, as well as supportive health-care services105.  
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Finally one qualitative study published in 2014 revealed that many adults with long-term HIV 
faced financial concerns, having been unable to work at a younger age due to HIV and not 
feeling the need to plan effectively for retirement106. The participants also identified that they 
were aware of the lack of information available to their doctors on 'normal' levels of health at 
prolonged survival, this being the longest any adult has lived with HIV106. They voiced concerns 
of feeling like 'guinea-pigs' for medication efficacy, being hyper-aware of changes in their 
bodies and that, with time, HIV medication may become less effective and options may run 
out106. As such adults ageing with HIV may face many similar concerns to newly-diagnosed 
OPWH in relation to ageing and health, as well as time-specific care needs. 
Longitudinal data can also be utilised to explore time-related changes, as it can show changes 
in well-being within individuals over time, and as such can be used to explore 'ageing with HIV'. 
Following this logic, six studies were identified which involved a longitudinal follow-up of 
longer than a year carried out between 1998 and 2010. The results showed an increase in CD4 
count30;77;107;108, frailty109;110, and mortality77;108;110, and a decrease in viral rebound77 in 
individuals across time. No quantitative results were found in relation to depression, anxiety, 
social support or positive well-being. The information available suggests that ageing with HIV 
creates unique issues in relation to well-being. 
 
1.1.4 The possibility for 'successful ageing' 
It would be narrow-minded to assume that ageing has a negative, blanketing effect on well-
being in PWH and so the possibility of 'successful ageing' in PWH must be addressed. 
Recognising the possibility of 'successful ageing' could also allow for the exploration of 
behaviours which could be encouraged in age-specific interventions. 
For example, it is also possible that, with age and/or time, PWH learn to cope with the stress of 
ill health and are become better equipped to protect their mental health. For example, recent 
'resilience' research has begun to focus on the coping behaviours of older adults. Resilience is 
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a multidimensional concept which seeks to explain how some individuals attain, maintain, or 
regain well-being in the face of hardship111. While research is still lacking, current results 
suggest that resilience may be higher in older- than younger- adults112-114 due to life-long 
experience of coping effectively with hardship115. This would suggest that OPWH may be more 
equipped to cope with age-related declines in health and social support and may even show 
better overall well-being than younger adults. This has yet to be applied to PWH, however. 
In general, models of 'successful ageing' - ageing with positive well-being - involve maximising 
active engagement with life, good physical function, and the prevention of disease and/or 
disability116. For obvious reasons this model is not suitable for older adults with chronic illness, 
such as HIV. However, Baltes and Baltes' selective optimization with compensation theory117 
suggests that, with age, adults learn to choose activities and behaviours which best maintain 
well-being, while reducing high-energy or physically unavailable activities. In this way, it is 
possible for older adults to maintain well-being despite reduced physical and social mobility. 
Similarly, Kahana and Kahana have developed a model of successful ageing for PWH67 which 
states that through planning, health promotion, social and financial support, and adaptation to 
limitations OPWH can mediate the effects of HIV on well-being67. While this model is reliant 
upon a large number of assumptions about physical, social, and mental ability, it does 
acknowledge the possibility of an optimistic response to HIV.  
In summary, older PWH are a rapidly increasing population both in the UK and globally, with 
specific care needs. This population is lacking focus in the literature, especially in relation to 
the UK population, and a better understanding of their well-being is needed in order to 
effectively address these needs. More specifically, the differences in well-being between 
chronologically older OPWH and adults 'ageing with HIV', or diagnosed for a longer time, need 
to be explored. This thesis intends to address the limitations of the literature and explore the 
biopsychosocial well-being of older PWH in relation to their younger counterparts. In doing so, 
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I hope to identify care needs specific to older age, or longer time since HIV diagnosis, which 
can be utilised by future health care interventions. 
 
1.2 Thesis Aims and Objectives 
1.2.1 Aims 
This thesis aims to assess biopsychosocial factors among older PWH in the UK. It will utilise 
evidence from literature reviews and two studies undertaken as part of this thesis to suggest 
an age-appropriate intervention. 
The research presented here will address several gaps identified in the literature. Foremost, it 
will explore the biopsychosocial wellbeing of adults with HIV across the age spectrum; 
assessing trends by age in symptom prevalence and distress, depression, anxiety, and social 
support. The effects of growing older with HIV will also be assessed, in terms of time living 
with diagnosed HIV, in relation to the above biopsychosocial variables. This will allow us to 
differentiate between the effects of chronological ageing and long-term HIV infection on well-
being. Part of the research will also utilise HIV-negative individuals, allowing us to explore 
factors associated with older age both among HIV-positive and HIV-negative populations, 
which is lacking in the research so far. In doing so it will contribute to the available UK studies 
on the psychosocial health of older PWH and add a large, multi-centre evidence base to a 
literature which mainly consists of small American studies.  
Resilience will also be explored in relation to mental and physical health. Specifically, among 
PWH, the prevalence of higher resilience by age and time with diagnosed HIV will be assessed, 
as well as whether resilience differs between adults with and without HIV, and whether 
resilience relates to depression, anxiety, difficulties with ADLs, and/or physical function. This 
will produce entirely new information within the field of ageing HIV research. The results will 
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be used, along with the above research, to discuss the potential development of a theoretical, 
focused intervention to improve quality of life in OPWH.  
 
1.2.2 Objectives 
To achieve these aims, two separate studies will be used: 
Study 1: The first study compares symptom prevalence, symptom distress, depression, 
anxiety, and social support in people with HIV by age and time diagnosed with HIV as well as 
the associations between these variables. It utilises data from the ASTRA study118- a large 
multi-centre UK study conducted in 2011-12 - to identify symptoms specifically distressing to 
older adults. The results will provide an overview of the effects of age and time with diagnosed 
HIV on the well-being of the HIV-positive population. Due to the large sample size and 
inclusion of a number of UK clinics, these results are likely to be representative of PWH in the 
UK as a whole. 
Study 2: I then developed and conducted a new smaller study of resilience, mental, and 
physical in relation to age, among PWH and age-matched HIV-negative counterparts. This will 
allow for identification of mental and physical health symptoms associated with HIV and/or 
ageing. 'Resilience' is included in this analysis to allow for the possibility of a form of 'positive' 
ageing and its effect on mental and physical health. While this is a smaller study, it will give us 
some insight into how health measures differ with age in the HIV-negative population, 
allowing differentiation between the effects of HIV and ageing. It also allows for identification 
of possible positive effects of ageing which can be drawn upon in interventions. 
A summary of the specific research questions and chapters by study are given on the next 
page. 
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1.2.3 Research Questions 
Study 1:  
i. What physical symptoms are most prevalent and/or distressing in adults with HIV and 
do they change with age and/or time with diagnosed HIV? (Chapter 3) 
ii. What problems with Activities of Daily Living (ADLs) are most prevalent in adults with 
HIV and do they change with age and/or time with diagnosed HIV? (Chapter 3) 
iii. What psychological symptoms are most prevalent in adults with HIV, do they change 
with age and/or time with diagnosed HIV and what are their relationships to physical 
well-being (symptoms and problems with ADLs)? (Chapter 4) 
iv. Does social support or disclosure of HIV status differ by age and/or time with 
diagnosed HIV in adults with HIV and what is the relationship to mental and physical 
well-being? (Chapter 5) 
v. Does financial stability differ by age and/or time with diagnosed HIV in adults with 
HIV? Is financial stability and employment status associated with mental or physical 
well-being of older adults with HIV? (Chapter 5) 
vi. What relationships are apparent between physical, mental and social factors of well-
being and do they change by age or time diagnosed with HIV? (Chapters 4 and 5) 
Study 2: 
a. Is resilience affected by age, time with diagnosed HIV and/or HIV status? (Chapter 7) 
b. Does depression, anxiety, problems with activities of daily living, or prevalence of 
regular physical activity differ by age or HIV status? (Chapter 7) 
c. Is resilience related to depression, anxiety, activities of daily living and/or physical 
activity? (Chapter 7) 
To answer these questions I began by exploring the literature, in the form of a systematic 
review. This identified currently recognised physical, mental, and social issues affecting OPWH. 
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1.3 A systematic review of the biopsychosocial evidence 
This systematic review was conducted to explore current research into the biopsychosocial 
health of older adults with HIV. 'Biological health' was defined as any physical illness, 
laboratory measures, or symptoms measurable through standardised means; including 
comorbidities and the possible biological effects of HIV and cART. This included CD4 count, 
viral load, mortality rates, and medical conditions (e.g. cardiovascular diseases). Comparisons 
of the efficacy and/or effects of HIV drugs and cognitive impairments were not included as 
they were considered to be beyond the scope of this thesis. 'Psychological health' included 
quality of life, depression, anxiety, distress, mood states, coping mechanisms, and measures of 
affect (expressed emotion). 'Social health' included reports of disclosure of HIV status, social 
support, stigma, and isolation. In line with previous work, an 'older adult' was defined as an 
adult over the age of 50.  
A key-word search was conducted using the online databases of: AIDS, Cochrane Database of 
Systematic Reviews (CDSR), database of systematic and non-systematic reviews of public 
health interventions (DoPHER), Medline/Pubmed, JAIDS, SAGE, JSTOR, LILACS, Mary Ann 
Liebert, METALIB, Psychnet, sciencedirect, Springerlink, Taylor and Francis, Wiley and EBSCO in 
July-August 2014. This was then updated in September 2015. 
 
1.3.1 Inclusion and exclusion criteria 
The search terms included were; 'HIV' OR 'AIDS' AND '50', 'age', 'aging', 'elder', 'fifty', 'mature', 
'old' and 'senior'. This keyword search generated 748 studies potentially relevant to this thesis, 
which were then examined for inclusion in this review according to inclusion criteria specified 
in advance (Table 1).   
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Table 1. Inclusion criteria in order of use. 
No. Inclusion Criteria Status of paper and response 
  Yes Unclear No 
0 Is the study clearly outside the scope of 
the review? 
Exclude 
Go to 
question 1 
Go to question 1 
1. Are at least one group of participants HIV 
positive? 
Go to question 2 Exclude 
Type of study  
2. Was the data collected solely after 1999?  Go to question 4 Go to question 3 
3. If collection date is unclear, was the data 
published after 2000? 
Go to question 4 Exclude 
4. Is the study quantitative? Go to question 5 Exclude 
Participants in study  
5.  Is at least one comparison group made 
up of participants over the age of 50 
years?  
Go to question 7 Go to question 6 
6. If some of the participants in the older 
group are under the age of 50, can the 
data be disaggregated to show that 80% 
of the group is over the age of 50 or, if 
indeterminate, is the mean age over 50? 
Go to question 7 Exclude 
7. Are participants studied in comparison to 
a control group of HIV negative adults 
over 50, HIV positive adults under 50 or 
HIV positive adults over 50 of a different 
demographic?   
Go to question 8 Exclude 
Focus of study 
8. Does the study explore physical, 
psychological or social factors for OPWH 
either as a primary or secondary aim? 
Go to question 8b Exclude 
8b. In the case of physical outcomes; does 
the study explore the effects of specific 
medications only? 
Exclude Go to question 9 
Outcomes 
9. Does the study measure physical, 
psychological or social factors measured 
by validated instruments? 
Include subject to clarification 
of 'unclear' points 
Go to question 8 
10. In the case of social outcomes, is the data 
quantitatively measured? 
Include subject to clarification 
of 'unclear' points 
Exclude 
 
N. Final Decision 
Include 
Unclear (more 
information) 
Exclude 
 
Papers were included if they provided quantitative data on biological, psychological, or social 
factors in older adults with HIV in comparison to a control group, with data collected from the 
year 2000 onwards. This date exclusion was incorporated in order to restrict attention to 
studies carried out in the current era of successful antiretroviral therapy. The control groups 
could involve younger people with HIV, HIV-negative older adults, or demographically 
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differentiated older adults with HIV. Studies in all geographical regions were included.  
Outcome measures needed to be gathered according to validated scales or inventories where 
appropriate. Only 'full text' articles were included. Qualitative studies, non-primary data, 
review articles and opinion pieces were excluded. Articles focused on older adults as 
caregivers for others with HIV were excluded, as were studies of older adults where the 
majority of participants in the older group were under the age of 50 years. 
After the search, papers were read independently for confirmation of inclusion by myself and 
two undergraduate psychology students who were given details of the study inclusion criteria. 
As the lead author, I took responsibility for adjudication in case of non-agreement (84.5% 
inter-rater agreement). The review was conducted following PRISMA standards119. 
Juxtaposition of author names, study groups, and population sizes were utilised to identify 
duplicate publications. All reports of a single study were considered, as long as the outcomes 
differed. For all included papers, detailed extraction of findings was recorded listing the 
reference, date and country of study, population details, aims, measure, and results (see Table 
2, Appendix A). 
 
1.3.2 Results 
The below criteria (see figure 3) generated 390 papers relevant to this review. After excluding 
duplicates, 386 remained which underwent a more detailed exploration of the full title and 
abstract. One hundred and eighty two papers were excluded due to non-relevance, leaving 
216 full-text articles for assessment via an in-depth search of the full text using the inclusion 
criteria. Of these, 130 were then excluded: 35 for data collection date, 30 for not reaching the 
standards in terms of methodology, 25 for participant age, 71 for lack of a control group, 2 for 
non relevant outcome and 3 for non-validated measures. Thirty eight published studies met 
the eligibility criteria for inclusion and were subjected to detailed data abstraction.  
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Figure 3. Preferred Reporting Items for Systematic Reviews diagram summarizing selection 
procedure for studies on physical, psychological, social or behavioural outcomes for OPWH. 
 
One paper was published in 2015, four in 2014, six in 2013, seven in 2012, ten in 2011, four in 
2010 and six between 2004-2009. On average, papers were published 3.3 years after data 
collection (median of 2), with a range of 1-9 years (see figure 4a). Five papers originated from 
the HIV Neurobehavioral Research Program (HNRP) Group79;120-123. All other studies had 
independent results. Overall, 197,313 (Range = 30-90,071) participants were included in 
analysis in total, 17,190 (8.7%) of whom were older PWH (aged 50 and over). America was the 
country of origin for 21 (55%) of studies, six occurred in Africa77;78;124-127, five in Europe 
(excluding the UK)107;128-131, two in Brazil132;133, two from Canada134;135, one from Singapore136 
and one in the UK137 (figure 4b).  
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Figure 4a. Data collection date differentiated by year of publication; the number of studies 
(n=38). 
 
Figure 4b. A pie chart of the geographical origin of papers included in the systematic review 
(N=38). 
 
All but four (89%) studies were not focused on sub-populations of PWH. Of those that were, 
one looked at rural and urban male PWH138, one focused on men who have sex with men 
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(MSM)55, one on bisexual men139 and one on men109. The control groups included younger 
PWH in 25 studies, HIV-negative older adults in four109;140-142, both in six55;79;121-123;130 (four from 
the HNRP group) and demographically different older PWH in three139;143;144.  
 
1.3.2.1 Assessment of study design and risk of bias 
Due to selection criteria, the methodology of all studies was considered to be of a 'fair' 
standard: valid, standardised outcome measures were required of all studies included, except 
in the case of health-related risk behaviours where no such measure is available. Participation 
in each design was limited only by the individual's ability to understand the questionnaire and 
give consent. However, by design, all psychological outcomes were self-reported and all 
participants were self-selected meaning that the results may be at risk of bias. No studies 
reported whether their samples were representative of the HIV population, but participant 
data was collected predominantly through AIDS service organisations (ASOs), which increases 
the likelihood that the data gives a representative picture of HIV service users. No power 
calculations were reported for study sample sizes. No conflicts of interest were reported. 
 
1.3.2.2 Biological Outcomes 
Twenty of the included papers focused on changes in biological health with age. Of these, 
twelve papers looked at differences in ART efficacy with age; eleven at CD4 count64;77-79;107;125-
128;132;133, six at viral load64;77;78;107;131;133 and one at T-cell frequency132. Mortality rates were 
assessed in seven studies64;107;124;126;127;131;136 and co-morbidities in 
eleven55;64;78;79;109;128;130;131;133;141-143. 
Data was primarily identified through the most recent medical records available. Of the studies 
utilising this method, the majority found no difference in CD4 count between older and 
younger PWH on ART. The individual results are described below. 
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The Swiss HIV Cohort Study (N=1497)128 found no significant difference in CD4 count between 
PWH aged under and over 50 years (median count of 513 (IQR=361-702) vs. 493 (355-68) 
respectively, p=0.126). Similarly, no difference was found in CD4 count by age in 1,478 PWH 
aged 18+ from Alabama (p>.05)64, three studies from Africa (Ns=90,071, 17,561, 3,316, 
ps>.05)77;78;126, the HIV Neurobehavioral Research Program (HNRP) Group's study79 of 302 
American PWH (mean count = 568(IQR = 402-806.5) in ≤40s vs. 507(381.3-759.5) in ≥50s, 
p=0.672) or a Brazilian sample of 30 PWH aged <40 or >55 (Mean count of 614(IQR=401-1007) 
and 603.8(371-976) respectively, p>.05)132.  
However a second, larger, Brazilian study133 (N=2,307) found no linear trend in CD4 count with 
age (mean count of 447(SD= 378) in PWH aged 18-39 vs. 497(309) in ≥60s, p=0.490) but a 
significantly lower CD4 count in participants aged ≥50 (p<.02) compared to younger groups. 
This result corresponded to studies identifying changes in CD4 cell count over time: Blanco et 
al.'s study of 2,726 Spanish PWH107 and Balestre et al.'s125 study of 24,107 PWH from West 
Africa. Blanco et al. identified increases of more than 100 cell/ml in CD4 count with increasing 
age, and a decrease in immunological response to ART with age (range of 32%-43% less likely 
to experience immunological response in ages 50-54 to ≥70 in comparison to participants aged 
<25, ps<.05)107. Similarly, Balestre et al.125 measured CD4 count gain after 12 months of ART 
and found a smaller increase in CD4 count with increasing age (p<.00001). Maskew's127 
population of 9,139 PWH from Johannesburg aged 18 and over also showed a decrease in CD4 
count improvement 6-12 months after ART initiation with age (p<.05). In contrast, Greig et al.'s 
study of several African countries found a higher median gain in CD4 cell count at 6 and 12 
months in adults over the age of 50 compared to those aged 15-49 (Hazard Ratio (HR) = 1.59, 
N=17,561, p<0.001).  
It is therefore possible that older adults attain similar CD4 counts to younger adults when on 
ART, but their immunological response to medication may be slower. Why the opposite would 
be true in Greig's study is unclear, especially as the demographic variables are similar to those 
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found in the other African studies. It is possible that the difference in results is due to the 
comparatively lower income areas of Africa covered in this study, within which older adults 
may be more likely to seek care (improving their prospects of diagnosis) and to adhere to their 
medication. However, further evidence is needed to confirm this theory. 
Viral load revealed a wider variation in results. No significant difference between older (>55 
years) and younger adults was found in Fatti and colleagues' South African study of medical 
records (N=90,0771, Odds Ratio (OR) = 1.42, CI=1.23-1.64, p<.05) or by age in the Spanish 
study (N=2,726, HR = 3.58, CI= 1.07–11.99, p>.05)107. An analysis of the clinical records of 
participants from Uganda and Zimbabwe78 showed a higher viral load at ART initiation in PWH 
over the age of 50 compared to those aged 18-49 (N=3,316, p=0.003) while the remaining 
three studies showed a lower viral load with increasing age in PWH on ART centred in Alabama 
(N=1478, p=0.018)64, Milan (N=1,217, p<.0001)131 and Rio de Janeiro (N=2,307, p<.001)133 as 
assessed by medical records. Finally, a second study based in Rio de Janeiro showed that naive 
and central memory T cells were less frequent in PWH aged over 55 than PWH aged <40 
(ps<.05) as assessed by blood sample132. This seems to suggest, overall, a better immunological 
- and possibly virological - response to ART in older than younger PWH despite age-related 
reductions in the efficacy of the immune system. 
Mortality rates generally increased with age. This occurred in a Singaporean sample of 121 
PWH aged over or under 50 as assessed via the VACS index (higher mean 5 year mortality rates 
of 25% vs. 50%, p<.001)136, a Spanish107 sample of 2,726 PWH aged <30 or ≥60 years (HR = 
3.58, Confidence Intervals (CI)= 1.07–11.99, p<.05) as assessed by death rates, 1,478 PWH 
aged over 18 from Alabama64 (p<.001) and two African studies124;126 (Ns=22,087 (31.4 deaths 
per 1000 person-years in ages 40-44 vs. 58.9 in ages 60-64) & 17,561, ps=<.001 & .016 
respectively). Similarly, mortality rates in the first 12 months of treatment also increased with 
age in 9,139 PWH from Johannesburg (HR = 1.67, 95% CI: 1.24-2.23, p<.05)127. A sample of 
1,217 Italian131 PWH aged over or under 50 showed no difference in mortality rates (assessed 
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via survival) to younger PWH at study end (p>.05). However, this is likely due to the relatively 
short length of this study (two years). 
Finally, comorbidities were assessed in eleven papers. Due to the wide variation in co-
morbidities assessed the detailed break-down of these papers is shown in table 2 in Appendix 
A. Briefly, compared to older adults without HIV, older PWH were more likely to show a frailty 
phenotype (an aging-related condition characterized by increased vulnerability to stressors 
and identified through decreased muscle mass, energy, weight, physical strength, and physical 
activity)55, to have lower bone mineral density of the femoral neck, total hip, and lumbar 
spine109;142, to show osteopenia or osteoporosis (reduced protein and mineral content of 
bones)109, bone fracture, renal failure130, hepatitis C79, hypertriglyceridemia and low body mass 
index and were more likely to use lipodystrophy-related, antihypertensive, and lipid-lowering 
medications141, and visit the hospital more frequently with age (p<.05)55. No difference was 
found, by HIV status, in relation to coronary heart disease, chronic viral hepatitis, non-AIDS-
deﬁning malignancies or cardiovascular risk130;141. Conflicting results were shown in relation to 
diabetes mellitus130;141 and hypertension (high blood pressure)130;141. 
Compared to younger PWH, older PWH showed higher rates of comorbidities64;130;133 and 
prescribed medications64;128. Specifically, older adults were identified as being at higher risk for 
drug-drug-interactions128, cardiovascular risk131;133, erectile dysfunction, hypertension64;78;119, 
renal dysfunction, diabetes mellitus64;119, dyslipidaemia/hypercholesterolemia (abnormal 
amounts of lipids (e.g. cholesterol, fat) in the blood) 64;133, non-AIDS-related cancers133, 
insomnia, coronary artery disease, hypogonadism (reduction in sex hormones), reflux disease, 
shingles/Herpes Zoster64, and to have progressed to AIDS79. Older PWH showed lower rates of 
condyloma (genital infection)64 and chronic liver disease131 than younger adults and no 
difference and/or conflicting results were found in relation to hepatitis C64;78;79;128;133, hepatitis 
B78;133, AIDS-related cancers133, pneumonia, Kaposi sarcoma, and obesity64. Within older PWH, 
African American were more likely to have liver disease or diabetes mellitus143.  
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As can be seen from the outcomes, a large number of co-morbidities have been explored, but 
rarely in more than one paper each. As such, while the results suggest a reduction in overall 
physical health with age and HIV status, the results are not conclusive. Furthermore, few 
studies have assessed patient-reported health and symptoms, leaving the effects of ill health 
on well-being to be assumed, and even fewer have included time with diagnosed HIV as a 
confounding factor. 
 
1.3.2.3 Psychological Outcomes 
Thirteen papers looked at depression64;120;129;133-135;138;143-148, three at anxiety64;120;140, two at 
mood120;122, one at overall affective disorders (depression, anxiety, bipolar disorder)79, and one 
at body change distress146. Quality of life was assessed in six studies79;121;123;135;137;146 and 
wellbeing in two122;139. Other outcomes of interest included self-efficacy (an individual's 
belief in their own ability to complete tasks and achieve goals)147, coping134;135;144, positive 
affect148, mastery135;140, spirituality149, successful aging, emotional functioning, resilience, 
optimism, and feelings towards aging140. 
Depression was by far the most explored psychological outcome in HIV/AIDS in older adults, 
but researched via seven standardised measures: the Center for Epidemiological Studies 
Depression (CES-D) Scale129;134;135;138;146;147, the Beck Depression Inventory(BDI)145, Participant 
Health Questionnaire (PHQ-9)148, the Geriatric Depression Scale (GDS)144, medical 
records64;133;143, the Composite International Diagnostic Interview (CIDI)79, and the Profile of 
Mood States (POMS)120, making meta-analysis of results problematic.  
Despite the use of separate measures and geographical regions, seven of the ten studies 
comparing depression by age found comparable results: no difference in depression 
prevalence between older and younger PWH. The details of these studies are documented 
here. 
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The Hawaii Aging with HIV Cohort study (n=285) assessed depression via the BDI and found no 
difference by age between PWH over 50 years of age and under 40 (mean scores = 9.1 vs. 8.6 
(p = 0.42))145. Similarly, no difference in depression rates in PWH over or under 50 years was 
found in Philadelphia using the PHQ-9 (mean=7.78 (SD = 5.61) vs. 4.9(5.49), p=0.83)148, in 226 
male PWH in Florida aged 20-39, 40-49 and 50-70 via the CES-D Scale138 (p = 0.523 and p = 
0.557) or in 130 PWH from the Midwest (mean score = 15(sd=10.16) vs. 15.84(12.8) p=0.8)147.  
Depression, anxiety, and mood were measured by age via POMS in 113 PWH in San Diego and 
no significant difference was found in lifetime depression prevalence (58.5% of <40 year olds 
and 54.2% of >50 year olds, p=0.653) or anxiety (12.2% vs. 19.4%, p=0.322)120. Nokes et al.'s 
2011146 study of 1,217 PWH from around America measured depression and body change 
distress using the CES-D scale and Body Change Distress Scale and also found no age 
differences in depressive symptoms (t = −1.258, df = 925, p = .20), Health-related Quality of 
Life (HrQoL) (p=0.92), or body change distress (t = −1.258, df = 925, p = .209)146, nor did a study 
of 440 Italian PWH (CES-D; 58.9% and 58.0% depression rates, respectively)129. Depression and 
anxiety were briefly mentioned in Vance et al.'s cross-section of American medical records64 
(N=1478) and no difference was found in prevalence of either with increasing age (40.6% of 
PWH aged 12-29 vs. 38.4% of ≥60s, p=0.685).  
However, Emlet and colleagues' 2015 paper found that maladaptive coping strategies 
(methods of coping which do not impact upon the stressor, such as avoidance; measured via 
Brief COPE) were used less frequently with age (p<.05) in 960 PWH from Canada, and 
depression (CES-D) decreased with age (44.9% of<40s vs. 26.2% of >55s, p<.001). Moore et 
al.79 identified a higher likelihood of affective disorders in younger than older PWH (N=302, 
p<.001). Torres and colleagues'133 exploration of Brazilian medical records found an increase in 
prevalence of depression with age (14.3% of <40s vs. 19.3% of ≥60s, p<.001). It is unclear why 
these studies would have achieved results contrary to the rest of the literature. However, it is 
possible that Torres' results are due to geographical differences in mental health, or that, 
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being based on medical record review, they are capturing age-related differences in diagnosis 
of depression. It is also possible, looking at the raw scores for each age group, that the overall 
increase reported in depression with age in the Brazilian population is due to the higher rates 
of depression reported in those aged 50-59 (23.3%) which overshadows the otherwise 
relatively stable rates across age groups. Why this age group is more depressed than older or 
younger PWH is still unclear. Emlet's results may be an artefact of the primary data collected in 
his study: namely data on stigma and social support. This may have biased younger adults 
towards more optimistic viewpoints, assuming that their levels of social support were higher 
than that of older adults. Finally, Moore et al.79 did not differentiate between PWH suffering 
from depression or anxiety, which may explain the identification of an age difference. 
In relation to sex differences within OPWH, Brennan's Canadian study on 136 older PWH 
measured depression via CES-D and found that women reported the highest mean scores for 
depression, followed by heterosexual men, (16.77(15.28) & 12.43(11.43), p < .001)135. These 
results reoccurred in an American study (N132)using medical records (p=0.012), which also 
found higher prevalence of depression in non-African American PWH (p=0.001)143. The GDS, 
however, found no difference by gender in older PWH (19.28(5.69) vs. 19.64(5.57), 
p=0.463)144. The difference in results is most likely to do with the variation in the scales used. 
The GDS is an age-related depression scale, which therefore focuses on measures of 
depression likely to occur in all older adults regardless of sex (e.g. "Is your mind as clear as it 
used to be?" and "Do you think it is wonderful to be alive now?"). On the other hand, the CES-
D reports depressive behaviour in the past week and focuses on the clinical signs of depression 
(e.g. "I did not feel like eating", "I felt that everything I did was an effort") which may differ 
more between sexes. As such, this might suggest that adults with HIV do not differ in their 
ability to cope with ageing in relation to gender, but do differ in rates of clinical depression. 
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1.3.2.4 Quality of Life 
Out of the six studies on quality of life (QoL), five explored differences by age79;121;123;137;146 and 
one looked at sex differences in QoL in older PWH135. The Rand 36-item Short Form (RAND-36-
SF) Health Survey was used to measure QoL in three studies79;121;123, the EUROQOL-5D in one21 
and the HIV Assessment Tool - Quality of Life Instrument (HAT-QOL) in one146. No difference in 
QoL by age was found in three of the five studies, which are outlined below. 
The HNRP group found no difference in QoL (physical (p=0.724) or mental (p=0.464)) by age or 
HIV status (p>.05) using the RAND-36-SF123. Another American study of 1,217 PWH aged above 
or below 50 years reported no difference in QoL by age in relation to the HAT-QOL (p=0.77)146, 
as did a UK sample of 778 PWH using the EUROQOL-5D (mean=0.7 and 0.7, p=0.5)137.  
However, two other HNRP studies (2x2 factorial studies of 115 and 302 adults from San Diego 
respectively) found that older PWH reported worse general, physical, and mental health QoL 
scores on the RAND-36-SF than older HIV-negative people, younger HIV-positive, and younger 
HIV-negative groups (ps < .01)121. They also found lower SF-36 scores in PWH aged ≥50 
compared to those aged ≤40 in relation to energy/fatigue (SF values=9.77 vs. 1.34, p<.01), 
emotional well-being (SFs=9.21 vs. 2.30, p<.01), social functioning (SFs=8.60 vs. 3.56, p<.01), 
and general health (SFs = 4.40 vs. 1.63, p=0.02) but not emotional role limitations (SFs=3.61 vs. 
4.54, p=0.31)79. This occurred despite the use of the same geographical population, selection 
criteria and measures as the aforementioned HNRP study123. The primary difference between 
the studies is that Rodriguez-Penney et al.123 reported a significantly larger number of ethnic 
minorities in the younger age group than the older, while Duarte et al.121 and Moore et al.79 
report no such difference. It is possible, therefore, that there was a reduction in QoL with age 
in this population which was masked by the sociodemographic differences between age 
groups.  
In relation to gender, women had the lowest physical health subscale scores (p < .05) in the 
older HIV-positive cohort when compared to men and MSM121. Women were also found to use 
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avoidance coping - a method of regaining wellbeing by avoiding acknowledging the stressor 
e.g. stress eating - more than men (mean score=2.13(SD=.674) vs. 2.36(.724), p=0.014)144, as 
assessed by the Way of Coping checklist. HrQoL, as assessed by the Medical Outcomes Study 
(MOS) SF-36 Health Survey in Brennan's study found that gay and bisexual men had 
significantly higher mean scores in the mental health–related quality of life compared to 
heterosexual men and women (49.05(10.76) and 49.48(9.29) vs. 42.90(15.87) & 47.72(11.96), 
p = .003)135. 
The HNRP also measured mental wellbeing and mood using the RAND 36-item Short Form 
Health Survey (SF-36) and Profile of Mood States (POMS). They found no significant age- or 
HIV-related effects on emotional well-being, role limitations or the social functioning subscales 
(ps > 0.05)122. Within older PWH, bisexual men reported lower wellbeing than other MSM, as 
found in 914 PWH from New York using the Ryff Scale of Psychological Well-Being (F(12,1596) 
= 1.96, p < .024)139. Bisexual men also had significantly lower scores than MSM in the “Personal 
Growth” domain, and significantly lower scores than both heterosexuals and homosexuals in 
the “Purpose in Life” domain. However, no values were given for these139.  
Many other measures of mental health and well-being were assessed by the HNRP group, but 
few were explored by any other researchers. They found that self-rated successful aging, 
emotional functioning, resilience, and feelings towards aging were lower in older PWH 
(p=0.005, .001, .007 and .009), stress was higher in older PWH (p=0.006) and optimism and 
personal mastery showed no difference (p=0.38 and .06) compared to younger PWH and HIV-
negative adults140. Frain et al. measured self-efficacy and found no difference by age in PWH 
(mean = 7.83(sd=1.9) vs. 7.68(SD=2.06) p=0.9)147 and Mavandadi found that 'Vigour' was 
higher in older PWH, based on results from the 37-item Profile of Mood States (POMS) 
(10.86(4.93) vs. 13.36(4.99), p=0.02)148. Brennan, looking at coping and personal mastery 
within older PWH, found that maladaptive coping - coping mechanisms which do not 
effectively mediate stress - was seen most often in heterosexual men, followed by women 
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(23.9(6.75) & 22.91(6.59), p<.001)135. Personal mastery was seen most often in MSM 
(20.48(3.27) vs. 19.22 (heterosexual men), 19.52 (women), p=0.006)135.  
In summary, depression prevalence does not seem to vary by age in PWH, while HrQoL may 
not, although reports are limited and conflicting. There is insufficient evidence to conclude 
upon the other measures of mental health and well-being, but it appears that older adults with 
HIV may have a reduced likelihood of 'ageing successfully' compared to the general ageing 
population. The interpretation of study results is complicated by differing use and patterns of 
adjustment for other factors, and the possibility that, by comparing broad age groups as done 
in most studies, a non-linear association between age and depression may be missed. 
 
1.3.2.5 Social Outcomes 
Social support was assessed in six studies134;135;140;144;148;150 using five separate scales and stigma 
was assessed in four studies134;135;150;151 using two scales. Despite the different measures, no 
studies found a difference in social support or stigma with age in people with HIV. The 
individual studies are presented below. 
PWH from Ohio (N=101) categorised by social isolation via the Hawthorne Friendship Scale 
showed no significant differences in isolation by age (n=16.5(5.2) vs. 17.5(4.5), p=0.33)150. The 
HNRP study measured social interactions via the Duke Social Support Index Social Interaction 
sub-scale (DSSI) and found no difference by age or HIV status (p=0.51)140. Mavandadi 
compared social support via an abbreviated version of the DSSI and found no differences in 
social interaction (6.42(2.48) vs. 6.61(2.82), p=0.74) or instrumental (active) support 
(7.72(3.42) vs. 7.53(3.48), p=0.8) by age, but did find that subjective (satisfaction with) support 
was higher in older adults (16.42(3.24) vs. 17.87(3.2), p=0.04)148. No difference in social 
support was found by gender in 242 older PWH in regards to the Provision of Social Relations 
Scale (mean = 3.56(SD=.762) vs. 3.69(.774), p=1.98)144 or in the MOS-HIV Social Support Survey 
(mean=66.85-72.60, p=0.26)135.  
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However, again, Emlet and colleagues' 2015134 paper differs from these results. In their 
Canadian sample (N=960) social support (MOS-HIV Social Support Survey) was found to 
increase with age in PWH (scores of 13.21 in <40s vs. 15.12 in >55s, p<.05). While this would 
aid in explaining the anomalous results relating to depression identified earlier from this study, 
it is unclear why social support would be higher in older adults in this population.  
Using the HIV stigma scale, no difference in stigma was found by age (mean score = 24.0 
(S.D.=9.0) vs. 21.3 (8.6), p=0.14) for 101 PWH in Ohio150 . Using the same scale, no difference 
was found by age in 88 PWH from the Pacific Northwest (23.03 vs. 25.18, p>.05), although 
younger adults did score higher on the Discrimination subscales (7.82 vs. 6.04, p<.01)151. 
Within older PWH stigma, using the Modified HIV Stigma Scale, was lowest in MSM (mean 
=43.57(11.90) vs. 51.19-52.38, p<.001)135. Finally, Emlet's Canadian study134 found no 
differences in 'enacted' (experienced) or 'anticipated' (internalised) stigma, but lower levels of 
'internalised' stigma with increasing age (scores of 12.83 in <40s vs. 9.76 in over 50s, p<.05). 
 
1.3.2.6 Limitations and risk of bias 
The lack of studies and the variation in scales prevented much comparison between studies, so 
no meta-analysis was performed. PRISMA119 note that studies with nonsignificant results are 
published less often. As such it is possible that these results are exaggerated towards a 
difference by age, although based on the number of non-significant results this appears 
unlikely. Similarly, no power calculations were given and so non-significant findings may be 
over-reported in the smaller studies. 
Papers published from 2001 onwards were included where the data collection date was 
unclear to ensure that no studies occurring this century were likely to be excluded. However, 
papers published as late as 2007 were excluded due to data collection ending before the turn 
of the century. As such I cannot be sure that all these studies occurred within the 21st century.  
48 
 
The majority (66%) of studies compared older PWH to younger PWH rather than to HIV-
negative adults, meaning that any differences found in psychosocial well-being or behaviour 
are likely to be due to age rather than HIV status.  
America was the country of origin for 55% of studies, meaning that the majority of the data is 
from one geographic location. The likelihood of the US results applying to other populations is 
uncertain. UK data was apparent in only one study, showing comparable HrQoL in older and 
younger PWH137. Despite this concurring with US data it is unclear whether this reveals 
comparability in population data, due to the small number of studies and undocumented 
differences in demographics and sociocultural background. Furthermore, the lack of repeat 
studies within a UK population means that this information should only be used to direct 
future UK research.  
 
1.4 Discussion 
Of 390 papers reviewed, 38 (<10%) studies met the inclusion criteria. A large number (N=71) of 
papers on older PWH did not compare them to a control group, meaning that it was impossible 
to assess the effects of age, HIV-status, or other factors and they were removed from the 
review.  
Of the studies included, the majority found no difference with age in CD4 count response to 
ART64;77-79;126;128;132, but an increase in mortality rates64;107;124;126;127;136, and higher rates of co-
morbidities and prescribed medications with age and HIV status. Age differences in viral load 
response to ART were less conclusive. It appears likely that older PWH do achieve a 
comparable level of response to ART to younger adults; albeit at a slower rate. It also seems 
likely that the increased mortality rates with age are related to the increased number of co-
morbidities found in older adults. However, it would be remiss to conclude with certainty that 
the increased mortality and physical illness is solely due to increased age as several studies 
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reported an increase in illness in relation to age-matched HIV-negative controls as well as 
younger PWH. Therefore it is possible that an accumulation of HIV- and age-related physical 
insults likely interact to increase the likelihood of illness and mortality in older PWH. It is also 
worth noting that no studies reported the levels of distress physical illness caused, so it is 
unclear how much of an impact physical symptoms may have on the wellbeing of older and 
younger PWH. 
Overall, no difference was found by age in rates of depression64;120;129;138;145-148 or 
HrQoL123;137;146, but there were too few studies on anxiety to form a conclusion and it is worth 
noting that, with the exception of depression, differences in the results were apparent. It 
appears likely that older PWH are not more at risk of depression than younger PWH, although 
three studies (30%) did find an increase with age. As such, I feel that it is important to note 
that, while alternative explanations for the results of these studies were found, their 
methodology was as reliable as that of the seven other depression studies and they should not 
be excluded from consideration. Similarly, I have claimed that 'overall' no difference in HrQoL 
was found with age, despite the fact that two of five papers (40%) reported worse HrQoL in 
older PWH than younger PWH. I can only suggest the likelihood of age-related differences 
based on the available data but it is possible that, should more information become available, 
older PWH may appear to have worse, or comparative, QoL. Therefore I would strongly 
suggest against ruling HrQoL (and to a far lesser extent depression) out of further research into 
the effects of age on wellbeing in adults with HIV.  
Social isolation135;140;150 and stigma134;150;151 generally showed no difference by age, although 
few studies explored these factors. Similarly, very little focus was given to the potential 
positive effects of ageing, or factors which protect against the negative effects discussed so 
far. Such positive effects could include resilience and hardiness which are thought to be 
related to 'successful ageing'; the ability to maintain mental health despite age-related health 
losses152. A relatively small study (N=83) by Moore et al.140 found that people with HIV 
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reported lower self-rated successful ageing, resilience, happiness and feelings towards ageing 
along with higher rates of depression, anxiety and stress compared to HIV-negative adults40. 
This suggests that HIV has a negative effect on ageing and the ability to age 'successfully'. 
However, no similar studies were identified and so the results are not conclusive. Based on the 
identified contrasts in physical and mental health reported, 'successful ageing' appears 
possible in an HIV positive population and warrants further study. 
Disclosure was lower in older PWH93, as was knowledge of HIV transmission153 although the 
lack of studies in these areas makes the results unclear. As disclosure is related to transmission 
risk and likelihood of accessing informal care this seems to be an important factor to expand 
upon further both in relation to assessing wellbeing and risk in relation to age.  
In conclusion, this systematic review identified the small amount of research available on the 
association of age with biopsychosocial wellbeing of PWH, in particular in relation to UK data. 
Clearly, any result which could increase the size of the pool of knowledge would be beneficial 
but in particular anxiety, positive psychology and HrQoL require further investigation, as do 
disclosure rates and social support. CD4 count appears to be well-researched and, promisingly, 
shows little difference by age in PWH regularly taking cART medication. However, mortality 
and comorbidity rates still increased with age. As such, CD4 count appears not to be an 
encompassing measure of physical well-being, especially in populations where high adherence 
is common. Furthermore, no studies reported data on the distress caused by ill physical health, 
meaning that it is unclear whether HIV affects the well-being of older and younger adults in 
the same way. As described in chapter 1, section 1.2.2 and 1.2.3, this thesis will explore 
possible differences between older and younger PWH in the UK in relation to physical, mental, 
and social health in detail to improve the overall knowledge in this area. 
  
51 
 
2 The ASTRA study - Methodology 
The ASTRA study is a multi-centre cross-sectional questionnaire study which was designed to 
assess sexual risk behaviours, beliefs about HIV transmission risk, and attitudes to use of early 
antiretroviral treatment in PWH in the UK. The methods of the study have been described in a 
published report118 but are presented here with particular focus on aspects relevant to this 
thesis. 
ASTRA recruited 3,258 HIV-diagnosed individuals from eight HIV out-participant clinics in the 
UK between February 2011 and December 2012. The clinics included were: Royal Sussex 
County Hospital, Brighton, Eastbourne Sexual Health Clinic, Homerton University Hospital, 
London, Mortimer Market Clinic, London, Newham University Hospital, London, North 
Manchester General Hospital, Royal Free Hospital, London and Whipps Cross University 
Hospital, London. The sample size was based on a calculation (80% power, 5% two-sided 
significance level) powered to detect the 4% expected difference in the prevalence of high risk 
sexual behaviour between patients on ART and not on ART. 
All clinic participants were eligible assuming that they fulfilled the following inclusion criteria: 
participants must be a) over 18 years of age, b) have sufficient English or French to be able to 
understand the questionnaire (which was available in both languages) and c) not be too ill or 
distressed to participate, as indicated by clinic staff. During the study period, 5,112 eligible 
participants were invited to take part in the study of which 3,258 completed the questionnaire, 
a response rate of 64%.  
Participants completed the self-administered pen-and-paper questionnaire on a range of 
demographic, health, and lifestyle issues. They were encouraged to complete the 
questionnaire at the clinic, but pre-paid envelopes were provided for participants who wanted 
to take the questionnaire away to complete118. In addition, the clinic-recorded viral load and 
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CD4 count (latest value at the time of the questionnaire that had been communicated to the 
participant) were documented for all participants. 
 
2.1 Ethical considerations 
NHS Ethical approval was obtained for this study (REC reference number: 10/H0720/70).  
Patients who were invited to participate were given an information sheet about the study and 
were asked to sign a consent form. The information sheet recognised that the questionnaire 
included personal questions on sexual lifestyle and suggested that if the questionnaire raised 
any issues or concerns for the participant they could ask the nurse to arrange a meeting with 
an appropriate professional, for example the clinic HIV counsellor. It also specified that 
participants were free to withdraw consent for the study at any time, including after 
completing the questionnaire, and that this would not affect their standard of care. A second, 
optional, consent form was also given to participants to request linkage of their questionnaire 
responses with routine clinic data. 
Private areas in the clinic were made available for completion of questionnaires, if preferred 
by participants. The questionnaires themselves contained a study number and no identifying 
personal information. Participants were able to place their completed paper questionnaires in 
a sealed envelope in a box in the clinic and were informed that their questionnaire responses 
would not be seen by clinical staff or recorded in their clinical notes. All information was 
treated as confidential and the study database was held securely in the research department 
(HIV Biostatistics and Epidemiology Group, Research Department of Infection and Public 
Health, Royal Free Campus) on encrypted PC and laptop drives. Paper forms (including 
questionaires and copies of the study log) were stored in locked cabinets within the 
department.  
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2.2 Symptom measures   
The primary aim of this research was to explore age-related differences in physical, mental, 
and social health. As such, the participants were grouped according to their age into: <30, 30-
39, 40-49, 50-59 or ≥60 years of age. Age groups were used to allow the exploration of non-
linear age differences. However, age as a continuous variable was also used in some analyses. 
Time with diagnosed HIV was defined based on self-reported month and year of HIV diagnosis 
and categorised as follows: <2 years diagnosed with HIV, 2-5 years, 5-10 years, 10-20 years and 
>20 years. The associations of these age and time-related groups with measures of 
biopsychosocial symptom prevalence were then assessed.  
The relationships between physical, psychological, and social symptom measures were also 
calculated. This was done overall and by age- and 'time diagnosed with HIV'- interactions to 
identify any age or 'ageing'-related changes in relationship strength. 
In relation to the analysis included here, these symptom measures can be divided into physical 
ability and symptoms measures, mental distress, and social factors. These were used to 
identify biopsychosocial factors which may be in need of intervention in the UK HIV-positive 
population, as well as age-related differences in these factors. The symptom measures 
included are listed below, and in their associated chapters (Chapters 3-5). 
 
2.2.1 Physical ability and symptom measures 
In relation to physical ability and symptom measures, age- and time-related differences in 
symptom prevalence, symptom-related distress and difficulty with activities of daily living 
(ADLs) were explored. For the purpose of logistic regression analysis these were categorised as 
binary variables. 
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2.2.1.1 Physical symptoms 
Symptom prevalence was assessed using a modified version of the MSAF-SF154, a 32 item, 5-
point Likert scale. This scale asks participants to report whether or not they have had any of 
the 32 symptoms in the past two weeks and, if so, whether it caused them distress. Response 
options were: 'No did not have symptom', 'Yes, had symptom but it did not bother me', 'Yes, 
had symptom and was bothered/distressed a little bit', 'Yes, had symptom and was 
bothered/distressed quite a bit' or 'Yes, had symptom and was bothered/distresses very 
much'. For the purpose of this analysis, the "psychologic symptom subscale" was removed: 
four questions on 'feeling sad', 'worrying', 'feeling irritable' and 'feeling nervous'. This was due 
inclusion of other 'psychological symptom distress' inventories and concern about overlap 
between the scales. The symptoms 'I don't look like myself', 'changes in skin', 'problems with 
urination', 'itching', 'difficulty swallowing', 'hair loss', and 'swelling of arms/legs' were also 
removed and replaced with the more HIV-specific symptoms: 'Trouble remembering things', 
'Headache', 'Muscle aches or joint pains', 'Skin problems (e.g. rash, itching, dryness)', and 
'Changes in fat in face or body'. This resulted in 26 symptoms which are listed in Table 5, 
chapter 3, section 3.3.2. Several symptom subgroups were also considered (Table 5), where 
symptoms of similar prevalence and type were combined. Symptom prevalence was then 
indicated by participants reporting 'yes' to the presence of an individual symptom in the past 
two weeks. This was explored in relation to the number of symptoms present and the 
presence of specific symptoms of interest (identified through high prevalence or distress 
scores). An overall symptom prevalence measure was also created of participants identifying 
ten or more symptoms as being present. Where symptoms were grouped into specific sub-
categories, the group was analysed as 'present' if participants reported at least one of the 
symptoms in that category.  
Symptom distress was analysed using the same modified scale. A symptom was considered 
distressing if participants reporting that the symptom 'bothered/distressed quite a bit' or 'very 
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much'. Identical to symptom prevalence, 'overall symptom distress' was also developed as a 
variable, wherein participants reported at least one symptom as distressing, symptom distress 
for sub-categories of symptoms, and number of distressing symptoms. While a low cut-off 
point, the presence of one symptom was chosen to indicate ‘overall distress’ as experiencing 
even one symptom as 'quite a bit' or 'very much' distressing was considered to have a 
significant impact on participant well-being. 
 
2.2.1.2 Difficulties with activities of daily living (ADLs) 
Finally, difficulty with ADLs were identified using the EQ-5D155, a five-item, three-point Likert 
scale. This scale asks participants to report their 'status of health today' in relation to Mobility, 
Self-care, 'Usual activities (e.g. work, study, housework, family or leisure activities)', 
Pain/discomfort and Anxiety/depression. Participants could report 1) no problems, 2) some 
problems or 3) being unable to perform each activity. For the purpose of this analysis the last 
two questions were discarded, as they overlapped with other measures, and difficulty with 
ADLs was assessed through the problems with mobility, self-care of usual activities. The three 
ADL domains were divided into participants having no problems compared to those showing 
some problems or being unable to perform each activity. This was assessed by individual 
domain and as an overall measure, where participants were classified as having ADL problems 
if reported issues with at least one of the three activities. 
 
2.2.2 Psychological distress 
Psychological distress was explored using questionnaire-assessed measures of depression and 
anxiety. Specifically, depression and anxiety were measured according to self-reported 
symptoms, using the PHQ-9156 and GAD-7 scales157. Both of these scales are validated 
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diagnostic instruments for measuring the prevalence and severity of mental health issues and 
based on the DSM-IV criteria for depression156 and generalised anxiety disorder (GAD)157.  
For both scales participants were asked to respond to the question "Over the past 2 weeks, 
how often have you been bothered by any of the following problems?". Participants could 
respond with 'not at all', 'several days', 'more than half the days' or 'nearly every day' to each 
of the symptoms. These responses were scored from 0-3 respectively and summated to create 
a score which can be used to measure the participant's diagnostic group for depression and 
GAD. Specifically, in the PHQ-9, there is a potential maximum total score of 27 (9 items). A 
score if 0-4 is indicative of no depression, 5-9 of mild depression, 10-14 of moderate 
depression, 15-19 of moderately severe depression and 20-27 of severe depression. In the 
GAD-7, there is a potential maximum score of 21 (7 items): a score of 0-4 is indicative of a no 
GAD, 5-9 of mild GAD, 10-14 of moderate GAD and 15-21 of severe GAD. 
For the purpose of this analysis the standard score-based definitions of depression and anxiety 
was used, defined by a score ≥10 in each case. In addition, for individual symptoms, those 
reporting the symptom for 'more than half the days' or 'nearly every day' were compared to 
those reporting the symptom 'not at all' or for 'several days' in the past two weeks. These 
comparisons were used to allow us to identify participants in significant distress, in comparison 
to those showing no - or mild - distress. This method was considered to be more clinically 
useful  than the use of continuous scales. 
 
2.2.3 Social factors 
Finally, the social factors explored involved measures of social support, relationship status, 
partner's HIV status, disclosure of HIV status, and employment and financial status. 
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2.2.3.1 Social support 
Social support was quantified using the modified Duke–UNC FSSQ scale158, a five point Likert 
scale including five measures of social support. Participants were asked to report the level of 
support closest to their own situation, from 'as much as I would like' to 'much less than I would 
like' in response to: 'I have people who care what happens to me', 'I get love and affection', 'I 
get chances to talk to someone I trust about my personal problems', 'I get invitations to go out 
and do things with other people', and 'I get help when I am sick in bed'. For the purpose of this 
analysis social support was classified as 'sufficient' if participants scored ≥20 on the scale, 
which correlated with average responses of 'almost as much as I would like' on all five 
measures or 'as much as I would like' on four measures. Scores under 20 (correlating with 
responses of 'some, but I would like more', 'less than I would like' or 'much less than I would 
like' on all five measures) were classified as 'insufficient' social support. Answers to each 
individual social support question was also assessed, where social support was considered to 
be present if participants reported having 'almost as much as I would like' or 'as much as I 
would like' in response to the individual question. 
 
2.2.3.2 Relationship status and disclosure of HIV status 
Relationship status was divided into those in an on-going relationship (living, or not living with 
partner) or not as assessed by the question "Are you currently in an ongoing relationship with 
a partner (wife/husband or civil partner or girlfriend/boyfriend)?". Length of relationship was 
divided into ≥10 years or less than ten years and partner's HIV status was analysed as 'HIV 
positive/HIV-negative or unknown. Participants were also asked to report whether or not they 
had children, which was categorised as 'yes' or 'no'. 
Disclosure was assessed as a combined measure, defined as responding 'yes' or 'no' to the 
question "Apart from health care staff, have you told anyone that you have HIV?", and 
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additionally by self-report of disclosing HIV status to 'some' or 'most or all' of each individual 
social group (partner, family, friends, and colleagues).  
 
2.2.3.3 Employment status 
Finally, employment status was categorised as 'employed', 'unemployed', 'sick/disabled', or 
'retired'. 'Money for basic needs' was assessed as a binary variable based on the question "Do 
you have enough money to cover your basic needs? (e.g. food, heating)". This was categorised 
as ‘always having money for basic needs' or not.  
 
2.2.4 Demographic variables 
Demographic variables were based on self-report. Participants were asked their date of birth 
(month, year) and when they first found out that they were HIV positive (month, year), which 
was used to calculate time diagnosed with HIV. They were asked to identify the ethnic group 
that best described them from a standardised list and whether they were both in the UK 
(yes/no). Participants were also asked to identify any religion that they belonged to, their work 
status (employed full/part-time, in education, unemployed registered/not registered for 
benefits, sick disabled for ≥3 months, sick/disabled for <3 months, look after 
home/family/dependents, retired or other) and their housing status (own, renting from 
council/housing association, renting from private landlord, temporary accommodation, staying 
with partner/friend/family, homeless or 'other'), their highest level of education (no 
qualifications, O levels/GCSEs, A levels or equivalent, university degree or higher or other) and 
whether they had enough money to cover their basic needs (all of the time, most of the time, 
some of the time or never). 
Gender was identified at participant recruitment and participants were given a gender-specific 
booklet. Within the booklet they were asked to describe their sexuality as 'gay/homosexual', 
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'straight/heterosexual', 'bisexual', or 'other'. Using this data the participants were divided into 
women, heterosexual men, and men who have sex with men (MSM: homosexual or bisexual 
men). 
 
2.2.5 Health and lifestyle factors 
Participants were asked whether they were currently on ART, which was corroborated using 
clinic data where permission was given. Participants were also asked their most likely form of 
HIV acquisition from sex with a man, sex with a woman, shared needles, blood transfusion, 
needle stick or exposure at work, born with HIV infection, unknown, or other. CD4 count and 
viral load were measured via clinic recorded values at the most recent test. For the purpose of 
the analysis participants reporting a CD4 count of above or below 350 cells/mm3, and a viral 
load above or below 50 copies/mL were compared.  
In relation to lifestyle factors, participants self-reported whether they were current, ex, or 
never-smokers, whether they had used recreational drugs in the past three months (and which 
drugs they had used), and completed the CAGE questionnaire159 on alcohol dependency. 
  
2.2.6 Missing data 
Missing values for individual questions on symptom questionnaires were counted as the 
absence of symptoms. For example, a participant who skipped answering the PHQ-9 would be 
categorised as having a PHQ-9 score of zero and not having depression. Results mentioned 
here can be treated as minimal estimates of symptom prevalence.  
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2.3 Statistical analysis  
In this section the main analyses methods used in the subsequent three results chapters of the 
thesis are described. Additional analyses specific to individual chapters are described in the 
relevant chapter. Categorical variables are summarised by proportions; continuous variables 
are summarised by means and standard deviations. Differences in participant characteristics 
by age group were assessed using chi-squared tests for trend. The prevalence of demographic 
variables was calculated overall and according to age group and time diagnosed with HIV 
group.  
Logistic regression was used to assess the association between age group, time with diagnosed 
HIV, and each of the well-being measures (dependent variables) used in the following 
chapters. These calculations were adjusted for demographic factors, where the causal 
direction of association was clear. Namely, they were adjusted for gender/sexuality (MSM; 
heterosexual man; woman) and ethnicity (white/non-white). Results are presented as adjusted 
odds ratios with 95% confidence intervals (CIs). Significance was assessed using the likelihood 
ratio statistic. Tests for trend in age and time with diagnosed HIV were assessed using the 
respective variables as ordinal variables in the model, rather than defining them as categorical.  
The associations between physical, mental, and social factors of well-being were also assessed 
using chi squares tests for trend and logistic regression analysis, adjusted for gender/sexuality 
(MSM; heterosexual man; woman) and ethnicity (white/non-white). Interaction tests were 
used to assess whether the associations between mental (depression and anxiety), physical 
(symptom prevalence, distress, problems with ADLs) and social (social support, partner and 
parental status, disclosure, employment, money for basic needs) differed according to a) age 
group and b) time with diagnosed HIV group as a grouped variables in a continuous form 
(Chapters 4 and 5). 
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2.4  Subject characteristics 
2.4.1 Geographic distributions 
Most participants were recruited from Mortimer Market Clinic (N=907, 27.8%), the Royal Free 
(N=899, 27.6%) and Brighton (N=523, 16.1%) clinics. Of the rest, 355 (10.9%) were recruited 
from North Manchester, 269 (8.3%) from Homerton, 179 (5.5%) from Newham, 65 (2.0%) from 
Whipps Cross and 61 (1.9%) from Eastbourne clinics.  
 
2.4.2 Demographic variables 
The mean age was 45 years (SD=9.6, range 18-88 years). By age, 173 (5.4%) participants were 
aged <30 years, 740 (23.3%) were aged 30-40, 1364 (42.9%) were aged 40-50, 686 (21.6%) 
were aged 50-60 and 215 (6.8%) were aged 60 and over years. By time diagnosed with HIV, 
410 (12.6%) participants had been diagnosed with HIV for 0-2 years, 498 (15.3%) for 2-5 years, 
878 (26.9%) for 5-10 years, 1130 (34.7%) for 10-20 years and 342 (10.5%) for more than 20 
years. 
The majority (N=2248, 69.0%) of participants were MSM, 373 (11.4%) were heterosexual men 
and 637 (19.6%) were women. 1751 (53.7%) were born in the UK. For the non-UK born 
participants, 614 (18.8%) were black African, 99 (3.0%) were black Caribbean, 26 (0.8%) were 
black other, 160 (4.9%) were Indian/Pakistani/Bangladeshi/Asian other, 133 (4.1%) were of 
mixed race, 13 (0.4%) were Chinese and 29 (0.9%) were 'other' ethnicity. Overall, 2310 (70.9%) 
were British citizens, 402 (12.3%) were EU citizens, 294 (9.0%) had 'indefinite leave to remain' 
in the UK, 72 (2.2%) had 'exceptional leave to remain' in the UK, 40 (1.2%) were refugees, 20 
(0.6%) had a UK student visa, 18 (0.6%) a work permit, 20 (0.6%) had no immigration papers to 
be in the UK and 29 (0.9%) reported 'other' immigration status. 
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The participants mainly reported having no religion (N=1418, 43.5%) or Christianity (N=1527, 
46.9%), but 85 (2.6%) were Islamic/Muslim, 67 (2.1%) were Buddhist, 36 (1.1%) were Jewish, 
12 (0.4%) Hindu, 1 was Sikh and 84 (2.6%) reported 'other' religion. 
371 (11.4%) of the sample had no academic qualifications, 716 (22.0%) had GCSE/O-levels, 632 
(19.4%) had A level qualifications, 1317 (40.4%) had university level or above qualifications and 
136 (4.2%) had ‘other’. 1821 (55.9%) were employed, 577 (17.7%) unemployed, 420 (12.9%) 
were not working due to sickness/disability, 192 (5.9%) were retired and 164 (5.0%)reported 
'other' work status. 1083 (33.2%) owned their home, 971 (29.8%) rented council or housing 
association houses, 786 (24.1%) rented from private landlords, 248 (7.6%) were staying with 
family/partner/friends, 59 (1.8%) were in temporary accommodation and 35 (1.1%) were 
homeless. 1392 (43.6%) of participants always had money for basic needs, 836 (26.2%) mostly 
had money for basic needs, 565 (17.7%) 'sometimes' had money and 400 (12.5%) never had 
enough money for basic needs (e.g. food, heating). 
 
2.4.3 HIV, health and lifestyle-related factors 
The majority of participants were currently on ART (N=2771, 86.5%), had a CD4 count of 500 
cells/mm3 or above (N=1836, 57.1%) and an 'undetectable' viral load (lower than 50 
copies/mL; N=2439, 75.9%). Of those who had never taken antiretroviral treatment, 406 
(55.2%) had been advised to start by their HIV doctor. Sex with a man was the most likely form 
of HIV acquisition (N=2517, 77.3%), followed by 233 participants who reported transmission 
route as 'having sex with a woman' (7.2%), 67 from blood products (2.1%), 60 from IVDU 
(1.8%), 26 from occupational needle stick (0.8%), four from vertical transmission (0.1%) and 
310 (9.5%) from unknown causes. 
In regards to risk factors, 1011 (31.5%) participants were current smokers, 938 (29.2%) were 
ex-smokers and 1264 (39.3%) had never smoked. Evidence of alcohol dependency was 
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apparent in 571 (17.7%) participants (based on CAGE questionnaire159 scores) and 1242 
(38.1%) reported recreational drug use in the past three months. Of these, 607(18.6%) 
reported using amyl nitrate, 549(16.9%) used cannabis, 475(14.6%) used cocaine, 459(14.1%) 
used Viagra, 280 (8.6%) used Ketamine, 263(8.1%) ecstasy, 220(6.8%) liquid ecstasy, 175(5.4%) 
Meth-amphetamines, 163 (5%) Mephedrone, 80(2.5%) Amphetamine, 61(1.9%) Anabolic 
steroids, 44(1.4%) Acid/LSD/magic mushrooms, 45(1.4%) Codeine, 27(0.8%) crack, 17(0.5%) 
heroin, 14 (0.4%) khat, 10 (0.3%) morphine, 5(0.2%) opium and 38(1.2%) other drugs. 
Intravenous drug use was reported by 74 (2.3%) participants. 
 
2.4.4 Age-related demographic differences 
Using chi-squared, demographic differences by age group were assessed. In terms of ethnicity, 
the proportion of participants who were Caucasian increased with age (58.4% of under 30s to 
77.2% of participants aged 60 and over), as did the proportion born in the UK (50.9% to 64.7% 
respectively). In terms of gender/sexuality,  the proportion of participants who were MSM and 
the proportion who were heterosexual men increased with age (63.6 to 71.6% from <30 to 60 
or over for MSM and 5.2-17.2% respectively for heterosexual men), while the proportion of 
women decreased with older age (31.2-11.2%). The proportion of participants who identified 
as Christian also increased with age (44.5 - 52.6%). 
Levels of education were highest in the 30-40s age group and lowest in the >60s (15.6% vs. 
23.3% respectively with no qualifications). Employment was highest in the 30-40s age group, 
while the proportion who were unemployment stayed relatively stable from age <30 to 50-60 
(17.4 to 20.8%). Being unable to work due to sickness/disability increased with age between 
the same ages (5.2% to 20.1%) and retirement was highest in those ≥60. Participants aged ≥60 
also reported lower levels of employment, unemployment and sickness/disability than those 
aged 50-60. Being a homeowner increased with age (7.5 to 57.7%) and odds of renting or 
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being in temporary accommodation decreased (48.6 to 8.8% and 25.4% to 9.1% respectively). 
Non-private rented housing status was highest in those aged 40-50 (35.7%) and homelessness 
stayed low across all age groups (0.7 to 1.8%). Always having money for basic needs increased 
with age (30.8 to 55.2%). 
The percentage of participants on ART increased with age (from 61.2% of those aged <30 to 
98.8% of those aged 60 and over) and, of those not on ART, those who had been advised to 
start by their doctor decreased (16.2 - 8.8%). Adherence (participants reporting ≥95% 
adherence to ART) rates among participants who were on ART were high across participants, 
but increased with age (83.8 - 91.8%). There was no overall difference in CD4 count with age – 
CD4 count stayed relatively stable at a rate of 75.9-83.0%. However, the odds of having an 
undetectable viral load increased with age, from a rate of 48.8% of participants aged <30 years 
to 88.7% of those aged 60 and over.  
Being a current smoker decreased with age (29.1 - 18.7%), as did being a non-smoker (45.0 - 
37.4%) while being an ex-smoker increased (16.0 - 43.9%). Evidence of alcohol dependence 
according to CAGE questionnaire was lowest in those aged 60 and over (11.7%) and highest in 
those aged 30-40 (19.8%) while recreational drug use and IVDU decreased with age (46.2 - 
21.9% and 5.8 - 0.9% respectively). These differences are reported in table 3 below. 
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Table 3. The demographic and health-related risk factors of the ASTRA population by age (N 
& percentage of age group). 
Characteristic <30 years 30-40 40-50 50-60 >60 Overall  
Years since diagnosis 
0-2 
2-5 
5-10 
10-20 
20+ 
 
59 (34.1%) 
55 (31.8%) 
50 (28.9%) 
4 (2.3%) 
5 (2.9%) 
 
124 (16.8%) 
185 (25.0%) 
257 (34.7%) 
166 (22.4%) 
8 (1.1%) 
 
135 (9.9%) 
171 (12.5%) 
355 (26.0%) 
561 (41.1%) 
142 (10.4%) 
 
62 (9.0%) 
53 (7.7%) 
146 (21.3%) 
290 (42.3%) 
135 (19.7%) 
 
20 (9.3%) 
19 (8.8%) 
42 (19.5%) 
84 (39.1%) 
50 (23.3%) 
p<.0001 
Gender/Sexuality 
MSM 
Het. Male 
Female 
 
110 (63.6%) 
9 (5.2) 
54 (31.2%) 
 
502 (67.8%) 
64 (8.6%) 
174 (23.5%) 
 
946 (69.4%) 
164 (12.0%) 
254 (18.6%) 
 
509 (74.2%) 
86 (12.5%) 
91 (13.3%) 
 
154 (71.6%) 
37 (17.2%) 
24 (11.2%) 
p<.0001 
Religion 
None 
Christian 
Other 
 
76 (43.9%) 
77 (44.5%) 
20 (11.6%) 
 
342 (46.2%) 
327 (44.2%) 
71 (9.6%) 
 
617 (45.2%) 
629 (46.1%) 
118 (8.7%) 
 
311 (45.3%) 
328 (47.8%) 
47 (6.9%) 
 
80 (37.2%) 
113 (52.6%) 
22 (10.2%) 
p<.0001 
Ethnicity 
Born in the UK  
Caucasian 
Black African 
Black Other 
Other 
 
88 (50.9%) 
101 (58.4%) 
34 (19.7%) 
14 (8.1%) 
24 (13.8%) 
 
317 (42.8%) 
472 (63.8%) 
160 (21.6%) 
30 (4.1%) 
78 (10.5%) 
 
761 (55.8%) 
931 (68.3%) 
279 (20.5%) 
45 (3.3%) 
109 (7.9%) 
 
430 (62.7%) 
531 (77.4%) 
86 (12.5%) 
25 (3.6%) 
44 (6.5%) 
 
139 (64.7%) 
166 (77.2%) 
22 (10.2%) 
5 (2.3%) 
22 (10.3%) 
p<.0001 
Work status 
Employed 
Unemployed 
Sick/disabled 
Retired 
 
103 (59.5%) 
36 (20.8%) 
9 (5.2%) 
0 (0.0%) 
 
503 (68.0%) 
129 (17.4%) 
50 (6.8%) 
1 (0.1%) 
 
816 (59.8%) 
253 (18.5%) 
193 (14.1%) 
13 (1.0%) 
 
324 (47.2%) 
130 (19.0%) 
138 (20.1%) 
53 (7.7%) 
 
41 (19.1%) 
15 (7.0%) 
25 (11.6%) 
125 (58.1%) 
p<.0001 
Housing status  
Home owner 
Renting 
Temporary 
Non-private rented housing 
Homeless 
 
13 (7.5%) 
84 (48.6%) 
44 (25.4%) 
28 (16.2%) 
3 (1.7%) 
 
169 (22.8%) 
288 (28.9%) 
91 (12.3%) 
164 (22.2%) 
13 (1.8%) 
 
444 (32.6%) 
293 (21.5%) 
110 (8.1%) 
487 (35.7%) 
9 (0.7%) 
 
318 (46.4%) 
88 (12.8%) 
36 (5.2%) 
220 (32.1%) 
7 (1.0%) 
 
124 (57.7%) 
19 (8.8%) 
19 (9.1%) 
45 (20.9%) 
2 (0.9%) 
p<.0001 
Highest education 
level 
University or above 
A levels 
GCSE/O-level 
None 
 
 
61 (35.3%) 
44 (25.4%) 
32 (18.5%) 
27 (15.6%) 
 
 
329 (44.5%) 
149 (20.1%) 
144 (19.5%) 
61 (8.2%) 
 
 
553 (40.5%) 
254 (18.6%) 
351 (25.7%) 
129 (9.5%) 
 
 
276 (40.2%) 
129 (18.8%) 
141 (20.6%) 
98 (14.3%) 
 
 
73 (34.0%) 
40 (18.6%) 
36 (16.7%) 
50 (23.3%) 
p<.0001 
Money for basic 
needs 
Always 
Never 
 
 
146 (84.9%) 
26 (15.1%) 
 
 
634 (87.1%) 
94 (12.9%) 
 
 
1192 (88.4%) 
156 (11.6%) 
 
 
576 (85.7%) 
96 (14.3%) 
 
 
197 (93.8%) 
13 (6.2%) 
p<.0001 
p values by chi-squared test and chi-squared test for trend 
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Table 3 cont. The demographic and health-related risk factors of the ASTRA population by 
age (N & percentage of age group). 
Characteristic 0-2 years 2-5 years 5-10 years 
10-20 
years 
>20 years Overall  
ART status 
Currently on ART 
Advised to start ART 
 
104 (61.2%) 
28 (16.2%) 
 
565 (77.8%) 
108 (14.6%) 
 
1200 (89.0%) 
172 (12.6%) 
 
638 (94.7%) 
66 (9.6%) 
 
198 (98.8%) 
19 (8.8%) 
p<.0001 
CD4 count 
>350 cells/mm
3 
<350 cells/mm
3
  
 
129 (75.9%) 
41 (24.1%) 
 
591 (81.0%) 
139 (19.0%) 
 
1117 (83.0%) 
229 (17.0%) 
 
549 (80.6%) 
132 (19.4%) 
 
172 (80.8%) 
41 (19.2%) 
P=0.22 
Viral load 
Detectable (>50 copies/mL) 
Undetectable (<50 copies) 
 
87 (51.2%) 
83 (48.8%) 
 
253 (24.8%) 
474 (65.2%) 
 
297 (22.1%) 
1047 (77.9%) 
 
96 (14.1%) 
585 (85.9%) 
 
24 (11.3%) 
189 (88.7%) 
p<.0001 
Adherence ≥95% 
among those on ART 
88 (83.8%) 497 (87.8%) 1042 (87.1%) 580 (91.2%) 178 (91.8%) p=0.02 
Smoking status 
Current 
Ex-smoker 
Non-smoker 
 
66 (39.1%) 
27 (16.0%) 
76 (45.0%) 
 
257 (35.4%) 
173 (23.8%) 
296 (40.8%) 
 
435 (32.2%) 
400 (29.6%) 
516 (38.2%) 
 
197 (29.1%) 
232 (34.3%) 
248 (36.6%) 
 
40 (18.7%) 
94 (43.9%) 
80 (37.4%) 
p<.0001 
Alcohol dependence 27 (15.9%) 144 (19.8%) 262 (19.3%) 107 (15.8%) 25 (11.7%) p=0.02 
Recreational drug use  80 (46.2%) 330 (44.6%) 536 (39.3%) 232 (33.8%) 47 (21.9%) p<.0001 
IVDU  10 (5.8%) 18 (2.4%) 33 (2.4%) 10 (1.5%) 2 (0.9%) p=0.01 
p values by chi-squared test and chi-squared test for trend 
 
 
2.4.5 Time with diagnosed HIV-related demographic differences 
Demographic differences by time with diagnosed HIV were also assessed. Unsurprisingly, as 
age increased so did time with diagnosed HIV (p<.001). As shown in figure 5 below, adults 
under the age of 30 had primarily been diagnosed for less than ten years. Those aged 30-40 
had been diagnosed with HIV for primarily between 2-20 years, with relatively stable 
percentages across these time groups. Participants aged 40 and over all showed the same 
pattern of time diagnosed with HIV; an increase in the percentage of participants in each 
group, peaking at 10-20 years (39.1-42.3%).  
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Figure 5. Time with diagnosed HIV by age group. 
 
In terms of ethnicity, the proportion of White participants increased with time with diagnosed 
HIV (62.9% of participants diagnosed for 0-2 years vs. 82.5% diagnosed for over 20 years), as 
did the number of participants born in the UK (46.6 – 62.6%). In regards to gender/sexuality, 
MSM were more likely to have had HIV for a longer time (63.4% of participants diagnosed for 
0-2 years – 81.9% of participants diagnosed for >20 years) and heterosexual men and women 
were more likely to be new to HIV (15.6 – 6.1% and 21.0 – 12.0% respectively). The number of 
non-religious participants also increased with time with diagnosed HIV (41.2 – 51.5%). 
Levels of education were highest in participants diagnosed for 2-5 years (47.0% university 
educated) and lowest in those diagnosed for over 20 years (17.2% with no qualifications). The 
proportion of people who were employed was also highest in participants diagnosed for 2-5 
years (67.8%) and decreased with time with diagnosed HIV to 35.4% of people diagnosed for 
over 20 years. Unemployment stayed relatively stable across categories of time with diagnosed 
HIV (19.0 – 19.6%) but not working due to sick/disabled increased with time with diagnosed 
with HIV (6.3 – 26.3%) as did retirement (3.4 – 13.2%). Being a homeowner increased with 
time with diagnosed HIV (30.5 – 40.1%) and odds of renting decreased (33.9 – 11.1%). Non-
private rented housing status, however, was highest in those diagnosed for 10 or more years 
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(40.8 and 40.4%) and homelessness stayed low across all groups (0.3 – 0.6%). Always having 
money for basic needs increased with time with diagnosed HIV (85.4 – 90.4%). 
The percentage of participants on ART increased with time with diagnosed HIV (57.6 – 96.4%) 
and, of those not on ART, those who had been advised to start by their doctor decreased (15.4 
– 10.2%). However, adherence to ART decreased with time diagnosed with HIV (92.1 – 81.7%). 
%). CD4 count increased with increasing time with diagnosed HIV from 63.0% - 87.4%, up until 
>20 years, where it declined slightly to 81.8% prevalence. The odds of having an undetectable 
viral load also increased with time diagnosed with HIV, from a rate of 39.6% of participants 
diagnosed for less than two years to 85.6% of those diagnosed for twenty or more years.  
The prevalence of current smoking was highest in those diagnosed for over 20 years (37.1% 
current smokers) and lowest in those diagnosed for 10-20 years (35.6% current smokers), 
while prevalence of ex-smoking increased with time (24.8 – 36.5%). Evidence of alcohol 
dependence remained stable across time diagnosed with HIV categories (18.8 – 17.9%), as did 
recreational (39.8 – 37.4%) and intravenous (2.9 – 2.0%) drug use. These differences are 
reported in table 4 below. 
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Table 4. The demographic and health-related risk factors of the ASTRA population by time 
with diagnosed HIV (N & percentage of age group). 
Characteristic 0-2 years 2-5 years 5-10 years 10-20 years >20 years Overall  
Gender/Sexuality 
MSM 
Het. Male 
Female 
 
260 (63.4%) 
64 (15.6%) 
86 (21.0%) 
 
335 (67.3%) 
65 (13.1%) 
98 (19.7%) 
 
548 (62.4%) 
105 (12.0%) 
225 (25.6%) 
 
825 (73.0%) 
118 (10.4%) 
187 (16.5%) 
 
280 (81.9%) 
21 (6.1%) 
41 (12.0%) 
p<.0001 
Religion 
None 
Christian 
Other 
 
169 (41.2%) 
198 (48.2%) 
43 (10.5%) 
 
214 (43.0%) 
244 (49.0%) 
40 (8.0%) 
 
361 (41.1%) 
442 (50.3%) 
75 (8.5%) 
 
526 (46.5%) 
507 (44.9%) 
97 (8.6%) 
 
176 (51.5%) 
136 (39.8%) 
30 (8.8%) 
p=0.02 
Ethnicity 
Born in the UK  
Caucasian 
Black African 
Black Other 
Other 
 
191 (46.6%) 
258 (62.9%) 
89 (21.7%) 
21 (5.1%) 
36 (8.8%) 
 
217 (43.6%) 
319 (64.1%) 
103 (20.7%) 
22 (4.4%) 
47 (9.4%) 
 
422 (48.1%) 
544 (62.0%) 
219 (24.9%) 
38 (4.3%) 
54 (6.2%) 
 
611 (54.1%) 
817 (72.3%) 
181 (16.0%) 
34 (3.0%) 
71 (6.3%) 
 
214 (62.6%) 
282 (82.5%) 
22 (6.4%) 
10 (2.9%) 
18 (5.3%) 
p<.0001 
Work status 
Employed 
Unemployed 
Sick/disabled 
Retired 
 
264 (64.4%) 
78 (19.0%) 
26 (6.3%) 
14 (3.4%) 
 
338 (67.8%) 
84 (16.8%) 
23 (4.6%) 
18 (3.6%) 
 
521 (59.4%) 
152 (17.3%) 
80 (9.1%) 
33 (3.8%) 
 
577 (51.1%) 
196 (17.3%) 
197 (17.4%) 
82 (7.3%) 
 
121 (35.4%) 
67 (19.6%) 
90 (26.3%) 
45 (13.2%) 
p<.0001 
Housing status  
Home owner 
Renting 
Temporary 
Non-private rented housing 
Homeless 
 
125 (30.5%) 
139 (33.9%) 
11 (2.7%) 
72 (17.6%) 
9 (0.3%) 
 
157 (31.5%) 
187 (37.6%) 
11 (2.2%) 
78 (15.7%) 
6 (1.2%) 
 
262 (29.8%) 
244 (27.8%) 
30 (3.4%) 
222 (25.3%) 
11 (1.3%) 
 
402 (35.6%) 
178 (15.8%) 
5 (0.4%) 
461 (40.8%) 
7 (0.6%) 
 
137 (40.1%) 
38 (11.1%) 
2 (0.6%) 
138 (40.4%) 
2 (0.6%) 
p<.0001 
Highest education level 
University or above 
A levels 
GCSE/O-level 
None 
 
177 (43.2%) 
69 (16.8%) 
92 (22.4%) 
58 (14.1%) 
 
234 (47.0%) 
90 (18.1%) 
106 (21.3%) 
47 (9.4%) 
 
338 (38.5%) 
167 (19.0%) 
189 (21.5%) 
139 (15.8%) 
 
434 (38.4%) 
243 (21.5%) 
253 (22.4%) 
154 (13.7%) 
 
134 (39.2%) 
63 (18.4%) 
76 (22.2%) 
59 (17.2%) 
p=0.04 
Money for basic needs 
Always 
Never 
 
345 (85.4%) 
59 (14.6%) 
 
433 (87.8%) 
60 (12.2%) 
 
726 (84.7%) 
131 (15.3%) 
 
987 (89.3%) 
118 (10.7%) 
 
302 (90.4%) 
32 (9.6%) 
p<0.01 
p values by chi-squared tests and chi-squared test for trend 
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Table 4 cont. The demographic and health-related risk factors of the ASTRA population by 
time with diagnosed HIV (N & percentage of age group). 
Characteristic 0-2 years 2-5 years 5-10 years 
10-20 
years 
>20 years Overall  
ART status 
Currently on ART 
Advised to start ART 
 
230 (57.6%) 
63 (15.4%) 
 
380 (76.9%) 
57 (11.4%) 
 
778 (90.5%) 
114 (13.0%) 
 
1059 (95.1%) 
137 (12.1%) 
 
324 (96.4%) 
35 (10.2%) 
p<.0001 
CD4 count 
<350 cells/mm
3 
>350 cells/mm
3
  
 
150 (37.0%) 
255 (63.0%) 
 
107 (21.7%) 
385 (78.3%) 
 
139 (16.1%) 
726 (83.9%) 
 
140 (12.6%) 
975 (87.4%) 
 
62 (18.2%) 
279 (81.8%) 
p<.0001 
Viral load 
Detectable (>50 copies/mL) 
Undetectable (<50 copies) 
 
243 (60.4%) 
159 (39.6%) 
 
166 (33.8%) 
325 (66.2%) 
 
162 (18.7%) 
704 (81.3%) 
 
154 (13.8%) 
959 (86.2%) 
 
49 (14.4%) 
292 (85.6%) 
p<.0001 
Adherence ≥95% 
among those on ART 
210 (92.1%) 347 (91.1%) 707 (91.3%) 913 (86.3%) 264 (81.7%) p<.0001 
Smoking status 
Current 
Ex-smoker 
Non-smoker 
 
131 (32.8%) 
99 (24.8%) 
169 (42.4%) 
 
152 (30.6%) 
128 (25.8%) 
216 (43.5%) 
 
252 (29.3%) 
217 (25.2%) 
391 (45.5%) 
 
350 (31.3%) 
370 (33.1%) 
398 (35.6%) 
 
126 (37.1%) 
124 (36.5%) 
90 (26.5%) 
p<.0001 
Alcohol dependence 75 (18.8%) 93 (18.8%) 139 (16.1%) 203 (18.1%) 61 (17.9%) p=0.66 
Recreational drug use  163 (39.8%) 198 (39.8%) 308 (35.1%) 445 (39.4%) 128 (37.4%) p=0.26 
IVDU  12 (2.9%) 12 (2.4%) 18 (2.1%) 25 (2.2%) 7 (2.0%) p=0.89 
p values by chi-squared test and chi-squared test for trend 
 
 
2.5 Conclusions 
According to a Public Health England report, in 2011-12160 the HIV positive population were UK 
born (52%), on ART (84%), and lived in London, and one in five (22%) PWH were over the age 
of 50. These proportions match the sample identified here, suggesting that it is representative 
of the UK HIV positive population. However, a smaller proportion of the general PWH 
population were MSM (44%) than reported here (69%) and no data was available on the 
general population's average time diagnosed with HIV or health risk behaviours such as 
smoking, alcohol dependence and recreational drug use during this time. 
The ASTRA study population were predominantly white, UK-born, MSM, and well-educated. 
However, only 43.6% always had money for basic needs. Overall, 17.7% had evidence of 
alcohol dependency and 38.1% currently used recreational drugs. As such this population may 
be considered to be at risk of lifestyle factors affecting their biopsychosocial health. As in the 
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overall HIV population160, the vast majority of participants were currently on ART and had a 
CD4 count greater than 350 cells/mm3 and an undetectable viral load. Of those who had not 
started ART, over half had been advised to start by their HIV doctor. This suggests that a small 
percentage of participants have unresolved issues with HIV care, but that most have a well-
managed HIV infection. 
The mean age of the ASTRA population was 45 (+/- 9.6) years and most participants had been 
diagnosed with HIV for 5-10 years. This suggests that the population overall is ageing and with 
time an increasing proportion of people with diagnosed HIV will be aged 50 years of over. This 
stresses the requisite for research which identifies treatment needs for this future population 
of older adults with HIV. However, only a small percentage of adults in any age group reported 
having HIV for longer than 20 years, suggesting that mortality rates, at least before the year 
2000, prevent very long-term HIV infection. 
Older adults were more likely to be diagnosed for longer, on ART, MSM, retired, and home-
owners with money for basic needs than younger adults in the ASTRA study. Older adults were 
also less likely to report being disabled/permanently sick as their employment status. 
However, it is likely that this difference is simply due to an increase in retirement rates. They 
were less likely to report use of recreational drugs or evidence of alcohol dependency 
(although 21.9% still used drugs) and were mostly ex-smokers. As such, their physical and 
mental health may be less diminished by behavioural factors than that of younger PWH. This is 
worth noting as it may impact our ability to recognise age-related differences.  
However, the results also showed that CD4 count did not differ with age, and the odds of 
having an undetectable viral load increased. This ties in with the literature which suggests that 
good response to cART is possible regardless of age, when adherence to ART is high. As 
adherence to ART increased with age, it is possible that the better response to ART observed in 
older adults is related to higher levels of adherence161-163. As such, it appears that, thanks to 
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high medication adherence, immunological and virological responses are not concerns for 
OPWH. 
It is also worth noting that roughly 9% of those aged 50 years and over had been diagnosed for 
less than two years and 16.7% (aged 50-60) and 18.1% (aged over 60) had been diagnosed for 
less than five years, respectively. This suggests that some adults are also becoming infected 
with HIV at older ages and therefore that older adults are still at risk of HIV infection. 
Participants who had been diagnosed with HIV for longer were more likely to be MSM, not 
identify with a religion, Caucasian, born in the UK, not working due to sickness/disability, non-
private rented house or home-owners, educated to a low level, and always have money for 
basic needs. They were more likely to be on ART, but less likely to be adherent and more likely 
to be current/ex-smokers. No difference was found in relation to alcohol or drug use. Unlike 
older adults, therefore, participants who have been diagnosed with HIV for longer were likely 
to show physical health issues in relation to smoking behaviour, non-adherence and disability. 
In comparison to OPWH, participants diagnosed with HIV for longer were more likely to be 
employed or sick/disabled (rather than retired). They were less likely to own a home and more 
likely to live in council/housing association housing. They were less likely to be adherent to 
ART and more likely to be current smokers, show alcohol dependency, drug use and IVDU. As 
such, they are likely to show worse physical and mental health and may show more concerns 
over financial issues. 
 
2.5.1 Contributions 
The ASTRA project was designed and implemented by the ASTRA team (see appendix E) and 
the data was entered and cleaned externally. The analysis and discussion of results shown here 
and in the following three chapters are the work of the author as identified on the cover of the 
thesis. 
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The ASTRA results displayed over the subsequent two chapters have been published as an 
abstract164, an oral and poster presentation at HIV Drug Therapy Glasgow 2014 (Junior 
Scholarship) and as a full text paper165 (Appendix G).  
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3 Age, time with diagnosed HIV, and physical well-being 
3.1 Background 
Physical function - the ability to carry out activities requiring physical capability - is an 
indispensable aspect of everyday self-care and is essential for promoting autonomy and 
participation in social and physical activities54. It can be reduced by ill health, disability, and 
fatigue, which in turn are thought to increase in prevalence with age and chronic illness54. As 
such, loss of physical function is a significant threat to the well-being of older adults. 
The decline of physical health with age is well documented, but the reason behind 'physical 
ageing' is more complicated and likely involves a mix of genetic, socio-demographic, 
behavioural, and environmental factors166. The physical changes that occur with age in the 
general and HIV-specific populations are summarised below, including their relation to physical 
function and mobility. 
 
3.1.1 Health and Mortality 
As people age there is an increase in morbidity and mortality rates. Current research suggests 
that this is due to the combined effects of oxidative stress and mitochondrial dysfunction167-170 
with age. During the process through which mitochondria create useable energy, oxygen is 
bonded and released from molecules. An oxygen molecule with free electrons is highly 
reactive, and so excess oxygen is usually rapidly converted into water. However, it is also 
possible for oxygen to bind with an electron from the mitochondrial cell wall, proteins or DNA, 
causing damage to the mitochondrial cell structure171. This imbalance is known as oxidative 
stress171 and can be a cause of mitochondrial dysfunction169;170. Dysfunction of mitochondria, in 
turn, increases the risk of oxidative stress occurring by decreasing the efficacy of the energy-
converting process172. It also increases the risk of bonded molecules being released into the 
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surrounding cell; thus increasing the risk of cell damage170. Over time the damage caused by 
these processes accumulates and causes physical signs of ageing, as well as immune function 
decline (immunosenescence)25;52;53;127;173, and a loss of homeostasis8. This, in turn, results in 
fatigue69;76;174, a poorer response to pathogens52, and an accumulation of chronic and complex 
illnesses such as coronary heart disease (CHD), hypertension (high blood pressure), diabetes, 
arthritis and chronic obstructive pulmonary diseases (such as bronchitis and 
emphysema)54;69;173. For example, the Health and Retirement Study54 (N=23,186) - a 
longitudinal study performed between the years 1992-2010 in America - found that older 
adults (60 and over years of age) not only had more difficulties with activities of daily living and 
chronic illnesses than younger adults, but showed worse physical function with the 
accumulation of illnesses. However, they also found that when participants were free of 
chronic illness, age had no effect on physical function54. This suggests that it is possible to 
achieve good physical function at any age, should illness be avoided. Unfortunately for people 
with HIV, the burden on immune function may make illness increasingly likely with age. 
Mobility and physical activity also generally reduce with increasing age26;55;175. The Office of 
National Statistics reports that prevalence of disability, for example, was 16% in the general 
adult population in 2011/12, but was 45% among adults over retirement age176. ; This is 
primarily due to increases in fatigue69;76;174 and frailty177 - a syndrome encompassing a number 
of features (unintentional weight loss, exhaustion, weakness, slow walking speed, and low 
physical activity26;55;175) - with age. This reduction in physical activity, subsequently, increases 
the risk of CHD, hypertension, diabetes, and musculoskeletal and connective tissue diseases 
such as osteoporosis (brittle/fragile bones) and osteoarthritis69. Physical activity is further 
reduced in older adults due to social and psychological pressures. For example, many older 
adults report giving up group and gym memberships because they believed that they no longer 
possess the minimum levels of fitness required to participate50. Others report that they were 
afraid to move too far away from home or over-exert themselves in case illness hit69;76. An 
Australian focus group of older adults with and without chronic illness (N=99) further identified 
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‘community’, ‘maintaining independence’, and ‘the safety/flatness of nearby terrain’ as 
motivators for undertaking physical activity, while ‘health’ and the ‘family's attitudes to 
exercise’ were identified as barriers69. These reports highlight the importance of social and 
contextual factors in promoting older adult's physical health. 
Finally, self-rated health has been found to predict mortality in older adults166;178. One 
longitudinal study of 1,198 Danes aged 40 and over showed that poor self-rated health 
(assessed via Likert scale) was related to mortality at 10- 20- and 29-year follow-up, even when 
lifestyle, age, sex, and socioeconomic status were accounted for178. Another Australian 
Longitudinal Study of 12,422 women aged 70-75 in 1996 found that the strongest predictor of 
mortality by 2005 (according to a proportional hazards models) was 'poor' or 'fair' self-rated 
health, with 52.3% and 28.0% of women rating their health this way dying during this 
period166. 
 In summary, while high levels of physical function are possible in older adults, older age is 
known to be related to higher rates of morbidity and mortality and lower rates of physical 
activity. 
 
3.1.2 Physical factors related to ageing with HIV 
Due to increases in the efficacy of HIV treatment, the impact of HIV on risk of morbidity and 
mortality has been greatly reduced179. Physical health is by far the most researched area of 
well-being in OPWH and, on examination of the literature, 95 papers were found which 
focused on physical health in older adults with HIV published since 2000 (51 papers since 
2010). Of these, 60 defined older adults as PWH '50-years of age'. In relation to country, 45 
papers (47%) were conducted in America, 19 from Europe, eight from Africa, eight from Brazil, 
three from Canada, three from more than one country and one each from Australia, Mexico, 
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South America and Singapore. Five papers were from the UK, which will be discussed 
separately in section 3.1.3.  
The majority (n=57) of papers were quantitative studies, of which 20 included a control group 
and validated instruments and were included in the systematic review (section 1.3.2.2). The 
remaining papers included 22 summaries and opinion pieces, two mathematical models, 
eleven reviews, and three quantitative studies. No studies were identified relating to distress 
related to symptoms, although one did mention that the risk of physical limitations due to 
physical health problems increased with age122.  
In interviews, similar to adults ageing in the general population, PWH reported becoming more 
selective of their activities to conserve energy (N=49)76. However, they also reported concern 
about a) whether their health challenges were related to ageing or HIV, b) the length of time it 
took to recover from illness comparative to HIV negative older adults, and c) the future effects 
of cumulative illnesses76. In some cases, specific illnesses were identified such as diarrhoea - a 
commonly reported effect of HIV and HIV medication87. Participants (100 PWH aged over 50) 
reported feelings of being controlled by their diarrhoea - often limiting their social mobility to 
reduce embarrassment - and fear of what the symptom meant for their health, weight, and 
HIV progression87. This suggests that side effects of HIV and HIV-medication may put OPWH at 
greater risk of reduced physical activity than adults ageing in the general population. It also 
suggests that illness causes greater distress to older adults with HIV, as it is unclear to them 
whether symptoms are benign or signify a drop in their immune function, or even progression 
to AIDS. With the increase in morbidities with age in both populations, this indicates the strong 
possibility of worse well-being in OPWH compared to both young PWH and the general 
population. 
While contentious, there is a train of research that suggests that the effects of HIV are 
comparable to 'accelerated' ageing47;80;81;167. That is, that the decreased efficacy of the immune 
system caused by HIV infection accumulates cell damage in a similar, but faster, way to that 
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described in natural physical ageing50;80;180. Similarly, oxidative stress and mitochondrial 
dysfunction can have pathological origins, including though inflammation and the metabolism 
of drugs (such as anitretrovirals181;182). Therefore it is arguable that HIV and HIV medication 
may speed up the process of physical ageing. This is thought to have a bearing on the shorter 
life expectancy and increased symptom burden of adults facing the effects of ageing and HIV 
infection simultaneously81. For example, one study (N=66, California-based) found that PWH 
aged 39-58 had a similar immune function to HIV negative adults 17-28 years older, suggesting 
that, while immune function may decline naturally with age in general population, it may 
decline more rapidly in adults with HIV183. Importantly, these researchers reported that the 
effects of age and HIV on immune function were additive - with no interaction between the 
variables. This implies that PWH are at an increased risk of illness due to their age and HIV 
status independently. However, evidence for the direct impact of HIV (as oppose to relation 
conditions or behavioural factors) on the speed of cellular dysfunction is limited and 
inconsistent80;184;185. Therefore, I will focus on the accelerated 'signs' of ageing associated with 
HIV. That is, I will argue that HIV - and the associated medications and medical conditions - 
may be related to an accumulation of age-related physical insults while not necessarily 
affecting the cellular ageing process directly. 
Evidence in support of accelerated signs of ageing include studies showing that age-related 
health issues such as frailty55, bone mineral density109;142 and possibly hypertension and 
diabetes130;141 are more apparent in the HIV-positive population23;45;186. Immunosenescence is 
also similar in younger OPWH and older adults in the general population (N=486)26;81, while 
frailty187;188 and difficulties with activities of daily living (N=1,536)189 are apparent at a younger 
age in PWH81 and there is some evidence that coronary artery “age” (N=440, assessed by 
coronary artery calcium score) can be accelerated by an average of 15 years (range = 1-43 
years) in PWH190. As such it seems possible that HIV does accelerate signs of ageing, along with 
the associated reductions in physical health. However, lifestyle factors (smoking, alcoholic 
intake, recreational drug use) and co-infections (e.g. hepatitis C, cytomegalovirus) may also be 
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implicated as causes for the differences in health between adults with and without HIV. The 
extent to which the roles of these factors are specific to HIV-positive populations or play a part 
in other chronic illnesses is questionable. Belsky et al.191, for example, reported 'visible 
variations in biological ageing' and health in adults aged 38 in the general population, which 
then related to mortality over a twenty-year follow-up. 
Related to a decrease in physical health is a decrease in independence and ability to perform 
activities of daily living (ADLs) with age and HIV status. In one Canadian study, difficulty with 
ADLs were reported in 81% of PWH (N=3,600)192, while a UK study found - using the EuroQoL-
5D - that 28% of PWH reported difficulty with mobility, 19% reported difficulty with self-care, 
and 38% reported difficulty with usual activities; which increased in prevalence with age 
(N=800, mean age =40.4 years (SD = 8.6))193. Unfortunately the first study did not explore age 
differences and the second primarily involved adults under the age of 50 and so OPWH's ability 
to perform ADLs in comparison to younger age groups is not known. Based on the evidence, 
however, it can be suggested that ability to perform ADLs decreases with age in PWH, as it 
does in the general population. 
In brief, older PWH experience lowered immune function and mobility and increased rates of 
mortality, morbidity and medications. This is similar to age-related changes found in the 
general population, but may begin at a younger age or become more severe in prevalence. It is 
also conceivable that OPWH may experience greater levels of distress due to uncertainty over 
the meaning and source of illness which could greatly affect well-being. Despite this, their 
response to cART medication appears to be similar to younger adults, with no difference found 
in CD4 count by age in the systematic review (section 1.3.2.2) or in the ASTRA analysis (Chapter 
2). Information on self-rated health and health-related distress was not included in any 
studies. These therefore should be areas of exploration when researching the effects of 
physical function on the well-being of OPWH, especially in relation to the evidence of 
decreased health in this population. 
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3.1.3 UK-specific data on physical well-being in PWH 
Fewer studies were available on physical well-being in OPWH using UK-specific data, but since 
changes in health are often identified based on geographical region and this thesis relates 
specifically to health among people with HIV in the UK, I felt it necessary to summarise this 
data separately. The Irish Longitudinal Study on ageing compared the health, social, and 
economic circumstances of older adults (aged 50+, N=16,242) in Ireland, England, and the 
USA194. They found that chronic disease (hypertension, diabetes mellitus, myocardial 
infarction, all cancers excluding skin, and lung disease) was reported more commonly in the US 
than UK194. As such it is important to identify evidence from the same region as this study data. 
A cohort study of 1,536 PWH (1996-2010) from Brighton reported a higher mortality rate in 
PWH over the age of 50 compared to younger PWH40. In relation to mortality, the D:A:D 
study195 - an observational study of eleven HIV-positive cohorts (N≥20 000) from 188 clinics in 
20 countries - reported reductions in overall mortality in PWH in the UK between 1999 and 
2008, with AIDS-related deaths reducing the most. However, they also reported that deaths 
due to cardiovascular disease and non-AIDS malignancies remained stable195, suggesting that 
these are increasingly becoming the primary cause of mortality in the HIV positive population. 
While this did not explore age-related differences, it does identify the most likely causes of 
mortality in OPWH. Furthermore, an 'over 50' clinic set up in Chelsea and Westminster hospital 
in 2009 reported that PWH are at high risk of 'age-related' morbidities such as CVD and 
reduced bone mineral density196, suggesting that the risk of mortality is high in older adults.  
 
In summary, morbidity and mortality increased with age in the UK data, similar to the global 
literature. No information from UK studies was found on mobility, difficulty with ADLs, self-
rated health, or health-related distress. Moreover, only one paper from the UK was considered 
methodologically rigorous enough to be included in the systematic review and, as such, data 
comparing physical well-being by age is lacking in the population. However, we do 
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acknowledge that it is possible that age-related differences are mentioned in papers which do 
not refer to age in their title or abstract and, as such, were missed by the review.  
While UK-related data was not forthcoming, mortality and morbidity appear to be fairly 
established as high in prevalence in OPWH in comparison to both younger PWH and older 
people without HIV, suggesting that they are at greater risk of reduced well-being due to 
physical health. Immune function, difficulty with ADLs and self-rated health require further 
research and need to be assessed in order to identify potential hazards to well-being.  
 
3.1.3.1 Aims 
The aim of this chapter, therefore, is to assess (amongst the ASTRA population) the association 
of age with a) symptom prevalence, b) symptom distress, and c) difficulty with ADLs taking into 
account time since HIV diagnosis, gender/sexuality and ethnicity.  
 
3.2 Methods 
The methodology of the ASTRA study and an overview of the statistical methods used for this 
thesis have been described in Chapter 2 (section 2.2). In this section, analysis methods relevant 
to this chapter will be described in relation to the variables of interest. 
Participants completed a self-administered questionnaire including, in relation to this analysis, 
questions on: issues with mobility, self-care and usual activities and the prevalence of 
symptoms related to age and HIV and associated distress. These variables are reported in 
overall prevalence and in relation to age group, time with diagnosed HIV, and other key socio-
demographic characteristics (gender/sexuality and ethnicity).  
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3.2.1 Symptom measures  
Symptom prevalence was assessed using a modified version of the MSAF-SF154. This included 
26 symptoms, listed in table 5 (section 3.3.2). Several symptom subgroups were also 
considered (table 5). Symptom prevalence was indicated by participants reporting the 
presence of a specific symptom in the past two weeks. In addition, the number of symptoms 
present by age and the presence of specific symptom subgroups of interest (identified through 
high prevalence or distress scores) were assessed. An overall symptom prevalence measure 
was also created of participants identifying ten or more symptoms as being present. Where 
symptoms were grouped, the group was analysed as 'present' if participants reported at least 
one of the symptoms in that category.  
Symptom distress was analysed using the same modified scale. A symptom was considered 
distressing if participants reporting that the symptom 'bothered/distressed quite a bit' or 'very 
much'. The number of distressing symptoms, grouped symptoms, and 'overall symptom 
distress'; where participants reported at least one symptom as distressing, were also assessed.  
Finally, difficulty with ADLs was identified using three domains from the EQ-5D155 on mobility, 
self-care and 'usual activities (e.g. work, study, housework, family or leisure activities)'. 
Responses were categorised as having no problems compared to some problems or being 
unable to perform each activity. This was assessed by individual domain and as an overall 
measure, where participants were classified as having difficulties with ADLs if reported issues 
with at least one of the three activities. 
 
3.2.2 Statistical analysis  
Age in years was grouped into the following categories: <30, 30-39, 40-49, 50-59, and ≥60 
years. Differences in participant characteristics by age were assessed by comparing means for 
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continuous variables, and chi squared tests and chi-squared tests for trend for categorical 
variables. 
Symptom prevalence, symptom distress, and difficulty with ADLs were calculated as overall 
prevalence and in association with age group and time with diagnosed HIV group, using chi 
squared test for trend. Logistic regression was used to assess the association between age 
group and each of the measures (dependent variables), adjusting for gender/sexuality (MSM, 
heterosexual man, woman), ethnicity (White, other), and time since diagnosis of HIV (<2 years, 
2-5 years, 5-10 years, 10-20 years, >20 years). Age was fitted as a categorical variable in the 
models, with age>=60 years used as the reference category. In additional models, age was 
fitted as an ordinal variable with values 1 to 5, rather than defined as categorical and tests for 
linear trend across age groups were performed. Results are presented as odds ratios with 95% 
confidence intervals.  
Where significant differences in symptom prevalence were found in relation to age or time 
with diagnosed HIV, further regression analysis was conducted adjusting for potential 
confounding or mediating health-related risk factors which had been identified as differing by 
age or time diagnosed with HIV in Chapter 2: money for basic needs (always/not always), 
alcohol dependence assessed by CAGE questionnaire (yes/no), recreational drug use in the 
past three months (yes/no) and smoking status (smoker/non/ex-smoker). 
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3.3 Results 
3.3.1 Symptom prevalence 
Table 5 reports the prevalence of each symptom. At least one of the 26 symptoms was 
reported as 'present' by 92.8% of participants, with 45.2% reporting over ten. The mean 
number of symptoms present was 9.47 (S.D.=6.6), the mode was 9. The five most prevalent 
symptoms were ‘lack of energy’ (64.9%), ‘Feeling drowsy/tired’ (64.6%) ‘Difficulty sleeping' 
(58.0%), ‘Muscle aches or joint pains’ (53.4%), and ‘Trouble remembering things' (47.0%).  
Table 5. Physical symptoms ordered in relation to prevalence. 
Symptom Present 
*Includes ‘lack of energy’; ‘feeling 
drowsy/tired’; ‘difficulty sleeping’ 
#
Includes ‘trouble remembering 
things’; ‘difficulty concentrating’ 
$
Includes ‘pain’; ‘headache’ 
£Includes ‘feeling bloated’; 
‘diarrhoea’; ‘nausea’; ‘constipation’; 
‘vomiting’ 
N=3258 N (%) 
Lack of energy 2116(64.9%) 
Feeling drowsy/tired 2105 (64.6%)  
Difficulty sleeping 1890(58.0%)  
Muscle aches or joint pains 1740 (53.4%) 
Trouble remembering things 1678 (51.4%) 
Problems with sexual interest/activity 1530 (47.0%) 
Difficulty concentrating 1514 (46.5%) 
Skin problems (e.g. rash, itching, dryness) 1375 (42.2%) 
Numbness, tingling or pain in hands or feet 1338 (41.1%) 
Headache 1294 (39.7%) 
Pain 1282 (39.3%) 
Feeling bloated 1253 (38.5%) 
Diarrhoea 1201 (36.9%) 
Sweats/fever 1192(36.6%) 
Shortness of breath 1056 (32.4%) 
Cough 981 (30.1%) 
Dry mouth 970 (29.8%) 
Dizziness 961 (29.5%) 
Changes in fat in face or body 947 (29.1%) 
Nausea 811 (24.9%) 
Lack of appetite 754 (23.1%) 
Constipation 663 (20.3%) 
Changes in way food tastes 564 (17.3%) 
Weight loss 543 (16.7%) 
Mouth sores 531 (16.3%) 
Vomiting 392 (12.0%) 
Sleep/energy/tiredness problems* 2556 (78.5%) 
Memory/concentration problems
#
 1927 (59.1%) 
Pain/headache
$
 1746 (53.6%) 
Gastrointestinal symptoms
£
 1986 (61.0%) 
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When looking at symptom prevalence by age group, the mean and median number of 
symptoms present was highest in the 50-60s age group, but no general relationship was 
apparent in number of physical symptoms reported in relation to age (table 6). 
Table 6. The average number of physical symptoms present by age group. 
Age in years Mean S.D. Median 
<30 (N=173) 9.3 6.7 8 
30-40 (N=740) 8.4 6.4 7 
40-50 (N=1364) 9.7 6.7 9 
50-60 (N=686) 10.5 6.7 10 
≥60 (N=215) 8.5 5.7 8 
 
Similarly, the number of participants reporting ten or more symptoms was highest in the 50-
60s group (52.3%). This was a significant increase, compared to the other age groups, in 
unadjusted analysis (χ2, (N=3178)=37.30, p<.001). 
The three most prevalent individual symptoms, however, differed by age group. In those aged 
50 and under the most prevalent symptoms were 'lack of energy' (reported by 62.4% of 
participants aged <30 to 66.1% of participants aged 50-60 years of age), 'tiredness' (62.0% -
64.0%), and 'difficulty sleeping' (51.8% -61.1%). In those aged 50 and over the two most 
prevalent symptoms were also 'tiredness' (65.5% -71.4%) and 'lack of energy' (60.0% -71.2%), 
but these were followed by 'muscle-ache/joint pain' in those aged 60 and over (59.5%), and 
those aged 50-60 (61.8%).  
Figure 6 shows the symptom prevalence overall and for specific symptom subgroups in 
relation to age group. In every group symptom prevalence was highest in participants aged 50-
60 and decreased in those aged ≥60. In unadjusted analysis an increase in symptom prevalence 
with age was found for all subgroups except 'gastric symptoms' which had no overall change. 
The largest increases in prevalence with age were found in relation to 'numbness/tingling or 
pain in hands or feet' (prevalence from 26.0% in participants aged <30 to 49.7% in those aged 
60 and over) and 'muscle ache/joint pain' (42.8 to 62.2% respectively). Interestingly, symptom 
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prevalence was also often higher in those aged <30 than those aged 30-40, then increased 
with age between the ages 30 and 60.  
Figure 6. Prevalence of physical symptoms (%) by age. 
 
When looking at symptom prevalence by time diagnosed with HIV, the mean and median 
number of symptoms present increased steadily with time diagnosed with HIV, before 
increasing sharply in participants diagnosed for over twenty years (table 7). 
Table 7. The average number of physical symptoms present by time diagnosed with HIV. 
Time diagnosed with HIV Mean S.D. Median 
0-2 years (N=410) 7.7 6.5 6 
2-5 years (N=498) 8.2 6.1 7 
5-10 years (N= 878) 8.8 6.4 8 
10-20 years (N=1130) 10.1 6.6 9 
>20 years (N=342) 12.8 6.6 13 
 
Similarly, the number of participants reporting ten or more symptoms increased significantly 
with time diagnosed with HIV from 34.4% of participants diagnosed for 0-2 years to 66.4% of 
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participants diagnosed for over twenty years, in unadjusted analysis (χ2, (N=3258)=113.23, 
p<.001). 
The three most prevalent individual symptoms did not differ by time diagnosed HIV, with 
'feeling drowsy/tired' (55.4% of participants diagnosed for 0-2 years to 80.4% of participants 
diagnosed for twenty or more years), 'lack of energy' (55.4% - 80.1%), and 'difficulty sleeping' 
(47.3% - 74.9%) being the most common symptoms across all groups. 
Figure 7 shows the symptom prevalence overall and for specific symptom subgroups in 
relation to time diagnosed with HIV. In relation to every symptom group, prevalence increased 
with increased time diagnosed with HIV. It then increased further in those who had been 
diagnosed for longer than twenty years. In unadjusted analysis an increase in symptom 
prevalence with time diagnosed with HIV was found for all subgroups except 'mouth sores' 
which had no overall change.  
 
Figure 7. Prevalence of physical symptoms (%) by time diagnosed with HIV. 
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The adjusted associations of age and time diagnosed with HIV with symptom prevalence are 
presented in Table 8. Using the overall symptom prevalence measure, after adjustment for 
gender/sexuality and ethnicity, there was no overall trend with age in prevalence of overall 
symptom distress, as was the case for the majority of subgroups. For 'gastric symptoms', 
however, there was a significant decrease in prevalence with age, and for 'muscle ache/joint 
pain' and 'numbness/tingling or pain in hands or feet', there was a significant increase in 
prevalence with age.  
Time diagnosed with HIV, however, was strongly related to overall symptom prevalence and 
each symptom subgroup: those diagnosed for longer were more likely to report distressing 
symptoms (test for trend across categories, ps<0.001) for overall symptom prevalence and all 
symptom measures in adjusted models). As before, a further increase in symptom prevalence 
was present between participants diagnosed for 10-20 and over 20 years. This relationship was 
not materially altered when further adjusted for by smoking status, alcohol, and drug use and 
money for basic needs (Odds Ratio=1.35, 95% C.I.=1.25-1.47, p=<.001). 
There were also differences in symptom distress by gender/sexuality. For many symptom 
subgroups the pattern was similar: compared to MSM, prevalence of distressing symptoms 
tended to be lower amongst heterosexual men, and equivalent (or somewhat lower) amongst 
women. Finally, being White was related to a higher chance of symptom prevalence in relation 
to the majority of symptom measures. 
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3.3.2 Symptom distress 
Table 9 reports each symptom according to whether they were (i) present and (ii) distressing. 
At least one symptom was reported as 'distressing' by 55.6% of the population. The mean 
number of symptoms causing serious distress was 3.2 (S.D.=4.8), the median was 1 out of 26. 
The most prevalent distressing symptoms were ‘lack of energy’ (25.9%), ‘difficulty sleeping’ 
(24.4%), ‘feeling drowsy/tired’ (24.2%), ‘muscle aches or joint pains’ (20.8%), and ‘problems 
with sexual interest/activity’ (19.2%). Although lower in prevalence, 'pain' and 'changes in fat' 
were also more likely to cause distress when present than other symptoms. 
Table 9. Symptom prevalence and symptom distress (most prevalent in bold). 
Symptom Present Distressing
1
 
N=3258 
N (%) N (%) % of 
‘present’ 
Lack of energy 2116(64.9%) 844 (25.9%) 39.9 
Feeling drowsy/tired 2105 (64.6%)  790 (24.2%) 37.5 
Difficulty sleeping 1890(58.0%)  796 (24.4%) 42.1 
Muscle aches or joint pains 1740 (53.4%) 678 (20.8%) 39.0 
Trouble remembering things 1678 (51.4%) 569 (17.5%) 33.9 
Problems with sexual interest/activity 1530 (47.0%) 627 (19.2%) 41.0 
Difficulty concentrating 1514 (46.5%) 462(14.2%) 30.5 
Skin problems (e.g. rash, itching, dryness) 1375 (42.2%) 430 (13.2%) 31.1 
Numbness, tingling or pain in hands or feet 1338 (41.1%) 514 (15.8%) 38.4 
Headache 1294 (39.7%) 343 (10.5%) 26.5 
Pain 1282 (39.3%) 586 (18.0%)  45.7 
Feeling bloated 1253 (38.5%) 366 (11.2%) 29.2 
Diarrhoea 1201 (36.9%) 358 (11.0%) 29.8 
Sweats/fever 1192(36.6%) 412 (12.6%) 34.6 
Shortness of breath 1056 (32.4%) 340 (10.4%) 32.2 
Cough 981 (30.1%) 242 (7.4%) 24.7 
Dry mouth 970 (29.8%) 226 (6.9%) 23.3 
Dizziness 961 (29.5%) 293 (9.0%) 30.5 
Changes in fat in face or body 947 (29.1%) 428 (13.1%)  45.2 
Nausea 811 (24.9%) 221 (6.8%) 27.3 
Lack of appetite 754 (23.1%) 204 (6.3%) 27.1 
Constipation 663 (20.3%) 199 (6.1%) 30.0 
Changes in way food tastes 564 (17.3%) 159(4.9%) 28.2 
Weight loss 543 (16.7%) 191 (5.9%) 35.2 
Mouth sores 531 (16.3%) 155 (4.8%) 29.2 
Vomiting 392 (12.0%) 125 (3.8%) 21.9 
Sleep/energy/tiredness problems* 2556 (78.5%) 1140 (35.0%) 44.6 
Memory/concentration problems
#
 1927 (59.1%) 736 (22.6%) 38.2 
Pain/headache
$
 1746 (53.6%) 688 (21.1%) 39.4 
Gastrointestinal symptoms
£
 1986 (61.0%) 704 (21.6%) 35.4 
1 Symptom causes ‘quite a bit’ or ‘very much’ distress   
*Includes ‘lack of energy’; ‘feeling drowsy/tired’; ‘difficulty sleeping’ 
#Includes ‘trouble remembering things’; ‘difficulty concentrating’ 
 $Includes ‘pain’; ‘headache’, £Includes ‘feeling bloated’; ‘diarrhoea’; ‘nausea’; ‘constipation’; ‘vomiting’ 
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When looking at symptom distress by age group, the mean and median number of distressing 
symptoms did not appear to deviate with age (table 10).  
Table 10. The average number of distressing symptoms present by age group. 
Age in years Mean S.D. Median 
<30 (N=173) 3.5 5.00 1 
30-40 (N=740) 2.6 4.4 1 
40-50 (N=1364) 3.4 4.9 1 
50-60 (N=686) 3.9 5.2 1.5 
≥60 (N=215) 2.5 3.7 1 
 
The most prevalent distressing symptoms were the same for each of the four age groups under 
the age of 60 years: ‘lack of energy’ (22.0% prevalence in participants aged <30 years of age to 
30.8% in those aged 50-60), followed by ‘feeling drowsy/tired’ (20.0-28.3%), and ‘difficulty 
sleeping’ (21.9 -26.5%), and the proportion who reported no distressing symptoms ranged 
from 38.9% to 48.5%. Among participants aged ≥ 60 years the pattern was different: ‘muscle 
ache/joint pains’ was the most prevalent distressing symptom (24.2%), followed by ‘pain’ 
(18.6%) and ‘lack of energy’ (18.6%), and 47.4% of participants over the age of 60 reported no 
distressing symptoms.  
Figure 8 shows the prevalence of symptom distress overall and for specific symptom 
subgroups by age group. As can be seen from the graph, prevalence did not differ much 
between distressing symptoms, with a large amount of overlap between almost all symptoms 
except 'sleeping/energy/tiredness' problems, for which prevalence of distressing symptoms 
was higher. In terms of the pattern of prevalence with age, the frequency of overall symptom 
distress tended to increase slightly with age over the 30-59 year age range, but decreased in 
the ≥60 age group in a manner similar to symptom prevalence. Most of the symptom groups 
followed this pattern, with ‘muscle-ache/joint pain’ (14.5-28.4%) and ‘numbness/tingling in the 
hands/feet’ (9.8-21.6%) having the strongest increases with age. However, sexual 
interest/activity did not vary by age in unadjusted analysis (p=0.09). 
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Figure 8. Prevalence of distressing symptoms (%) by age. 
 
When looking at symptom distress by time diagnosed with HIV, the mean and median number 
of distressing symptoms increased with increasing time diagnosed; with the mean number of 
distressing symptoms doubling (table 11). This was a significant increase in unadjusted analysis 
(χ2, (N=3258)=37.30, p<.001). 
Table 11. The average number of distressing symptoms present by time diagnosed with HIV. 
Age in years Mean S.D. Median 
0-2 years (N=410) 2.3 4.1 0 
2-5 years (N=498) 2.4 4.2 0.5 
5-10 years (N= 878) 3.0 4.7 1 
10-20 years (N=1130) 3.6 5.0 1 
>20 years (N=342) 4.9 5.6 3 
 
The most prevalent distressing symptoms were the same for participants diagnosed for 
between 0 and 20 years: 'lack of energy' (20.2% - 29.8%), followed by 'difficulty sleeping' 
(15.4% - 25.8%) and 'feeling drowsy/tired' (18.3% - 28.3%). Among participants diagnosed for 
over twenty years the pattern was different: ‘lack of energy' was still the most prevalent 
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distressing symptom (37.4%), followed by ‘difficulty sleeping’ (35.4%) and ‘muscle ache/joint 
pains' (34.8%).  
Figure 9 shows the prevalence of symptom distress overall and for specific symptom 
subgroups by time diagnosed with HIV. As can be seen from the graph, prevalence of 
distressing symptoms increased with increasing time with diagnosed HIV, becoming 
particularly prevalent in participants diagnosed for over twenty years. 
Figure 9. Prevalence of distressing symptoms (%) by time diagnosed with HIV. 
 
The adjusted associations of age and time diagnosed with HIV with symptom distress are 
presented in Table 12. Using the overall symptom distress measure, after adjustment for 
gender/sexuality and ethnicity, there was no overall trend with age in prevalence of overall 
symptom distress. However, age-related variation in relation to specific symptoms was 
identified. For 'pain/headaches', 'numbness/tingling in the hands or feet', and 'muscle 
ache/joint pain' there was a significant increase in the prevalence of distress with age and for 
'sleep/energy/tiredness' and 'sexual interest/activity' the prevalence of distress decreased 
(test for trend across categories p<0.001). No difference was found with increasing age for 
'memory/concentration' problems, 'gastric symptoms' or 'changes in fat'. For almost all 
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symptom subgroups, prevalence of distressing symptoms was lower among those aged ≥60 
years than those aged 50-60 years. In fact for most symptom groups, participants aged ≥60 
years had the lowest prevalence of distressing symptoms overall.  
Time diagnosed with HIV was strongly related to prevalence of overall symptom distress and 
each symptom subgroup: those diagnosed for longer were more likely to report distressing 
symptoms (test for trend across categories p<0.001 for overall symptom distress and all 
symptom measures in adjusted models). This relationship was not materially altered when 
further adjusted for by smoking status, alcohol and drug use and money for basic needs (Odds 
Ratio=1.25, 95% C.I.=1.16-1.36, p=<.001 for trend across categories of time with diagnosed 
HIV). 
There were also differences in symptom distress by gender/sexuality. For many symptom 
subgroups the pattern was similar: compared to MSM, prevalence of distressing symptoms 
tended to be similar (or somewhat lower) among heterosexual men, and higher among 
women. There were few significant differences according to ethnicity. 
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3.3.3 Activities of Daily Living 
The prevalence of ADL problems was 38.1% overall and prevalence of individual components 
was as follows: mobility problems (27.6%), self-care problems (12.6%), and problems with daily 
activity (32.7%). Furthermore, participants reporting ten or more symptoms (65.1% vs. 15.8%, 
p<.001) or symptom distress (58.4% vs. 12.6% reporting no distress, p<.001) were more likely 
to report ADL problems.  
The prevalence of having one or more ADL problem increased significantly with age (24.7-
54.0%) in unadjusted analysis (χ2, N=3178(4)=115.09, p<.001 for linear trend across age 
groups). An increase in prevalence with older age was found for all three domains, with 
mobility problems increasing the most with age (prevalence 12.0 among those <30 years 
compared to 47.9% among those >=60 years) and self-care the least (corresponding 
prevalences: 4.6 and17.2% respectively). Interestingly, participants aged <30 still reported 
more mobility problems than those aged 30-40. These results are depicted in figure 10. 
Figure 10. Prevalence of ADL problems (%) by age. 
 
The odds of having one or more ADL problem also increased significantly with time diagnosed 
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0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
<30 (N=173) 30-40 
(N=740) 
40-50 
(N=1364) 
50-60 
(N=686) 
>60 (N=215) 
P
e
rc
en
ta
ge
 
Age in years 
One or more ADL 
problem 
Mobility problems 
Problems with Usual 
activities 
Self-care problems 
99 
 
found for all three subcategories, with problems with ADLs becoming increasingly prevalent in 
participants diagnosed for longer than ten years. These results are depicted in figure 11. 
Figure 11. Prevalence of ADL problems (%) by time diagnosed with HIV. 
 
Table 13 shows the adjusted associations of age and time diagnosed with HIV with ADL 
problems. Using the overall symptom distress measure, after adjustment for gender/sexuality 
and ethnicity, there was a strong increasing trend in the prevalence of ADL problems with age 
overall and for each domain. This relationship was not materially altered when further 
adjusted for by smoking status, alcohol and drug use and money for basic needs (Odds 
Ratio=1.36, 95% C.I.=1.25-1.49, p<.001 for trend across age groups). 
Longer time since HIV diagnosis was also strongly related to higher prevalence of ADL 
problems. This relationship was not materially altered when further adjusted for by smoking 
status, alcohol and drug use and money for basic needs (Odds Ratio=1.42, 95% C.I.=1.31-1.55, 
p=<.001). 
In addition, mobility problems were more common among women than MSM and 'problems 
with usual activities' were more common in White participants than other ethnicities. 
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3.4 Discussion 
The aim of this chapter was to assess the associations of age and time diagnosed with HIV with 
a) symptom prevalence, b) symptom distress and c) difficulty with ADLs, taking into account 
demographic factors.  
Almost all (92.8%) participants reported experiencing physical symptoms, with the majority 
reporting nine. The most commonly reported symptoms were fatigue-related across all age 
groups (which are known to be common in PWH197-199), although those over  the age of 50 also 
commonly reported 'muscle-ache/joint pain'. In adjusted analysis there was no trend with age 
in relation to the majority of symptoms, except that the prevalence of 'gastric symptoms' 
decreased with age, and the prevalence of 'muscle ache/joint pain' and 'numbness/tingling or 
pain in hands or feet' increased with age.  
Overall, 55.6% of the study population reported distress in relation to their physical symptoms, 
of which the most distressing symptoms (the symptoms most likely to cause distress, if 
present) were 'pain', 'changes in fat in face or body', and 'difficulty sleeping'. Older adults did 
not report more distress - in fact the prevalence of distressing symptoms was generally lowest 
in participants over the age of 60 than in younger age groups. However, the most common 
distressing symptoms differed by age group: 'pain/headaches', 'numbness/tingling in the 
hands or feet', and 'muscle ache/joint pain' increased in prevalence of distress with age while 
'sleep/energy/tiredness' and 'sexual interest/activity' decreased. Finally, over a third (38.1%) of 
the study population reported difficulties with activities of daily living, of which mobility 
problems were most prevalent (27.6%). This is more than double the reported rates in the 
general population176, according to the Office of National Statistics. Problems with ADLs 
increased with age in all three domains. 
Declines in physical health are well documented with age in the general population and are 
likely due to age-related reductions in immune function25;52;53;127;173, loss of homeostasis8, and 
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mitochondrial disfunction167;168. This results in fatigue69;76;174, a poorer response to pathogens52 
and an accumulation of chronic and complex illnesses. Older adults with HIV show similar 
reductions in physical health with age, but may experience them at a faster rate, which has led 
researchers to suggest that PWH are at risk of 'accelerated signs of ageing'47;80;81;167. 
 
3.4.1 Symptom Prevalence 
Symptom prevalence was extremely high in the ASTRA population, with fatigue-related 
symptoms being reported most often. The prevalence of fatigue was high across age groups 
and did not tend to increase with older age, as found in the general ageing population. Gastric 
symptoms did decrease in prevalence with age, while 'muscle ache/joint pain' and 
'numbness/tingling or pain in hands or feet' increased. Gastric symptoms are common in 
people taking cART87, but are not particularly related to age. Tingling in hands and feet is often 
related to nerve damage from viral infections, toxic exposures, and systemic diseases (most 
often diabetes) while muscle ache and joint pain may be related to osteoarthritis or a 
rheumatic condition. Diabetes and rheumatic conditions increase with age in the general 
population54;69;173 which may explain the difference apparent here, but it is also possible that 
'numbness/tingling or pain in hands or feet' is due to prolonged HIV infection or a higher 
toxicity in response to medication in older adults due to drug-drug interactions64;128 and/or 
age-related homeostatic loss8 reducing the bodies' ability to metabolise the chemicals. 
Therefore the changes observed with age in this study may be due to onset of age-related 
illness or age-related changes in HIV or drug toxicity. 
In the literature very little evidence was available from the UK in relation to physical well-being 
in OPWH, so these results are important for understanding the well-being of OPWH in this 
population. In the global literature, symptom prevalence increased with age which does not 
correlate with the results presented here. This may be due to the majority of previous papers 
coming from the US, where physical health has been found to be lower than in the general UK 
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population194;200. Alternatively it may be due to the high levels of ART adherence among people 
with HIV in the UK reducing the risk of 'accelerated signs of ageing' and related symptoms. 
 
3.4.2 Symptom distress 
While no previous studies were identified which focused on symptom distress in PWH, in 
interviews OPWH did report high levels of health-related distress due to uncertainty over the 
meaning and source of illness. They reported concern about a) whether their health challenges 
were related to ageing or HIV, b) the length of time it took to recover from illness comparative 
to HIV negative older adults, and c) the future effects of cumulative illnesses76. 
High levels of symptom distress were apparent in the study population, but there was no 
change in prevalence of overall symptom distress with age. However, the symptoms causing 
distress did differ with age: younger adults found fatigue symptoms and declines in sexual 
interest/activity more concerning while older adults were distressed by 'pain/headaches', 
'numbness/tingling in the hands or feet', and 'muscle ache/joint pain'. These age differences 
may be due to "Social comparison". "Social comparison"201;202 is the process through which 
individuals identify changes from the norm in themselves by comparing them to those 
experienced in people with similar demographic factors (e.g. sex, economic status and age) or 
those identified through popular media203. In relation to health, social comparisons are used to 
identify causes for concern and decide when to seek care202-204. When chronic illness is 
present, social comparisons may become more frequent in order to alleviate stress by 
accumulating health information204-206. Positive health-related social comparisons have 
previously been identified in older adults coping with chronic illness and/or disability across 
several countries207;208. An example of this present in this study would be fatigue: as fatigue is 
higher in older adults69;76;174 it may be less distressing to older PWH because they recognise, 
through social comparisons, that it is a common function of ageing. Younger adult's social 
comparisons, on the other hand, would suggest that fatigue is abnormal and therefore more of 
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a cause for concern. There is some evidence for this in the literature also, with one study 
reported that 30% of OPWH regarded their fatigue to be due to ageing209.  
Another example can be seen in relation to distress with sexual interest. Numerous studies 
have confirmed that while sexual activity declines with age93, many adults stay sexually active 
well past the age of 50210-214. In fact, the National Bulletin of the National Advisory Council on 
Aging reported that in 2002 92% of respondents 60 and over considered sex to be an 
important part of their lives212. Similarly, a community-based study of older women revealed 
that 98% believed that an active sex life was good for their health and 89% reported that 
sexual satisfaction was important for life fulfillment214. However, social norms encourage the 
belief that sexual interest/activity should decline with age and so decreases may not be 
concerning to older adults. In contrast, common media suggests that younger adults are 
sexually active, which increases concern in younger adults not experiencing these urges. This 
could also be particularly distressing in adults wanting to procreate, who are likely to be of a 
younger age. Social comparison could also explain the decreases in overall distress in PWH 
over the age of 60 who expect to experience age-related reductions in health. 
However, the social comparison theory would not explain older adult's concern with 'muscle-
ache/joint pain', which commonly increases with age54;69;173. That is, unless it is combined with 
the theory of 'accelerated ageing'. If OPWH consider themselves to have experienced age-
related symptoms at a younger age than the general population then social comparisons could 
increase their distress.  
 
3.4.3 Activities of Daily Living 
Mobility and physical activity are also generally found to reduce with increasing age26;55;175.; 
This is primarily due to increased fatigue69;76;174 and frailty55;177 and many older adults 
subsequently report becoming more selective of their social activities69;76. However, the 
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prevalence of problems of ADLs in PWH over the age of 60 was 9% higher than in adults over 
65 in the general population176, suggesting that HIV may have an additional detrimental effect 
on health. Indeed, a separate analysis of the ASTRA data in comparison to data from the 
Health Survey for England (HSE) in 2011 (N=7424) also reported more problems with ADLs in 
the ASTRA population215. Frailty187;188 and difficulties with ADLs189 become apparent at a 
younger age in PWH81 than the general population and have been reported at rates of up to 
81% in PWH192 (Colombian study), with increases with age193. In conjunction with previous 
research, this study reported a prevalence of ADL difficulties of 38.1% of PWH overall, a 
prevalence which increased with age. Furthermore, these changes with age were not 
significantly mediated by demographic or risk factors (money for basic needs, alcohol 
dependency, smoking status, and recreational drug use). This result is therefore likely due to 
age-related changes in health, as in the general population. However, since the prevalence of 
problems with ADLs appeared particularly high (over one in three PWH) it is conceivable that 
'accelerated signs of ageing' may also be responsible for these statistics. This would mean that 
OPWH are likely at higher risk of problems with ADLs than age-matched individuals in the 
general population as well as younger PWH. 
 
3.4.4 Time with diagnosed HIV 
With longer time diagnosed with HIV the prevalence and distress caused by all reported 
symptoms along with the likelihood of problems with ADLs increased. Furthermore, 
participants who had been diagnosed with HIV for twenty or more years showed even stronger 
prevalence of physical symptoms and symptom distress. These changes continued to be 
significant when adjusted for demographic and risk factors associated with growing old with 
HIV (smoking status, alcohol and drug use and money for basic needs). This ties in with 
previous theories about changes in physical health in PWH. Namely that HIV, drug toxicity and 
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age-related immunosenescence likely interact to increase symptom prevalence and ADL 
problems in PWH in a process akin to accelerated signs of ageing. 
Symptom distress likely increases with time due to the increase in symptom prevalence which 
leaves participants with higher levels of stress and fear about the physical effects of their HIV 
status. Similarly, adults who were diagnosed in the pre-cART era have lived through HIV as a 
terminal illness and have seen symptom prevalence increase in other PWH in relation to 
progression to AIDS and eventual death. As such 'social comparison' could be causing them 
greater levels of distress. This relationship with 'social comparison' may seem arbitrary, 
especially since the same argument was used to explain decreases in distress in OPWH. For 
example, one could argue that symptom distress should be lower in PWH diagnosed for longer 
because compared to the individuals in their symptom group they are better off (i.e. not dead). 
However, the important distinction here is in relation to the number of symptoms prevalent. 
Specifically, no difference in prevalence was found by age in relation to the majority of 
symptoms while symptom prevalence increased dramatically in relation to time with 
diagnosed HIV. In a situation where physical health remains relatively stable individuals are 
less likely to consider their health, overall, to be different to the norm and so social 
comparison can have a positive effect on well-being. Where health declines and many 
symptoms are apparent -such as in chronic illness - health-related stress increases and 
individuals are more likely to monitor their symptoms and compare them negatively to adults 
of the same age, especially if they are concerned about mortality204;206. For example, in 
previous research OPWH expressed fear related to the 'unknown' future of their health and 
HIV status106. If adults living with HIV for a long time are aware of the lack of information 
available to clinicians on their future health and care - as these participants were - then this 
could plausibly result in hyper-vigilance and distress in relation to physical health symptoms. 
This could explain why participants diagnosed for twenty or more years showed even stronger 
increases in prevalence of physical symptom and distress than participants diagnosed for less 
time. Alternatively, this could be a result of higher levels of toxicity apparent in early ART 
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medication. These results suggest that both calendar year of diagnosis date and the presence 
of HIV over time affect physical well-being of PWH. However, it is important to note that all 
such theories were included post-hoc and are therefore entirely speculative in nature. This 
occurred for two reasons. Firstly, the nature of epidemiological research is exploratory: this 
thesis aimed to identify  changes in well-being with age, not explain them. Secondly, the lack  
of literature available which was directly applicable to the research population prohibited the 
inclusion of directional hypotheses. As such all explanations, while based on the most probable 
theories available, were not tested directly and should only be used as suggestions for future 
guided research.  
 
3.4.5 Limitations 
Several other limitations were apparent in this chapter. As the focus of this research was well-
being, rather than biological response to HIV per se, we did not identify comorbidities or take 
medical history when collecting information - the results here are based solely on self-reported 
symptoms and their effects on daily function and distress. As such we are unable to say with 
certainty whether the associations with age and time with diagnosed HIV are due to biological 
changes in health, only that this seem likely due to the results and literature. 
Very few of the ASTRA participants had severe mobility problems. This may be correlated to 
the ability to travel to the clinic, and so would exclude participants with severe health 
conditions from the conclusions presented here. As such, symptom prevalence and problems 
with ADLs may be more prevalent than reported here. Finally, mental, physical and social 
health are inextricably interlinked, and several symptoms (e.g. fatigue) are related to 
depression. While we have discussed the possible effects of physical health on the results, it 
cannot be ruled out that changes in symptom prevalence with age may be mediated by mental 
health. This will be discussed further in the next chapter. 
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3.4.6 Conclusions and Implications 
Previous UK data on age differences in health in PWH showed increases in mortality and 
morbidity with age, similar to the global literature. No information was found on age-related 
differences in mobility, difficulty with ADLs, self-rated health or health-related distress in UK 
PWH populations, and symptom distress was noticeably lacking from all OPWH literature. The 
information provided in this chapter makes a contribution towards filling these gaps. It shows 
that older adults with HIV were not more likely to be symptomatic than younger adults, 
although some specific symptoms were more likely. They were also no more likely than 
younger PWH to experience distress at their physical symptoms, although this differed greatly 
based on the individual symptom. However, OPWH are at greater risk of having problems with 
ADLs than younger PWH. This suggests that OPWH's well-being is likely to be affected by 
problems with self-care and that they require a different focus on health care but do not, 
overall, have worse experience of physical well-being than younger adults. Adults ageing with 
HIV (those who have lived with HIV for longer), however, show great prevalence of symptoms, 
problems with ADLs and distress. 
It appears possible that the physical health differences apparent by age here may be due to 
age-related changes in health, coupled with HIV-related changes. Further, it can be suggested 
that the differences noted in symptom-related distress are due to more positive social 
comparison in older adults.  
Physical function is indispensable in maintaining autonomy and participants in health-care 
actiities54. As such ADLs, while only one of several factors assessed here, are important to 
consider when assessing well-being in this population and should be managed in age-related 
interventions. It is also worth noting that physical symptoms differed in prevalence and stress 
with age and so HIV-related care should be tailored to the age of the patient. However the 
overall image here is extremely positive in relation to older adult's physical adjustment to HIV 
and, barring ADLs, physical health should not be the primary focus of further care for OPWH. 
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Adults ageing with HIV, however, show a high prevalence of symptom distress as well as a high 
prevalence of physical functional problems and require tailored care. 
The next chapter will explore mental health differences with age and their possible effect on 
well-being. 
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4 Age, time with diagnosed HIV, and psychological well-
being 
4.1 Background 
Stressors are defined by psychologists as 'events or situations which cause an imbalance 
between perceived demands and resources'216. In chronic illness individuals are faced with a 
whole new range of demands including symptoms, illness, medication management, behaviour 
management, and health monitoring which affect their available mental and physical 
resources217. This increase in stressors may tax the individual's current coping strategies and 
they may need to adjust or replace these strategies to maintain - or regain - their well-being. 
Most participants with chronic illness do reach a state of good psychological adjustment over 
time217 but for some the 'adjustment phase' is prolonged or unsuccessful217. In these cases 
mental health becomes increasingly salient to well-being.  
Depression and anxiety are the most common mental disorders in the UK218, and are often 
reported in participants with chronic illness (e.g. arthritis, diabetes, cancer, HIV)63;219. Indeed, it 
has been reported that depression was rated as the fourth leading cause of disease burden in 
the general population in 2000; accounting for 4.4% of disability-adjusted life years220. As such, 
depression and anxiety are the mental health measures which are considered in this study. 
 
4.1.1 Depression 
According to the DSM-IV, a major depressive disorder involves depressed mood and loss of 
interest or pleasure in daily activities for more than two weeks, causing impaired social, 
occupational and/or educational function. A report by the Office of National Statistics (ONS), 
states that 2.3% of the general UK population has depression, making it the most common 
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mental illness after anxiety218. Depression is also common in chronic illness58;63;219;221 and older 
age56-58. For example, a longitudinal study by the National Institute of Ageing (N=4,162) found 
increases in depression prevalence with age across ten-year time points59. Similarly, the SHARE 
study of ten European countries (N=22,777) found increases in depression with increasing age 
in participants aged 50 and over in nine countries57, as did the English Longitudinal Study of 
Ageing (N=11,104)222. Depression is associated with increased mortality and physical symptom 
burden, difficulties with ADLs and decreased health-care use56;57;200;221;222. 
It is thought that depression can be high in older adults due to disengagement with social 
roles, declining health, bereavement and increased economic strain57;59;60. This loss of loved 
activities and people, and financial and emotional independence, may results in an increased 
susceptibility to depression. It is likely that depression is high amongst people with chronic 
illness due to similar processes63. However, depression may also increase the risk of chronic 
illnesses through 'depression-related' behaviours (e.g. over eating, over-sleeping, sedentary 
behaviour)60;63;91;222;223. Several longitudinal studies, for example, have found that major 
depression is a predictor for heart disease and type 2 diabetes58;224-226. A meta-analysis also 
showed that adults with depression are three times less likely to partake in self-management 
activities (e.g. diet, exercise) or adhere to medication than those without, which likely causes 
or exacerbates ill health227. This likelihood, in several studies from 2002, includes adherence to 
ART228-230. Finally, depression is shown to increase the number of symptoms experienced in 
several chronic illnesses (e.g. heart disease231, COPD232, diabetes233, cancer234;235 and HIV236). As 
such, mental and physical health are strongly and inextricably linked and may reduce overall 
well-being in older adults. 
Data from the ONS, however, show depression prevalence which peak at the ages of 45-54 
years and decrease in older adults218. As such, older age is not universally reported as a 
negative psychological life event. Figure 12 shows the levels of depression reported in the 
general UK population using data adapted from the ONS (2007)218. 
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Figure 12. The percentage of the UK population reporting depressive episodes by age and 
gender218. 
 
There is evidence, in relation to other measures of mental well-being, that older adults may 
have a lower burden of symptoms than younger adults. They have been found, for example, to 
report fewer negative emotional experiences than younger adults237-239, greater emotional 
control237, and increased positive affect240. There are several possibilities given for these 
improvements in mental well-being despite age-related reductions in health. Cartensen's 
Socioemotive selective theory241, for example, suggests that as age increases and mortality 
becomes more imminent, individuals become more selective of their activities; investing more 
time and energy into emotionally meaningful - rather than future-oriented – goals and 
improving their short-term well-being242;243. This is thought not only to affect behaviour but 
also cognitive processing, such that older adults show a selective attention and retention of 
positive information not present in younger adults241;244. This is known as the 'positivity effect' 
and has been replicated in cognitive239 and neurological243 studies. For example, using a 
reaction time test, older adults (aged 62-94, N=117) were shown to respond faster to happy 
faces than sad or angry faces, while younger adults showed no attentional bias239. In a 
separate study this was found to be related to lower activation of the amygdala in older adults 
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in response to negative images245, suggesting a neurological adaptation with age towards 
positive mental well-being.  
This may explain the patterns in depression with age shown in the ONS data, although this 
would not be consistent with the results found from other countries. Alternatively, since 
depression is related to chronic illness, it is possible that depression is high in older adults in 
relation to ill health (which is common in older adults) and therefore that high levels of mental 
health are possible in older adults only in the absence of illness246.  
Under this assumption mental health should decline with age in PWH unless a ‘selective 
survival’247 effect becomes apparent. That is, if strong mental and physical health are strongly 
correlated, you could expect only physically and mentally fit adults to reach older age, thus 
skewing the available data towards more healthy older adults. If selective survival occurs in 
this population, this would likely become apparent through increases in mental health with 
time diagnosed with HIV. 
 
4.1.2 Anxiety 
Anxiety is a 'mental response to an irrational fear or situation over which the individual has no 
control'248. Generalised anxiety disorder (GAD) is a disorder in which the individual feels a 
constant state of high anxiety. According to the DSM-IV, GAD involves 'excessive anxiety and 
worry which is difficult to control for at least 6 months' and can be related to any aspect of life 
(e.g. employment, social support, health) or any combination of stressors. 
GAD is considered to be the most common anxiety disorder in older adults249;250. According to 
a report by the ONS, 4.4% of the general population has GAD218 and hospital admissions for 
anxiety increase in those aged 60 and over251. Figure 13 shows levels of GAD in the general UK 
population by age group, using data adapted from the ONS in 2007, which shows a peak in 
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anxiety in the 45-54 age group followed by a decrease with age218. Therefore, while overall 
anxiety may be high in older adults, GAD appears to decrease in the UK population. 
Figure 13. The percentage of the UK population reporting Generalised Anxiety Disorder by 
age and gender218. 
 
Unfortunately, the systematic review (section 1.3.2.3) identified few research papers on age- 
or chronic illness-related differences in anxiety, and even fewer published since 2000. 
However, similar to depression, anxiety has been related to the prevalence of chronic illnesses 
- such as hypertension252-254 - and to be higher in prevalence in clinical populations250;255 and in 
adults with poor health and low social support249;255. Unlike depression, anxiety has been 
related to an increase in health-related behaviours including information-seeking and health-
care utilisation256;257. 
 
4.1.3 Mental health factors related to ageing with HIV 
Compared to physical health, mental health is under-researched in OPWH with, on review of 
the literature, 35 papers focusing on mental health or quality of life (QoL) in older adults with 
HIV published in the last 15 years (25 papers since 2010). The majority (n=28) of papers were 
quantitative studies, of which 12 included a control group and validated instruments and were 
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included in the systematic review (section 1.3.2.3). Seven further studies were identified from 
the systematic review as measuring mental health (primarily depression) as a secondary aim. 
Of those included in the systematic review, the majority found no difference with age in 
depression rates64;120;129;138;145-148 but there was insufficient evidence to conclude upon age-
related differences in anxiety, stress, coping mechanisms, resilience, or overall well-being. The 
remaining papers included three qualitative studies, two summaries, one mathematical model, 
and one literature review which are detailed below.  
Depression is known to be higher in the HIV-positive population than the general population. 
Indeed, a meta-analysis of the relationship between HIV and depression from 2001 reported 
that PWH are twice as likely to have depression as those without84. More recently, in 2010-
2011, an Australian nation-wide study of older (≥40 years, N=1135) MSM found that having 
HIV increased the likelihood of being treated for a mental health condition by 12%85, although 
the causation here was unclear. 
The association between HIV and depression has been attributed to multiple factors, including 
poor physical function84;85;87;88;258;259, health-induced anxiety84;89;90, a feeling of lack of 
control86;258;260, and social isolation85;90-92;258;261. Higher rates of depression, anxiety, and suicidal 
ideation have also been linked to maladaptive coping strategies (e.g. 'avoidance': ignoring 
activities related to the stressor, such as doctor visits and/or medication)89;91, suggesting that it 
may be related to behaviours with negative health benefits, and higher HIV status disclosure 
rates89.  
Generally, depression prevalence in OPWH is thought to be around 30%91. The Research on 
Older Adults with HIV (ROAH) study (N=914), in America, reported that 39.1% of OPWH exhibit 
symptoms of major depression (score of ≥23, CES-D scale)261, but that younger OPWH (aged 
50-55) reported higher levels of depression to older OPWH261. This suggests that older adults 
may cope better as age increases. Other studies have reported depression prevalence ranging 
from 25%259 to 39%261 in OPWH and an American study of PWH over the age of 45 (N=113) 
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found a prevalence of self-reported suicidal tendencies of 27%89. These prevalence rates 
appear to be comparable to those in the HIV-positive population overall, which suggests that 
older PWH are not at higher risk of depression than younger PWH, but are at considerably 
higher risk compared to the HIV-negative population (UK percentage of 2.3%), although 
different scales were used here than in the general population and so the results may not be 
directly comparable. However, there is another possibility. In a few studies, high rates of 
suicidal ideation have been reported in PWH who are newly diagnosed88;89;258. As only 16% of 
new diagnoses in the UK are over the age of 5019, the psychological impact of new diagnoses 
may disproportionately affect younger PWH, resulting in a higher prevalence of depression 
among younger than in older PWH. In order to assess this potential confounding it is important 
for studies to take into account 'time diagnosed with HIV' when assessing mental health by 
age. 
As in the general population, high depression rates and avoidant coping mechanisms in OPWH 
have been related to low physical function and high levels of distress38;87;91;258. Additionally, 
they have been related to low adherence to ART and low CD4 count91. One example of this is 
an American study of 453 OPWH which reported a relationship between depression and the 
number of chronic conditions experienced38. Another is a study of middle-aged and older MSM 
with HIV (N=173) which identified a strong association between the number of physical 
symptoms reported, difficulties with ADLs and the severity of depression irrespective of CD4 
count and viral load87. This suggests not only a strong relationship between physical function 
and mental health - as found in the general population - but also that improving clinical status 
may not necessarily positively impact mental well-being. 
In one study, in interviews OPWH also reported distress related to the death of family and 
friends86 and feelings that they were ageing prematurely262. When HIV-related risks for 
depression are combined with the age-related reductions in physical and social function this 
creates a large combination of stressors for OPWH88. In theory this might be expected to result 
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in higher levels of depression in OPWH than younger PWH - unless their coping strategies are 
more advanced, or their coping resources more widespread, than those of younger adults. 
In summary, depression and anxiety, in and of themselves, are important factors to address 
when improving the well-being of PWH, but as they have been related to lower disclosure and 
ART adherence rates, they are also important to participant care and infection control. 
Depression rates are high in PWH, but there is evidence that older PWH experience similar 
depression rates to younger PWH. This appears to occur despite worse physical function and 
social stress in older PWH, which may be related to more adaptive coping strategies in older 
adults and/or be an artefact of increased depression rates at HIV diagnosis. Along with these 
hypotheses, several gaps were identified in the literature which need to be addressed. 
Specifically, only one 'high-quality' study (systematic review, section 1.3.2.3) was found on 
age-related differences in mental health in PWH from the UK, meaning that our understanding 
of this population is limited. Anxiety was also explored in very few studies, preventing 
conclusions on age differences in PWH from being drawn. Finally, one study reported higher 
depression rates in younger OPWH (50-55 years of age) than older OPWH (over 55 years of 
age)261. This suggests that depression rates may vary within the OPWH population and so 
information into mental health is required across the age spectrum in order to identify these 
differences. 
 
4.1.3.1 Aims 
The aim of this chapter is to assess, amongst our ASTRA population, the association of age with 
a) depression symptoms, b) anxiety symptoms and c) associations between mental and 
physical symptoms associations between mental and physical symptoms and whether these 
associations differed according to age, taking into account gender/sexuality and ethnicity.  
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4.2 Methods 
Full details of the study were described in chapter 2. Participants completed a self-
administered questionnaire including, in relation to this analysis, questions on depression and 
anxiety symptoms. These variables are reported in relation to age group and other key socio-
demographic characteristics (gender/sexuality, time with diagnosed HIV and ethnicity).  
 
4.2.1 Symptom measures  
Depression and anxiety were measured via self-report, using the PHQ-9156 and GAD-7 scales157. 
Both of these scales are validated diagnostic instruments, based on the DSM-IV criteria for 
depression156 and GAD157, for measuring the prevalence and severity of mental health issues 
(depression and GAD) respectively.  
For the purpose of this analysis w the standardised score-based definitions for anxiety and 
depression were used, comparing participants who reported 'moderate' to 'severe' depression 
and anxiety (scores ≥10) to those reporting 'mild' or 'no' depression/anxiety. This created the 
'overall' depression and anxiety variables. For the individual symptoms that comprise the PHQ-
9 and the GAD-7, those reporting the symptom for 'more than half the days' or 'nearly every 
day' were compared to those reporting the symptom 'not at all' or for 'several days' in the past 
two weeks. These comparisons were used to identify participants potentially in need for 
intervention in comparison to those showing no - or mild - distress. 
Where participants did not complete the questionnaires, a missing response was analysed as a 
response of 'not at all' and scored as '0'. As such, it is possible that the results somewhat 
under-represent the levels of depression and anxiety in this population.  
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4.2.2 Statistical analysis  
Age in years was grouped into the following categories: <30, 30-39, 40-49, 50-59, and ≥60 
years. Differences in participant characteristics by age were assessed using compared means, 
chi-squared tests and chi-squared tests for trend.  
Depression and anxiety were assessed using raw scores from PHQ-9 (range of 0-27) and GAD-7 
(range of 0-21) and the individual components of each measure, as well as by clinical 
diagnostic group (none, mild, moderate, moderately severe or severe depression/anxiety) and 
comparing adults with PHQ-9 and GAD-7 scores ≥10 to those without (the 'overall' scores). 
Statistics were collected for the entire ASTRA population and compared by age group and time 
with diagnosed HIV group using chi squared test for trend. Logistic regression was used to 
assess the association of age groups and time with diagnosed HIV groups with the prevalence 
of each individual symptom (present for at least ‘more than half the days’)and with 'overall' 
prevalence of depression and anxiety, adjusting for gender/sexuality (MSM, heterosexual man, 
woman), ethnicity (White, other), and time since diagnosis of HIV (<2 years, 2-5 years, 5-10 
years, 10-20 years, >20 years). Age was fitted as a categorical variable in the models, with 
age>=60 years used as the reference category. In additional models, age was fitted as an 
ordinal variable with values 1 to 5, rather than defined as categorical and tests for linear trend 
across age groups were performed. Results are presented as odds ratios with 95% confidence 
intervals.  
Where significant differences in depression or anxiety prevalence were found in relation to age 
or time with diagnosed HIV, further regression analysis was conducted adjusting for potential 
confounding or mediating health-related risk factors which had been identified as differing by 
age or time diagnosed with HIV in Chapter 2: money for basic needs (always/not always), 
alcohol dependence assessed by CAGE questionnaire (yes/no), recreational drug use in the 
past three months (yes/no) and smoking status (smoker/non/ex-smoker). 
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The relationship between depression, anxiety and physical symptom measures (symptom 
prevalence, distress, problems with ADLs and CD4 count) were also assessed using chi squares 
tests for trend and logistic regression analysis, adjusted for gender/sexuality (MSM, 
heterosexual man, woman) and ethnicity (white/non-white). These associations were also 
analysed as interactions of anxiety and depression adjusted for a) age and b) time diagnosed 
with HIV as grouped variables in a continuous form, in comparison to physical symptom 
measures. 
 
4.3 Results 
4.3.1 Depression 
Out of the study population, 884 (27.1%) had a score of ≥10 on the PHQ-9: indicative of 
moderate/severe depression. By diagnostic group, 645 (20.3%) of the population showed mild 
depression, 415 (13.1%) showed moderate depression, 247 (7.8%) showed 'moderately severe' 
depression and 206 (6.5%) showed severe depression. The mean PHQ-9 score was 6.5 
(S.D.=6.8) , indicative of mild depression; the median was 4 out of 27 (no depression). Table 14 
reports the mean and median PHQ-9 scores by age and Table 15 reports the prevalence of 
each level of depressive symptoms by age.  
Table 14. The average depression score (PHQ-9) by age group. 
Age in years Mean S.D. Median 
<30 (N=158) 7.6 7.3 5 
30-40 (N=676) 5.9 6.4 3 
40-50 (N=1261) 6.7 7.0 4 
50-60 (N=630) 7.0 7.1 5 
≥60 (N=185) 5.0 5.8 3 
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Table 15. Prevalence of levels of depression (PHQ-9 diagnostic group) by age group. 
Age None Mild Moderate 
Moderately 
severe 
Severe 
<30 (N=173) 80 (46.2%) 33 (19.1%) 27 (15.6%) 19 (11.0%) 14 (8.1%) 
30-40 (N=740) 425 (57.4%) 140 (18.9%) 87 (11.8%) 53 (7.2%) 35 (4.7%) 
40-50 (N=1364) 695 (51.0%) 274 (20.1%) 184 (13.5%) 114 (8.4%) 97 (7.1%) 
50-60 (N=686) 335 (48.8%) 151 (22.0%) 93 (13.6%) 54 (7.9%) 53 (7.7%) 
>60 (N=215) 130 (60.5%) 47 (21.9%) 24 (11.2%) 7 (3.3%) 7 (3.3%) 
 
When looking at raw depression scores by age group, the mean and median score was highest 
in the <30s age group and lowest in those aged 60 and over. In terms of levels of depressive 
symptoms, however, the majority of participants reported 'none' or 'mild depression' in all 
groups.  
In unadjusted analysis, depression was highest in those aged <30 years and lowest in those 60 
and over (χ2, N=3178)=33.57, p=0.006, test for trend). However, this effect was not linear, as 
depression prevalence rose somewhat across the middle aged groups (30-60 years), then was 
lower among those aged ≥60. Next, individual symptoms of depression were explored. These 
are depicted, by question, in table 16, with prevalences shown for participants reporting 
symptoms as present for at least ‘more than half the days’. 
Table 16. Depressive symptoms ordered in relation to prevalence. 
 
Similar to the previous chapter, the most prevalent symptoms were ‘lack of energy’ (31.9%) 
and ‘Difficulty sleeping' (29.1%). These were followed by 'feeling bad about yourself' (24.4%) 
Symptom Present 
N=3178 N (%) 
Feeling tired or having little energy 1013 (31.9%) 
Trouble falling or staying asleep, or sleeping too much 924(29.1%) 
Feeling bad about yourself - or that you are a failure or have let yourself or your 
family down 
777 (24.4%) 
Feeling down, depressed, or hopeless 731 (23.0%) 
Little interest or pleasure in doing things 644 (20.3%) 
Poor appetite or overeating 590 (18.6%) 
Trouble concentrating on things, such as reading the newspaper or watching 
television 
567 (17.8%) 
Thoughts that you would be better off dead, or of hurting yourself in some way 342 (10.8%) 
Moving or speaking so slowly that other people could have noticed 227 (7.1%) 
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and 'feeling down, depressed, or hopeless (23.0%). In fact, as shown in Figure 14, fatigue 
symptoms were reported at a higher prevalence than depression overall. However, 'trouble 
concentrating' was far less prevalent (17.8%). The least prevalent depressive symptoms were 
'suicidal tendencies' and 'moving/speaking slowly'. This pattern held true for all age groups, 
but in those aged 60 and over 'feeling bad about self' and 'trouble concentrating' became less 
prevalent and 'little interest or pleasure in doing things' increased in likelihood.  
Figure 14. Prevalence of depressive symptoms (% reporting symptom for 'more than half 
days' or more) by age. 
 
Table 17 reports the mean and median PHQ-9 scores by time diagnosed with HIV. As can be 
seen, the mean and median depression scores increased with increasing time diagnosed with 
HIV, with an even greater increase between participants diagnosed for 10-20 years and over 20 
years. 
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Table 17. The average depression score (PHQ-9) by time diagnosed with HIV. 
Time diagnosed with HIV Mean S.D. Median 
0-2 years (N=410) 5.5 6.4 3 
2-5 years (N=498) 5.4 6.3 3 
5-10 years (N= 878) 6.4 6.9 4 
10-20 years (N=1130) 6.8 6.8 4 
>20 years (N=342) 8.1 6.9 7 
 
In unadjusted analysis, this effect was statistically significant (χ2, N=3258)=35.46, p<.001), with 
depression symptom prevalence increasing with increasing time diagnosed with HIV. 
Furthermore, this trend held for the majority of variables, except for 'suicidal tendencies', 
'moving/speaking slowly', and 'feeling bad about yourself', for which no significant difference 
was found in relation to time. This data is depicted in figure 15. 
Figure 15. Prevalence of depressive symptoms (% reporting symptom for 'more than half 
days' or more) by time diagnosed with HIV. 
 
The adjusted associations of age and time diagnosed with HIV with symptom prevalence are 
presented in Table 18. Using the overall symptom prevalence measure for depression, after 
adjustment for gender/sexuality and ethnicity, depression prevalence decreased with age. This 
trend held true across the majority of individual PHQ-9 symptoms, except 'trouble 
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concentrating', for which there was no overall trend with age. However, when further adjusted 
for by smoking status, alcohol and drug use, and money for basic needs the linear trend 
association between age and depression became non-significant (Odds Ratio=0.91, 95% 
C.I.=0.83-1.00, p=0.06 for trend across age groups). This suggests that some of the association 
between older age and lower depression prevalence was accounted for by differences in socio-
economic and/or lifestyle factors. 
Longer time diagnosed with HIV, on the other hand, was strongly related to higher prevalence 
of depression overall, and for each individual PHQ-9 symptom (test for trend across age 
categories ps<0.001). This relationship was not materially altered when further adjusted for by 
smoking status, alcohol and drug use and money for basic needs (Odds Ratio=1.31, 95% 
C.I.=1.19-1.44, p=<.001 for trend across time with diagnosed HIV groups). In general there was 
no difference in depression prevalence by gender/sexuality or ethnicity. 
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4.3.2 Anxiety 
Of the study population, 715 (21.9%) scored ≥10 on the GAD-7, indicative of moderate/severe 
anxiety. By diagnostic group, 696 (21.9%) of the population showed mild anxiety, 386 (12.1%) 
showed moderate anxiety, and 315 (9.9%) showed severe anxiety. The mean GAD-7 score was 
12.49 (S.D.=5.9), indicative of moderate anxiety: the median was 11 out of 21, also indicative 
of moderate anxiety. Table 19 reports the mean and median GAD-7 scores by age and Table 20 
reports the prevalence of each level of symptoms group by age.  
Table 19. The average anxiety score (GAD-7) by age group. 
Age in years Mean S.D. Median 
<30 (N=160) 13.7 6.3 12 
30-40 (N=688) 12.0 5.6 10 
40-50 (N=1260) 12.7 5.9 11 
50-60 (N=633) 12.9 6.2 11 
≥60 (N=190) 10.7 4.8 9 
 
Table 20. Prevalence of levels of anxiety (GAD-7 diagnostic group) by age group. 
Age None Mild Moderate Severe 
<30 (N=173) 86 (49.7%) 38 (22.0%) 23 (13.3%) 26 (15.0%) 
30-40 (N=740) 432 (58.4%) 163 (22.0%) 83 (11.2%) 62 (8.4%) 
40-50 (N=1364) 735 (53.9%) 308 (22.6%) 181 (13.3%) 140 (10.3%) 
50-60 (N=686) 379 (55.2%) 147 (21.4%) 80 (11.7%) 80 (11.7%) 
>60 (N=215) 149 (69.3%) 40 (18.6%) 19 (8.8%) 7 (3.3%) 
 
When looking at raw anxiety scores by age group, the mean and median score was highest in 
the <30s age group and lowest in those aged 60 and over, but in all groups the majority of 
participants reported 'none' or 'mild anxiety'. Therefore this effect was not significant. In 
unadjusted analysis, anxiety was highest in those aged <30 years and lowest in those 60 and 
over (χ2, N=3178)=33.77, p=0.001). Next, individual symptoms of the GAD-7 were explored. 
These are depicted, by question, in table 21. 
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Table 21. Symptoms of anxiety ordered in relation to prevalence. 
 
 
 
 
The most prevalent symptoms were ‘worrying too much (25.4%), ‘feeling nervous' (23.1%), 
and 'becoming easily annoyed' (22.2%). The least prevalent anxiety symptoms were 'feeling 
afraid', and 'restlessness'. As depicted in figure 16, this pattern held true for all age groups, but 
in those aged 60 and over 'feeling nervous' became less prevalent and 'lack of control' 
increased in likelihood. All anxiety symptoms were lowest in those aged 60 and over and 
highest in those aged <30, with little variation over the middle age ranges (30-60 years).  
Figure 16. Prevalence of anxiety symptoms (%) by age. 
 
Table 22 reports the mean and median GAD-7 scores by time diagnosed with HIV. Both the 
mean and median anxiety scores increased with increasing time diagnosed with HIV. 
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N=3178 N (%) 
Worrying too much about different things 806 (25.4%) 
Feeling nervous, anxious or on edge 735 (23.1%) 
Becoming easily annoyed or irritable 706 (22.2%) 
Trouble relaxing 703 (22.1%) 
Not being able to stop or control worrying 690 (21.7%) 
Feeling afraid as if something awful might happen 602 (18.9%) 
Being so restless that it is hard to sit still 460 (14.5%) 
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Table 22. The average anxiety score by time diagnosed with HIV. 
Time diagnosed with HIV Mean S.D. Median 
<30 (N=160) 4.4 5.2 3 
30-40 (N=688) 4.7 5.4 3 
40-50 (N=1260) 5.5 6.0 3 
50-60 (N=633) 5.7 5.8 4 
≥60 (N=190) 6.4 6.1 5 
 
In unadjusted analysis, this increase in anxiety with increasing time diagnosed with HIV was 
significant (χ2, N=3258)=29.53, p<.001). As depicted in figure 17, this pattern held true for all 
variables, except for 'feeling afraid as if something awful might happen' which did not differ 
significantly with time diagnosed with HIV. 
Figure 17. Prevalence of anxiety symptoms (%) by time diagnosed with HIV. 
 
The adjusted associations of age and time diagnosed with HIV with symptom prevalence are 
presented in Table 23 for anxiety overall and for individual symptoms of GAD-7. Using the 
overall symptom prevalence measure, after adjustment for gender/sexuality and ethnicity, 
anxiety prevalence decreased with age. This trend held true for the symptoms 'easily 
annoyed/irritable', 'trouble relaxing', and 'restlessness', but no significant trend with age was 
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found for any of the other symptoms. Anxiety was significantly higher in all age groups less 
than 60 years of age, in comparison to participants aged 60 and over, and highest in those 
aged under 30, in relation to all symptoms. This relationship was not materially altered when 
further adjusted for by smoking status, alcohol and drug use and money for basic needs (Odds 
Ratio=0.89, 95% C.I.=0.80-0.99, p=0.03 for trend across age groups). 
 Longer time diagnosed with HIV, on the other hand, was strongly related to increases in 
prevalence of anxiety and each GAD-7 symptom (test for trend across categories ps<0.001). 
This relationship was not materially altered when further adjusted for by smoking status, 
alcohol and drug use and money for basic needs (Odds Ratio=1.24, 95% C.I.=1.13-1.37, p=<.001 
for trend across age groups). In general there was no difference in anxiety prevalence by 
gender/sexuality or ethnicity in adjusted models.  
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4.3.3 The associations between physical and psychological symptoms 
Of the whole study population, 598 (18.8%) reported both depression and anxiety. This was 
equivalent to 68.9% of the participants with depression reporting anxiety and 85.2% of the 
participants with anxiety reporting depression(p<.001). Using chi squared tests, the association 
of depression and anxiety with CD4 count, symptom distress, and problems with ADLs were 
assessed. Both depression (PHQ-9 score ≥10) and anxiety (GAD-7 score ≥10) were related to a 
higher likelihood of physical symptom prevalence, increasing linearly from 8.2% (depression) 
and 2.6% (anxiety) among participants reporting no present symptoms to 58.4% and 41.2% 
reporting ten or more respectively. The same was found for distressing symptoms with 
prevalence of 12.6% and 3.4% for those reporting no distressing symptoms, compared to 
89.9% and 76.9% respectively among those reporting at least one. Finally, both depression and 
anxiety were also reported to a greater likelihood of reporting problems with ADLs. Neither 
depression nor anxiety prevalence were related to CD4 count. These associations were not 
greatly altered after adjustment for age and gender/sexuality. The percentages and p values 
are reported in table 24. 
Table 24. Physical symptom prevalence in relation to anxiety and depression. 
 Anxiety (GAD-7 score of ≥10) Depression (PHQ-9 score of ≥10) 
 Yes No 
p. value 
Yes No 
p. 
value 
10 or more 
symptoms 
606 (84.8%) 865 (34.0%) <.001 770 (87.1%) 701 (29.5%) <.001 
1 or more 
distressing 
symptom 
666 (93.1%) 1145 (45.0%) <.001 830 (93.9%) 981 (41.3%) <.001 
1 or more ADL 
problem 
518 (72.4%) 722 (28.4%) <.001 671 (75.9%) 569 (24.0%) <.001 
CD4 count >350 
573 (80.9%) 2047 (81.6%) 0.37 702 (80.4%) 
1918 
(81.8%) 
0.20 
 
Using a logistic regression model, interactions between a) age and b) time with diagnosed 
HIV (as grouped variables in a continuous form) with depression and anxiety were 
assessed in relation to physical health as the dependent variable. The models were 
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adjusted for ethnicity and gender/sexuality. Only one significant interaction was found. 
The logistic model assessing an interaction between age and anxiety, with ≥10 symptoms 
as the dependent variable, included the following factors: age (as a grouped variable in a 
continuous form), depression, time with diagnosed HIV (categorical variable), 
gender/sexuality, ethnicity, and the interaction between age (grouped variable in a 
continuous form) and anxiety. This revealed an interaction between age by anxiety, in 
relation to physical symptom prevalence (Odds Ratio for interaction=1.37, 95% C.I.= 1.07-
1.75, p=0.01). Table 25 shows that the association of anxiety with prevalence of ten or 
more physical symptoms, while present across all age groups, tended to increase with age.  
 
Table 25. The relationship between age, anxiety, and physical symptom prevalence. 
Age in years Anxiety* 
Physical symptom prevalence 
0-9 symptoms 10 or more symptoms 
<30 
No 85 (68.5%) 39 (31.5%) 
Yes 16 (32.7%) 33 (67.3%) 
30-40 
No 429 (72.1%) 166 (27.9%) 
Yes 32 (22.1%) 113 (77.9%) 
40-50 
No 684 (65.6%) 359 (34.4%) 
Yes 39 (12.1%) 282 (87.9%) 
50-60 
No 311 (59.1%) 215 (40.9%) 
Yes 16 (10.0%) 144 (90.0%) 
60+ 
No 120 (63.5%) 69 (36.5%) 
Yes 3 (11.5%) 23 (88.5%) 
*GAD-7 score of ≥10 
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4.4 Discussion 
The aim of this chapter was to assess, amongst the ASTRA population, the association of age 
with a) depression, b) anxiety, and c) associations between mental and physical symptoms and 
whether these associations differed according to age or time diagnosed with HIV, taking into 
account ender/sexuality and ethnicity.  
The results showed that 27.1% of the ASTRA population had moderate or severe depression, 
21.9% had moderate or severe anxiety, and 18.8% reported both. In adjusted analysis 
depression and anxiety prevalence there was a significant linear trend of decreasing 
prevalence with age. The changes with age in anxiety prevalence were not mediated by 
demographic or risk factors (money for basic needs, alcohol dependency, smoking status, and 
recreational drug use), but the changes in depression with age neared significance. This 
suggests that the comparatively high prevalence of depression in younger PWH are to some 
extent related to lower levels of health-related behaviours, or poorer socio-economic 
circumstances, among younger compared to older PWH. 
Anxiety and depression were both found to be related to an increase in symptom prevalence, 
symptom distress and problems with ADLs, but not CD4 count. With increasing age the 
relationship between anxiety and symptom prevalence strengthened, such that older adults 
with anxiety were more likely to report physical symptoms.  
Depression and anxiety are common in chronic illness58;63;219;221 and older age56-58 up until the 
age of 55, where prevalence may decrease again (according to UK statistics)218. Similar to the 
general population, the results showed rates of poor mental health which increased from the 
ages of 30-60, before decreasing in older age. However, the results also showed evidence that 
depression prevalence is roughly ten times higher amongst PWH when compared to 
prevalence found in the general UK population, and anxiety rates four times higher (27.3 vs. 
2.3% and 22.1 vs. 4.4% respectively)263. This strongly highlights the detrimental effects of HIV 
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on mental health, although it cannot prove causality. The results also underline the need to 
assess changes in well-being across the entire age spectrum, rather than combining all adults 
over the age of 50. 
 In the HIV-specific literature, depression has generally not been found to differ by age 
group64;120;129;138;145-148. This may be due to the high levels of depression identified in PWH of all 
ages84;85, which is thought to be related to poorer physical function84;85;87;88;258;259, health-
induced anxiety84;89;90, feeling a lack of control86;258;260, social isolation85;90-92;258;261, and 
maladaptive coping strategies89;91. Strong relationships were apparent between physical 
function, anxiety, and depression, in line with the first two conclusions. Only one question in 
the ASTRA study explored feeling of control ("Not being able to stop or control worrying" - 
GAD-7), which identified that 21.7% of PWH did not feel in control of their anxiety: very similar 
to the prevalence of overall depression and anxiety. However, as the data presented here is 
not longitudinal we cannot comment on the direction of these relationships. For example, 
while it is possible that poor physical function causes distress in PWH, it is also possible that 
depression causes poorer physical function through over-eating, sedentary 
behaviour60;63;91;222;223, and worse adherence to medication and health-management 
activities227-230. 
Unlike the previous literature, these results identified a decrease in depression and anxiety 
prevalence with age. As depression and anxiety prevalence increased with time diagnosed with 
HIV, this suggests that previous results shown in the literature are caused by the 
amalgamation of these two factors. Specifically, this may in part explain lack of trend with age 
in previous studies, as decreasing trends with age become more marked once adjusted for 
time with diagnosed HIV. As such, future studies should adjust for time with HIV when 
assessing the effects of age. However, the differences between ASTRA - and previous - results 
may also reflect differences between American and English populations, such as the lessened 
mental health burden caused by universal healthcare. 
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Depression was previously thought to be apparent in roughly 30% of OPWH91, which matched 
the unadjusted rates identified in the ASTRA participants aged 50-60 years old (29.2%) but not 
those aged 60 and over (17.7%). Only one previous study reported age-difference in 
depression in OPWH, which also found that depression became less prevalent in older-
OPWH261. This suggests that, with age, PWH may develop more adaptive coping methods and 
that this process may continue into later life.  
Anxiety has not been researched much in relation to older age, chronic illness or HIV, meaning 
that there is little data to compare to the present results. However, anxiety has been found to 
be higher in adults who report poor overall health249;255 and/or chronic illness252-254, which 
corresponds with the higher prevalence found in this population. Depression and anxiety are 
thought to be high in older adults in the general population due to disengagement with social 
roles due to declining health, bereavement, and increased economic strain57;59;60. In PWH these 
stressors are available at most ages so older adults may not be at an increased risk. Previous 
research also posits that older adults may face fewer high-demand situations due to 
retirement, leaving increased time and mental reserves for coping with physical distress264-266.  
Older adults have also been found to report fewer negative emotional experiences than 
younger adults237-239 and may selectively attend to positive events and situations241-244. This 
may explain the comparatively lower prevalence of depression with increasing age. It would 
also suggest that Cartensen's Socioemotive selective theory241 may still be applicable to an 
HIV-positive population. Alternatively, it is also possible that the results reflect better 
'resilience' in older adults200, developed throughout their lifespan90;135;152. However, the age-
related differences in depression (if not anxiety) were also mediated by the improved 
demographic variables in the older population (greater proportion with money for basic needs, 
lower alcohol dependency etc.), suggesting that age itself is not the only factor that needs to 
be taken into account when assessing depression in PWH. 
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In relation to the specific symptoms of depression and anxiety, the most common symptoms 
were 'feeling tired' (31.9%) and 'trouble sleeping' (29.1%). This correlates with the physical 
symptom prevalence reported in the last chapter, where the most common symptoms were 
'lack of energy' (64.9%), 'feeling drowsy/tired' (64.6%), and 'difficulty sleeping' (58.0%). The 
fact that the rates were twice as high in the MSAS-SF scale may indicate that participants 
consider these symptoms to be physical - rather than psychological - in origin. Alternatively 
this difference may be due to physical symptoms being coded as occurring at all in the past 
two weeks, while psychological symptoms had to occur for 'more than half the days' in the 
past two weeks.  
 
4.4.1 The relationship between mental and physical symptoms 
In the literature, depression has been associated with increased mortality and symptom 
burden, difficulties with ADLs and decreased health-care use56;57;200;221;222. Anxiety has been 
related to poor overall health249;255, chronic illness252-254, and an increase in health-related 
behaviours256;257. With anxiety and depression present, the prevalence and severity of 
symptoms and likelihood of reporting problems with ADLs increased in the ASTRA population. 
However, CD4 count did not differ by mental health status in relation to either variable. It can 
be argued that this occurred for two reasons: firstly a CD4 count of over 350 cells/mm3 was so 
prevalent in this sample (81.2%) that no statistical difference was apparent. Secondly, PWH 
who were highly depressed/anxious to the point of avoidant behaviour are unlikely to come to 
the clinics for check-up and so were not included in this study. However, the length of the 
study (two years) may preclude this. It is worth noting, at this point, that while we can accept 
the association between physical and mental health suggested in the literature due to its 
correlation to the current results, the association between depression and symptom 
prevalence can also be explained through methodological similarities: the PHQ-9 includes four 
questions on symptoms which were also present in the MSAS-SF (tiredness, difficulty 
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concentration, lack of appetite and difficulty sleeping). As this account for 44% of the PHQ-9 
symptoms one would expect a high rate of correlation between these two variables. 
Some differences in the association between mental and physical health were also observed 
by age. Specifically, in older PWH anxiety was related more strongly to symptom prevalence 
than in younger adults. This suggests that declines in physical health are of more concern to 
OPWH. It is possible that older PWH who report symptom prevalence are more anxious due to 
feelings of ageing prematurely262, bereavement86 and/or a failure to adapt to age-related 
health limitations267. However, in light of the lower symptom distress and lower anxiety 
reported in older adults than younger adults, it is more likely that the reverse is true: that 
having anxiety increases the likelihood of reporting symptom prevalence in older adults. This 
could relate to maladaptive health behaviours, which can cause disproportionately greater ill 
health in older adults due to immunosenesnce25;52;53;127;173.  
 
4.4.2 Time with diagnosed HIV 
With longer time diagnosed with HIV, depression, and anxiety prevalence increased both 
overall and in relation to each individual symptom. Furthermore, these changes continued to 
be significant when adjusted for demographic and risk factors associated with growing old with 
HIV (smoking status, alcohol and drug use, and money for basic needs). This result allows us to 
exclude the theory that depression is lower in OPWH due to increased depression prevalence 
at diagnosis. It also makes it likely that the ‘selective surivival’247 theory of positive mental 
health in older adults can be excluded from discussion. In other words, based on the strong 
correlation between good mental and physical health, it is unlikely that this population 
survived longer with HIV due to high prevalence of depression and anxiety. 
The few studies identified in the literature which explored time with diagnosed HIV reported 
that depression is higher in newly diagnosed PWH88;89;258 and improves as participants develop 
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more effective coping strategies and come to terms with their diagnosis. However the ASTRA 
results reported the opposite - with particularly high depression rates in PWH diagnosed for 
over 20 years - which suggests that PWH may not be developing effective coping strategies, or 
are experiencing too many changes in health-related stress over time to design effectively 
adaptive strategies.  
Alternatively, it is possible that the high rates of depression in participants diagnosed for 
longer than twenty years is due to the physical symptoms of depression included in the PHQ-9. 
Namely, the largest increases in prevalence in this group were in relation to 'tiredness/lack of 
energy' and 'difficulty sleeping', which is a common side-effect of HIV197-199. This would not, 
however, explain the increases in depression and anxiety over time overall, which suggests 
that mental symptom distress is not wholly related to the trauma of early HIV infection. 
These results suggest that adults are likely to cope better with HIV at older ages, but that this 
does not hold true for adults growing older with HIV. Based on the linear relationship between 
depression, anxiety and time diagnosed with HIV this does not appear to be related to 
calendar year of diagnosis, but it more likely a cumulative effect of living with HIV. In other 
words there is a need to distinguish between people who are diagnosed with HIV at an older 
age, and those who at a similar age have lived with HIV for many years: the latter are the 
group at much higher risk for psychological distress. It is possible that the reported increases in 
symptom prevalence and distress with time diagnosed with HIV leaves this subpopulation at 
risk of higher levels of HIV- and mortality-related stress. Furthermore, when faced with worse 
physical stressors, and changing health and mobility, it may be more difficult for these PWH to 
develop effective coping strategies217.This would be especially true in the face of reduced 
social support though bereavement. Indeed, anxiety rates have been related to low social 
support249;255, which will be explored in-depth in chapter 5.  
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4.4.3 Limitations 
Some limitations have already been mentioned in the discussion but, briefly, there are several 
main limitations to this analysis. Firstly, mental and physical health are inextricably interlinked, 
as were the measures used to assess symptom prevalence and depression. The overlap 
between these two scales may be responsible for the strong link between depression and 
symptom prevalence. Secondly, where no response was indicated in regards to questions from 
the PHQ-9 and GAD-7 we recorded the respondent as not feeling the symptom in the past two 
weeks. As such, the depression and anxiety prevalence reported here may be lower than is 
prevalent in the HIV-positive population. 
As mentioned before, the cross-sectional nature of this data prevents us from defining the 
direction of the relationship between mental and physical variables. Finally, due to the number 
of statistical tests run type I errors are a possibility. As such, the interactions between variables 
should be interpreted with caution. This should also be kept in mind in relation to the 
interactions presented in Chapter 5. 
 
4.4.4 Conclusions and Implications 
Previous data on PWH reported no difference in depression rates with age and insufficient 
data in relation to anxiety. Only one high-quality UK study was identified and the majority of 
researchers did not explore depression across more than two (<50> years of age) age groups, 
or the impact of amount of time diagnosed with HIV. The information provided in this chapter 
begins to address these limitations and suggest that a) depression and anxiety decrease with 
age in a UK population of PWH, b) that age-related changes in mental health occur beyond the 
'≥50 years of age' cut-off, and c) that time with diagnosed HIV needs to be taken into account 
when assessing age-related changes in mental health. More specifically, extremely high 
depression and anxiety prevalence was identified in the HIV-positive population, which in turn 
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were related to increased physical symptom prevalence, symptom distress and problems with 
ADLs. The results presented here appear to disprove the theory that low depression 
prevalence in OPWH is an artefact of increased depression prevalence at HIV diagnosis, as 
depression and anxiety increased in prevalence with time diagnosed with HIV. Finally, CD4 
count was shown to not be an appropriate measure of well-being in PWH, as it was generally 
unrelated to mental health. It can be suggested that the high prevalence of depression and 
anxiety in PWH are due to poorer physical function84;85;87;88;258;259, health-induced anxiety, and 
feeling a lack of control: as suggested in the literature.  
Depression and anxiety may be lower in OPWH due to adaptive coping methods, developed 
over the lifespan (as found in the general UK population), the 'positivity effect', fewer high-
stress demographic characteristics and/or mediating factors such as higher rates of resilience. 
Once again, time with diagnosed HIV was a much stronger predictor of poor well-being than 
age, and this did not seem to be related to calendar year of diagnosis before and after 
effective ART. This should be explored further.  
Depression and anxiety are important facets of well-being, both in themselves and in relation 
to their effects on health. The results so far strongly suggest differences in physical and mental 
well-being with age, but that older adults do not necessarily have a higher burden of 
symptoms. Adults ageing with HIV, however, show consistently poorer well-being and are in 
need of tailored care. In light of the high prevalence of depression and anxiety in the HIV-
positive population, however, it can be suggested that coping-improvement programmes are 
included in interventions to improve the well-being of PWH at all ages. It can also be 
suggested, in light of the 'time with diagnosed HIV' results, that it is imperative for HIV 
participant care to continue across a participant's lifespan: even when CD4 count is stable.  
  
143 
 
5 Age, time with diagnosed HIV, and social well-being 
5.1 Background 
Social, mental and physical health are strongly and inextricably linked as measures of well-
being. From a theoretical perspective, there are several possibilities as to why these 
relationships might exist. Social relationships might boost feelings of self-worth and self-
mastery, which are needed for health maintenance and well-being65;268. They may also enable 
encouragement of health-seeking and health-promoting behaviours - such as adherence to 
medication - through mimicry and reinforcement72;166;268;269. Finally, social relationships may 
create a buffer to psychological distress and provide physical support in the case of 
illness269;270. In the case of older adults, where chronic health conditions and complex 
medication management regimens are increasingly likely, social support may be especially 
important to physical and mental health adjustment. 
 
5.1.1 Social support 
Levels of social support are generally found to be lower in older adults than younger adults64-66. 
This difference has been attributed to several factors, including retirement97, illness64;97, loss of 
friends and family through bereavement64;97;117;271 and reduced mobility69;76. As such it has 
been observed that many older adults tend to focus on maintaining small, highly valued social 
groups in order to conserve emotional and physical resources, rather than developing a large, 
diverse, social network (Cartensen's socioemotional selectivity theory)64;67;68. An example of 
this is present in the Louisiana Healthy Aging Study (LHAS), which explored the effects of social 
support across age group in 364 American participants in 201371. They found that adults aged 
60-89 showed lower satisfaction with social support and a lower proportion of time spent in 
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social activities or outside their home compared to those aged 21-5971. This illustrates that not 
only is social support lower in older adults, but that may be affected by reductions in mobility. 
The reduction in social network size that may occur in older age does not undermine the 
importance of these relationships to older adult's mental and physical health. Indeed, social 
support has been well documented as being associated with health outcomes in later life70 as 
mentioned briefly in the previous chapters in relation to PWH. For example, older adults' 
family's attitudes to exercise have been identified as a barrier to physical fitness69 and, in 
return, PWH report becoming more selective of their social activities with age in order to 
conserve energy69;76. Similarly, depression may reduce social function in older PWH through 
disengagement with social roles57;59;60, and reduced social health, in turn, increases the risk of 
depression and anxiety through isolation85;90-92;258;261 and reduced coping resources (social 
support)249;255. Social isolation has also been associated with increased systolic blood 
pressure272 infection273, depression274 and mortality275. These relationships are especially 
salient in older adults72 with recent cross-sectional, longitudinal and qualitative studies 
showing that increased social support is related to reduced age-related declines in 
health71;72;276, increased physical activity69, decreased mortality risk73 and lower prevalence of 
depression74.  
 
5.1.2 Partner and Parental status 
Stable, long-term relationships can also promote health in a very similar way to general social 
support; stable relationships provide emotional and physical care, as well as economic 
support270. The health effects of marital status have been shown to accumulate over time277, 
becoming disproportionately large in older adulthood; with one study findings that married 
individuals show far higher rates of physical health than those without a partner; assuming 
that the partner is in good health269. This may be due to an increase in reliance on partners for 
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social support and physical support with decreasing social circle size269, as well as the role 
spouses have as informal care-givers in promoting their partner's well-being and medication 
management269. It is also possible that individuals feel an increased need for self-regulation of 
health in order to protect their loved ones from bereavement or chronic health care needs270. 
However, it is worth noting that no literature into the health effects of stable, long-term 
relationship or civil partnerships was found in relation to MSM; barring literature on fidelity 
and sexual health. While these relationships are likely to have a similar effect across 
sexualities, the lack of evidence is a limitation when applying these results to an HIV-positive 
population. 
Relative to their married counterparts, unmarried older adults have higher rates of chronic 
illness278 and mortality70. Furthermore, adults over 50 in self-assessed 'positive' relationships 
(those where they felt that they could rely on their partner for support) show lower prevalence 
of anxiety, depression and suicidal ideation than those in 'negative' relationships74. However, it 
is important to note that there is a level of selection in marriage; that is, partners with higher 
physical, mental, emotional and economic health are considered more desirable and are more 
likely to attain long-term relationship status268;279. Therefore it is possible that marriage itself 
does not have a large effect on health outcomes, but is simply an outcome of health-related 
selection bias. For example, a study using data from the 'National Health Interview Survey-
Longitudinal Mortality Follow-Up' (1986–2000, N=517,314) found no difference in mortality 
rates between married and divorced/separated adults, but found that participants who had 
never married had far higher mortality rates270; suggesting a difference in health-related to 
ability to attain, rather than retain, a partner. They did, however, find an increase in mortality 
rates in widowed participants270, suggesting that bereavement can have a large effect on 
health, which is particularly salient for the HIV-positive population. 
In relation to parental status, stress is often higher in adults with young children than those 
without280-282; possibly due to decreased sleep283-285 and increased responsibility and time-
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management concerns amongst care-givers286-289. Similarly, it has been noted that parents of 
young children may neglect their own health-related behaviours in favour of child care290;291; 
especially if the child is ill292;293. As such, it is possible that the presence of young children may 
detrimentally affect the medication management and mental health of PWH294. Adult children, 
however, are consistently recognised as important care-givers for elderly parents in terms of 
financial, physical and emotional care295-298. As such, they may be related with better mental 
and physical health in older PWH. 
 
5.1.3 Retirement 
Research from the general literature shows competing theories on the effects of retirement on 
physical and mental health. Compared to continued employment, retirement may improve 
health through lowered stress61;299 and increased time for social and physical activity300;301. For 
example, the German Socio-Economic Panel Study (SOEP) (N≈30,000) found that retirement 
improved self-rated health satisfaction and mental health and reduced the number of hospital 
visits when compared to employed participants in ages 60-65301. In multivariable analysis, 
higher health satisfaction and mental health in retired participants was related to longer sleep 
duration (p<.01) than in non-retired older adults, regular physical activity (p<.01) and longer 
time spent on home repairs and gardening (p<.05), suggesting that health-related behaviours 
are more frequent in retired adults in this population301. Similarly, the Survey of Health, Ageing 
and Retirement in Europe (SHARE) found that retirement was associated with a 35% decrease 
in reports of 'fair', 'bad', or 'very bad' health302 and the English Longitudinal study of ageing 
reported increases in exercise and leisure time physical activity after retirement174.  
In contrast, where occupation is a core concept of identity, retirement may worsen mental 
health; especially in those retiring early due to redundancy, ill health or familial health 
needs303;304. It also may reduce financial freedom305 and opportunities for social 
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engagement260;306. A large Australian, cross-sectional, study (N=267,000) of adults over the age 
of 45 collected in 2006-2008 found that psychological distress was higher in retired adults than 
those still employed, but lower than in participants who were unemployed or not working due 
to sickness/disability (p<.001)301;304. The Whitehall Study - a longitudinal study of UK civil 
servants (N=7,584) reported that retirement was related to fewer physical and mental health 
problems compared to continued employment past that age of 60 unless the retirement was 
due to ill health, in which case physical and mental health deteriorated after retirement300. 
While it is possible that this is related to distress due to illness rather than retirement, it is also 
possible that retirement in this situation may have a further deleterious effect on adjustment 
to older age. This fits with the results of the Australian study301;304 which seems to suggest 
adverse psychological consequences for retirement independent of physical health. 
 
5.1.4 Social factors related to ageing with HIV 
From the systematic review (Section 1.3.2.4) eight papers were found focusing on stigma, 
disclosure and social support in older adults with HIV. Geographical spread was somewhat 
skewed, with 19 papers from the USA, two from Africa and four from Canada. None were 
found using UK populations. No studies were identified relating to the effects of retirement or 
relationship status on the wellbeing of older PWH, although one study did mention that the 
fluctuations in health found in HIV make it difficult to maintain employment (published 
2012)96. 
Of these eight studies, six studies93;135;140;144;148;150 assessed differences in social support with 
age and three135;150;151 assessed differences in stigma. Overall, no differences were found, in 
relation to age group, for social isolation150, interactions140, support148 or stigma135;150;151 but 
subjective (satisfaction with) support was higher in older adults148 and disclosure was lower93. 
However, there were a limited number of studies addressing these issues, making conclusions 
148 
 
uncertain. As social support is extremely subjective, qualitative work and quantitative studies 
using non-validated instruments were also explored to identify social issues specific to older 
PWH. The results are described below. 
Ten further studies were identified, utilising interviews with PWH, with a total population of 
803 (range 15-226) OPWH, all published since 2003. Many participants expressed 
dissatisfaction with levels of emotional and practical support; especially in relation to friends 
and family94;96;307. Solitude was mentioned specifically as a defining factor of ageing with HIV, 
due to a loss of friends over time and difficulties in creating new social connections due to old 
age, HIV-related stigma, fatigue and illness96;98;99;308;309. In one study, HIV stigma in particular 
was considered by participants to be worse in older adults, who have a reduced understanding 
of the risks of transmission compared to younger family members96. However, the majority of 
reasons given for lack of support were personal, rather than due to HIV stigma. The most 
common reasons given for lack of support were; (1) nondisclosure of HIV status; (2) others’ 
fear of HIV/AIDS; (3) desire to be self-reliant and independent; (4) not wanting to be a 
burden310; (5) unavailability of family and (6) death of friends to AIDS307. 
The qualitative literature (2008-2015) also identified several themes related to reasons for 
non-disclosure amongst older adults. These included a) fear of consequences, b) protection of 
loved ones and c) not knowing how to disclose94;95;309;311. Specifically, it was founds that older 
adults were sometimes afraid of the potential for stigma and discrimination in their social 
group through direct and indirect (via second party) disclosure and were concerned about a 
decline in their desirability as a sexual partner95. Amongst social groups who were disclosed to, 
HIV-positive network members were most commonly identified94-96; in one case being over 16 
times more likely to be disclosed to than HIV-negative social groups95. The advantages of this 
group were that there was less need to monitor disclosure and there were opportunities to 
gain HIV-related advice and support94. The disadvantage was that the group is limited in size 
and availability due to illness and death94. Family were also mentioned as a source of physical 
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and emotional support; especially adult children94;99;309, but were also reported as a stressor by 
requiring support from the PWH or rejecting their sexual orientation97. 
These results coincided with those found in quantitative literature on older PWH. Specifically, 
of 160 PWH over the age of 50 in New York, 79% of participants reported unmet physical 
support needs and 57% reported unmet emotional support needs310;312. Participants were 
found to rely heavily on HIV positive friends for support312 and, while 67% had no partner and 
71% lived alone, family members were reported as a key source of support312. In another 
qualitative study (N=49) PWH reported their partners as a key source of social support and 
those without partners were concerned that ageing reduced their opportunity for future 
intimate relationships97. Similar results were found in a study focusing solely on older MSM, of 
which 65% lived alone but only 20% were receiving informal care from family313, suggesting 
that they may be at further risk of isolation. 
The Research on Older Adults with HIV (ROAH) study of 914 New York City-based OPWH in 
2005 found high levels of loneliness (UCLA Loneliness Scale) and stigma (HIV Stigma Scale) - 
scores of 43.9 and 88.9 respectively261. In relation to health, both stigma and loneliness were 
related to major depression in multivariable analysis (CES-D, 39.1% prevalence); a one unit 
increase on either the loneliness or stigma scales being related on average to a 6.4% and 1.3% 
increase in the odds of major depression respectively261. Bivariate analysis of HrQoL (SF-8) 
found a relationship with increased social support and a negative relationship to limited 
physical activity (ps<.05)313. A second American study of 199 MSM with HIV showed, through 
hierarchical multiple regression analysis, that social support (23-item Social Relationships 
Scale) was related to a 'Distress Composite Index', including stress, (10-item Perceived Stress 
Scale) depression (21-item BDI) and negative affect (16-item Affect Balance Scale) regardless of 
age308. While they found no direct relationship between social support and age, the authors 
did identify an age-by-social support interaction (B=-.190, p<.01); with lower social support 
causing more distress for older than younger MSM308. This suggests that, with age-related 
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stressors, small changes in social support may cause larger variations in mental health. This is 
depicted in Figure 18 below, adapted from the original paper308. 
Figure 18. "Social support by age interaction effect on the distress composite index 
(Regression lines illustrate the interaction effect for three age levels)"308. 
 
Finally, and in contrast to the previous literature, the AIDS Community Research Initiative of 
America (ACRIA) - a 12-year study of 160 PWH in New York published in 2005- reported that 
satisfaction with emotional support was related to higher levels of comorbid illnesses, HIV-
related care needs and higher levels of physical strain (ps<.05) when adjusted for age, sex and 
race310. The researchers suggest that this contrary finding relates to individuals' ability to 
mobilise their support networks more effectively when they have previous experience of 
illness, leading to higher satisfaction. Alternatively, the increased reliance on formal care 
systems related to ill health may alleviate their need for informal social support, thus 
increasing satisfaction with low levels of support310. However, I suggest a third option: that 
with increased support needs comes a more accepting outlook on the limitations of an 
individual's social system, such that older PWH who are more reliant on their informal care 
network are more aware of the burden they place on care-givers and so are happier with 
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lower levels of support. This could be further explored using a larger sample size and 
standardised measures of social support to validate the findings. 
It appears that, similar to the general ageing population, social support affects mental and 
physical health in older PWH, and overall satisfaction with support tends to be low; making it 
an important factor to consider when measuring well-being in this population. Few of these 
studies included participants under the age of 50 - so it is unclear whether these findings differ 
by age group. However, several of the factors studied appear to be related to age: age-related 
reductions in social support were reported, as were higher levels of HIV stigma in older 
friends/family and more experience of bereavement. HIV positive support groups also appear 
to be particularly important to OPWH94-96 and could be potentially be utilised by clinicians to 
improve well-being. 
 Since no difference was found in levels of social support by age in the systematic review, it is 
possible that overall levels of social support do not differ with age in this population but that 
the reasons behind isolation and disclosure are age-specific. However, since there were few 
studies addressing these issues, no UK studies, and the results that were available generally 
did not include information on retirement or relationship status, this conclusion is tentative 
and further studies are needed. Similarly, no studies compared social health factors by 
gender/sexuality, making it unclear whether MSM have unique issues in support and 
disclosure. 
 
5.1.5 Aims 
The current analysis aims to address these issues using the ASTRA118 study. The aims are as 
follows: to assess the association of age with a) social support, b) relationship and parental 
status, c) disclosure of HIV status and d) employment status, taking into account time since HIV 
diagnosis and other demographic factors. The relationship of each of these social factors with 
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physical and mental symptom symptoms will also be explored individually and as interactions 
in relation to age and time with diagnosed HIV.  
 
5.2 Methods 
As described in chapter 2, section 2.2.3, participants completed a self-administered 
questionnaire including, in relation to this analysis questions on; their relationship status, 
relationship length, partner's HIV status, state of disclosure to their partner, family, friends and 
work colleagues, their current levels of social support (the modified Duke–UNC FSSQ scale)158 
and current occupational status. 
 
5.2.1 Symptom measures  
Social support was quantified using the modified Duke–UNC FSSQ scale158, wherein 
participants were asked five questions relating to their satisfaction with their social support. 
These questions were: 'I have people who care what happens to me', 'I get love and affection, 
'I get chances to talk to someone I trust about my personal problems', 'I get invitations to go 
out and do things with other people' and 'I get help when I am sick in bed'. Each question was 
scored from 1-5, with five being 'as much [support] as I would like' and one being 'much less 
than I would like'. These scores were then amalgamated to create an overall scale of social 
support, ranging from 5-25. For the purpose of the analysis, social support was classified as 
'sufficient' if participants scored ≥20 on the scale, which corresponded with scoring 'almost as 
much [support] as I would like' on all five questions, or 'as much [support] as I would like' on at 
least four. Answers to each individual social support question was also assessed, where social 
support was considered to be present if participants reported having 'almost as much as I 
would like' or 'as much as I would like' in response to the individual question. 
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Relationship status was divided into those in a relationship (living, or not living with partner) or 
not as assessed by the question "Are you currently in an ongoing relationship with a partner 
(wife/husband or civil partner or girlfriend/boyfriend)?". Length of relationship was divided 
into ≥10 years or <10 years and, where a partner was identified as being present, partner HIV 
status was analysed as 'HIV positive/not positive'. Participants were also asked to report 
whether or not they had children, which was categorised as 'yes' or 'no'. 
Disclosure was assessed as a combined measure, defined as responding 'yes' or 'no' to the 
question "Apart from health care staff, have you told anyone that you have HIV?", and by self-
report of disclosing HIV status to 'some' or 'most or all' of individual social groups (partner, 
family, friends, and colleagues). 
Finally, employment status was categorised as 'employed', 'unemployed', 'not working due to 
sickness/disability' or 'retired'. 'Money for basic needs' was assessed as a binary variable; 
'always having money for basic needs' or not (the latter category included ‘mostly’ ‘sometimes’ 
and not having enough money).  
 
5.2.2 Statistical analysis  
Age in years was grouped into the following categories: <30, 30-39, 40-49, 50-59, and ≥60 
years. Differences in participant characteristics by age were assessed using chi squared tests 
and chi-squared tests for trend.  
Prevalence of social support, relationship status and length, child presence, disclosure, 
employment status and 'money for basic needs' were calculated overall and according to age 
group, and differences between age groups were assessed using chi squared tests for trend. 
Logistic regression was used to assess the association between age group and each of the 
social measures (dependent variables), adjusting for gender/sexuality (MSM, heterosexual 
man, woman), ethnicity (White, other) and time since diagnosis of HIV (<2 years, 2-5 years, 5-
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10 years, 10-20 years, >20 years). Age was fitted as a categorical variable in the models, with 
age>=60 years used as the reference category. In additional models, age was fitted as an 
ordinal variable with values 1 to 5, rather than defined as categorical and tests for linear trend 
across age groups were performed. Results are presented as odds ratios with 95% confidence 
intervals. 
Where significant differences in symptom prevalence were found in relation to age or time 
with diagnosed HIV, further regression analysis was conducted. This was adjusted for potential 
confounding or mediating health-related risk factors which had been identified as differing by 
age or time diagnosed with HIV in Chapter 2: money for basic needs (always/not always), 
alcohol dependence assessed by CAGE questionnaire (yes/no), recreational drug use in the 
past three months (yes/no) and smoking status (smoker/non/ex-smoker). Due to the nature of 
social measures, the results may also differ by gender/sexuality. As such, associations between 
age group, time with diagnosed HIV and each social measure are further presented by 
gender/sexuality group (MSM, heterosexual men, women), and interaction tests were 
performed between gender/sexuality and (i) age, (ii) time with diagnosed HIV (grouped 
variables in a continuous form), in relation to each of the social measures as dependent 
variables, in order to formally assess whether associations differed between the 
gender/sexuality groups.  
The relationship between psychological (depression and anxiety), physical (symptom 
prevalence, distress, problems with ADLs and CD4 count), and social (social support, partner 
and parental status, HIV status disclosure, employment and money for basic needs) symptom 
measures were assessed using chi squares tests for trend and logistic regression analysis, 
adjusted for gender/sexuality (MSM; heterosexual man; woman) and ethnicity (white/non-
white). These associations were also analysed as interactions of anxiety and depression 
adjusted for a) age and b) time diagnosed with HIV (grouped variables in a continuous form) in 
comparison to physical and psychological symptom measures (section 5.3.5). 
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5.3 Results 
5.3.1 Social support 
Sufficient social support (assessed by Duke–UNC FSSQ scale) was apparent in 1936 (63.9%) of 
participants and insufficient social support in 1095 (36.1%). By individual question: 77.0% of 
participants indicated sufficient support in terms of having people who cared what happened 
to them, 71.5% got help when sick in bed, 70.2% got sufficient love and affection, 69.2% got 
chances to talk to someone about personal problems and 67.4% got invitations to go out with 
other people. Figure 19 shows the associations with age. 
Figure 19. Prevalence of sufficient social support (%) by age. 
 
 The prevalence of sufficient social support decreased with age between the years of 40 and 
60, being stable beforehand and higher in those aged 60 and over. When adjusted for time 
with diagnosed HIV, sexuality/gender and ethnicity the overall association between age and 
sufficient social support became non-significant. However, participants aged 50-60 had 
significantly lower levels of social support compared to PWH aged 60 and over. Similar results 
were observed across individual questions, except for 'I get invitations to go out' and 'I get help 
when sick in bed', where there was stronger evidence for an increasing trend of adequate 
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social support with older age, and almost all age groups reported significantly lower 
satisfaction with social support than those aged 60 and over. 
As shown in Figure 20, longer time diagnosed with HIV, on the other hand, was strongly 
related to decreases in the overall prevalence of adequate social support and each individual 
component (test for trend across categories, ps<0.001). In general there was no difference in 
prevalence of adequate social support by gender/sexuality or ethnicity in adjusted analyses. 
Results are depicted in Table 26. 
Figure 20. Prevalence of sufficient social support (%) by time diagnosed with HIV. 
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5.3.2 Partner status and Parental status 
Relationship status was as follows: 1284 (39.4%) participants were living with a partner, 523 
(16.1%) had a partner but did not live together and 1420 (43.6%) did not have a long-term 
partner. Of those that were in a relationship, 707 (21.7%) had been in the same relationship 
for ten or more years and 765 (23.5%) had partners who were diagnosed with HIV. No 
association was found between partner's HIV status and relationship length. In regards to 
parental status, 883 (27.3%) of participants reported having children. Of those with children, 
59.6% were in a relationship and 48.2% had been in the relationship for ten or more years. 
Figure 21 shows the associations of partner status factors and parental status with age as a 
percentage of the whole ASTRA population. 
Figure 21. Prevalence of relationship and parental status' (%) by age. 
 
 Older HIV-diagnosed people were less likely to be in a relationship (46.5% of 60 and over vs. 
60.7% of under 30s, p=0.017, chi-squared test for trend across age groups) but, where they 
were in a relationship, were much more likely to have been in the same relationship for ten or 
more years (39.5% of >50s vs. 1.5% of <30s, p<.001). With age, PWH became increasingly likely 
to have children (40.6% of >60s vs. 15.8% of <30s, p<.001). No age difference was found for 
partner's HIV status in unadjusted analysis.  
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
<30 (N=163) 30-40 
(N=693) 
40-50 
(N=1281) 
50-60 
(N=643) 
>60 (N=185) 
P
e
rc
e
n
ta
ge
 o
f 
ag
e
 g
ro
u
p
 
Age in Years 
Partner present 
Partner >10 years 
Partner HIV positive 
Children 
160 
 
Figure 22. Prevalence of relationship and parental status' (%) by time diagnosed with HIV. 
 
As shown in Figure 22, participants were less likely to be in a relationship with increasing time 
diagnosed with HIV between 2-5 years of diagnosis and over twenty years (60.2% vs. 51.9%, 
p=0.03) but, where they were in a relationship, were more likely to have been in the same 
relationship for ten or more years (32.7% vs. 59.6%, p<.001). With increasing time diagnosed, 
PWH became less likely to have children (31.9% of participants diagnosed for 0-2 years vs. 
16.6% of participants diagnosed for over 0 years, p<.001). No difference was found for 
partner's HIV status in relation to time diagnosed with HIV in unadjusted analysis.  
When adjusted for time with diagnosed HIV, sexuality/gender, and ethnicity, the association 
between age and relationship status remained, with the odds of being in a relationship 
decreasing with increasing age. The opposite linear relationship was found for relationships 
lasting ten or more years, with PWH over the age of 60 being the most likely to be in a long-
term relationship, and no relationship was found between partner's HIV status and age. 
Finally, the likelihood of being a parent increased with age (table 27). The relationship 
between age and relationship status was not materially altered when further adjusted for by 
smoking status, alcohol and drug use and money for basic needs (Odds Ratio=0.89, 95% 
C.I.=0.82-0.97, p=0.01, for trend across age group), nor was the relationship between age and 
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relationship length (Odds Ratio=2.00, 95% C.I.=1.75-2.30, p<.001, for trend across age group) 
or parental status (Odds Ratio=2.24, 95% C.I.=1.94-2.57, p<.001, for trend across age group). 
In relation to time diagnosed with HIV, in adjusted analysis the odds of being in a relationship 
were higher in those who had been diagnosed for 2-20 years than 0-2 years, but no linear 
trend was apparent in relation to partner status. Participants were more likely to be in a long-
term relationship the longer they had been diagnosed with HIV and less likely to be a parent, 
but no trend was observed in relation to partner's HIV status. In terms of gender/sexuality or 
ethnicity, few associations were observed, except that heterosexual males were more likely to 
be in a relationship than MSM or women, women were more likely to have an HIV positive 
partner and both heterosexual men and women were much more likely to have a child than 
MSM. Participants of white ethnicity were less likely to have children. The results are depicted 
in Table 27.  
When logistic regression analysis was stratified by gender/sexuality, test for trends across age 
groups and time with diagnosed HIV groups in relation to having a partner present only 
continued to be significant for women, where the odds of having a partner decreased with 
age. No significant trend was apparent for the two male groups (MSM and heterosexual men). 
This interaction between age and gender/sexuality with regard to partner status was 
significant (Odds Ratio for interaction term for women vs. all men =0.83, 95% C.I.=0.76-0.92, 
p<.001). Similarly, odds of being in a long-term relationship increased with age in women but 
decreased with age for MSM and did not change significantly with age for heterosexual men. 
Parental status increased with age for all three gender/sexualities, with no significant 
interaction. The number of years diagnosed with HIV was not related to relationship or 
parental status in any gender/sexuality group individually, except that the odds of being a 
parent decreased with time diagnosed with HIV in MSM. No interaction tests were significant 
in relation to time with diagnosed HIV and gender/sexuality. These results are depicted in 
Table 28a-c. 
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Table 28a. Adjusted association of age and time with diagnosed HIV with relationship and 
parental status in MSM (logistic regression analysis). 
(N=2248) Partner present Partner for ≥10 years Parental status (child 
present) 
Independent 
Variable 
p. 
value 
Odds 
ratio 
95% C.I. p. 
value 
Odds 
ratio 
95% C.I. p. 
value 
Odds 
ratio 
95% C.I. 
Age  0.37   0.30   <.001   
Test for trend 0.76 0.99 (0.90, 1.08) 0.05 0.88 (0.77, 1.00) <.001 2.06 (1.70, 2.48) 
<30 0.35 1.28 (0.76, 2.13) 0.09 1.89 (0.90, 3.96) <.001 0.12 (0.04, 0.33) 
30-40 0.20 1.29 (0.88, 1.88) 0.06 1.72 (0.98, 3.02) <.001 0.08 (0.04, 0.15) 
40-50 0.07 1.38 (0.97, 1.95) 0.22 1.38 (0.82, 2.33) <.001 0.22 (0.13, 0.36) 
50-60 0.05 1.44 (1.00, 2.07) 0.25 1.38 (0.80, 2.37) <.001 0.39 (0.24, 0.64) 
60+*  1   1   1  
Years with 
diagnosed HIV  
0.44   0.44   0.62   
Test for trend 0.87 1.01 (0..93, 1.09) 0.88 1.01 (0.91, 1.12) 0.01 0.82 (0.71, 0.94) 
0-2*  1   1   1  
2-5 0.16 1.27 (0.91, 1.76) 0.17 1.39 (0.87, 2.20) 0.27 0.69 (0.36, 1.33) 
5-10 0.14 1.26 (0.93, 1.70) 0.09 1.44 (0.94, 2.21) 0.28 0.73 (0.41, 1.29) 
10-20 0.21 1.21 (0.90, 1.62) 0.27 1.28 (0.84, 1.92) 0.04 0.57 (0.33, 0.99) 
20+ 0.83 1.04 (0.73, 1.49) 0.67 1.12 (0.67, 1.86) 0.01 0.37 (0.19, 0.74) 
Ethnicity  Other*  1   1   1  
White 0.47 1.07 (0.89, 1.28) 0.03 1.32 (1.03, 1.70) 0.16 0.77 (0.53, 1.11) 
    * reference group 
 
Table 28b. Adjusted association of age and time with diagnosed HIV with relationship and 
parental status in heterosexual men (logistic regression analysis). 
(N=373) Partner present Partner for ≥10 years Parental status (child 
present) 
Independent 
Variable 
p. 
value 
Odds 
ratio 
95% C.I. p. 
value 
Odds 
ratio 
95% C.I. p. 
value 
Odds 
ratio 
95% C.I. 
Age  0.36   0.14   <.001   
Test for trend 0.71 0.95 (0.74, 1.22) 0.66 0.94  (0.70, 1.25) <.001 2.00 (1.50, 2.66) 
<30 0.29 0.43 (0.09, 2.04) 0.74 0.66 (0.06, 7.45) <.001 0.02 (.003, 0.14) 
30-40 0.98 0.99 (0.39, 2.48) 0.23 2.00 (0.65, 6.21) .001 0.12 (0.04, 0.40) 
40-50 0.92 1.04 (0.47, 2.30) 0.03 3.07 (1.12, 8.39) .003 0.19 (0.06, 0.58) 
50-60 0.28 0.63 (0.27, 1.45) 0.07 2.74 (0.93, 8.12) 0.06 0.32 (0.10, 1.06) 
60+*  1   1   1  
Years with 
diagnosed HIV  
0.80   0.89   0.18   
Test for trend 0.83 1.02 (0.84, 1.24) 0.81 1.03 (0.82, 1.28) 0.34 0.90 (0.74, 1.11) 
0-2*  1   1   1  
2-5 1.00 1.00 (0.47, 2.14) 0.92 1.05 (0.43, 2.55) 0.03 0.41 (0.18, 0.93) 
5-10 0.48 1.29 (0.64, 2.59) 0.60 1.24 (0.56, 2.71) 0.43 0.74 (0.34, 1.58) 
10-20 0.82 0.93 (0.47, 1.80) 0.89 0.95 (0.43, 2.09) 0.22 0.62 (0.29, 1.33) 
20+ 0.50 1.46 (0.49, 4.38) 0.50 1.53 (0.45, 5.16) 0.10 0.39 (0.13, 1.19) 
Ethnicity  Other*  1   1   1  
White 0.08 0.62 (0.37, 1.06) 0.54 0.82 (0.43, 1.56) 0.01 0.46 (0.27, 0.81) 
    * reference group 
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Table 28c. Adjusted association of age and time with diagnosed HIV with relationship and 
parental status in women (logistic regression analysis). 
(N=637) Partner present Partner for ≥10 years Parental status (child 
present) 
Independent 
Variable 
p. 
value 
Odds 
ratio 
95% C.I. p. 
value 
Odds 
ratio 
95% C.I. p. 
value 
Odds 
ratio 
95% C.I. 
Age  <.001   0.10   <.001   
Test for trend <.001 0.60 (0.49, 0.73) 0.01 1.48 (1.12, 1.96) <.001 2.61 (2.01, 3.40) 
<30 <.001 12.54 (3.70, 42.57) 0.05 0.09 (0.01, 0.96) .001 0.02 (.003, 0.20) 
30-40 .002 5.49 (1.89, 15.99) 0.09 0.14 (0.01, 1.32) 0.02 0.09 (0.01, 0.71) 
40-50 0.01 4.12 (1.45, 11.74) 0.14 0.19 (0.02, 1.76) 0.09 0.17 (0.02, 1.32) 
50-60 0.14 2.30 (0.76, 6.92) 0.27 0.28 (0.03, 2.77) 0.75 0.70 (0.08, 6.21) 
60+*  1   1   1  
Years with 
diagnosed HIV  
0.01   0.24   0.06   
Test for trend 0.85 0.99 (0.84, 1.16) 0.52 0.93 (0.74, 1.17) 0.13 0.86 (0.71, 1.05) 
0-2*  1   1   1  
2-5 .002 2.85 (1.47, 5.51) 0.48 0.73 (0.30, 1.77) 0.72 0.88 (0.42, 1.82) 
5-10 0.21 1.42 (0.82, 2.47) 0.76 1.14 (0.50, 2.57) 0.71 1.13 (0.59, 2.19) 
10-20 0.07 1.69 (0.95, 3.01) 0.81 0.90 (0.38, 2.12) 0.56 0.81 (0.40, 1.63) 
20+ 0.68 0.84 (0.36, 1.94) 0.08 0.26 (0.06, 1.15) 0.02 0.32 (0.12, 0.81) 
Ethnicity   Other*  1   1   1  
White <.001 2.91 (1.67, 5.07) 0.28 1.42 (0.75, 2.68) 0.89 0.96 (0.52, 1.76) 
    * reference group 
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5.3.3 Disclosure 
Self-report of disclosure of HIV status to persons other than health-care staff was reported by 
2962 (91.6%) of participants. Of these, 1770 (59.8%) had told their partner/wife/husband, 
1626 (49.9%) had told some family members, 2055 (63.1%) had told some friends and 774 
(23.8%) had told work colleagues. Figure 23 shows the associations with age. 
Figure 23. Prevalence of HIV status disclosure (%) by age. 
 
Disclosure of HIV status to friends was high across all age groups, followed in prevalence by 
disclosure to a partner or family member. In unadjusted analysis prevalence of disclosure 
remained relatively constant between the ages of 30 and 60, but decreased significantly in 
those aged 60 and over (ps<0.01, for trend across age groups). This occurred in all disclosure 
sub-groups except family members, which was similar across age group, but lower in 
participants aged 30-40 compared to other age groups (p<0.03).  
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Figure 24. Prevalence of HIV status disclosure (%) by time diagnosed with HIV. 
 
Disclosure of HIV status increased with increasing time diagnosed with HIV, especially in 
relation to disclosure to friends and family (ps<.001). This occurred in all disclosure sub-groups 
(figure 24). 
In adjusted analysis the relationship between age and disclosure of HIV status became more 
significant, with odds of disclosure decreasing with older age for the overall disclosure 
measure and each individual subcategory. This relationship was not materially altered, but was 
somewhat attenuated, when further adjusted for by smoking status, alcohol and drug use and 
money for basic needs (Odds Ratio=0.80, 95% C.I.=0.67-0.94, p=0.01 for trend across age 
groups). 
Time with diagnosed HIV was also related to disclosure prevalence overall and in each social 
group in adjusted analyses, with increased time with diagnosed HIV relating to higher levels of 
disclosure (ps≤.001 for trends across categories for all). Compared to MSM, heterosexual men 
were less likely to have disclosed overall or to friends or work colleagues (ps<.001) but more 
likely to have disclosed to a partner (p=0.001). Women were also less likely to have disclosed 
overall or to friends or colleagues but were also less likely than MSM to have disclosed to their 
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partner and more likely to have disclosed to family (ps≤0.01). Participants who were white 
were more likely to have disclosed to someone other than health care professionals and more 
likely to have disclosed to family, friends and work colleagues (ps≤.001) than other ethnicities. 
These results are depicted in Table 29. 
As gender/sexuality differences were apparent in the regression analysis, disclosure 
associations were also assessed within gender/sexuality group. Overall disclosure rates were 
highest in MSM (95%) and lowest in heterosexual men (84.3%) and women (83.4%). 
Heterosexual men were most likely to have disclosed to their partner (62.2%), followed by 
MSM (55.1%) and women (47.1%) but women were most likely to have disclosed to other 
family members (52.1%; MSM=50.2%, het. men=44.2%). MSM were far more likely to have 
disclosed their status to their friends (76.3%) than women (36.9%) or heterosexual men 
(28.2%), as well as to have disclosed to work colleagues (31.1%; heterosexual men=8.8%, 
women = 6.6%).  
When logistic regression analysis was stratified by gender/sexuality, test for trends across age 
and time with diagnosed HIV remained significant, with increasing age associated with lower 
odds of disclosure, and increasing time diagnosed with HIV associated with higher odds of 
disclosure within each gender/sexuality group. Trends of decreasing disclosure with increasing 
age were similar across groups (although not significant among heterosexual men), with no 
significant interaction between gender/sexuality and age (Odds Ratio=1.08, 95% C.I.= 0.93-
.125, p=0.31, odds ratio for interaction). Similarly, ‘years diagnosed with HIV’ was only related 
to disclosure to friends and colleagues; which increased with time diagnosed with HIV in 
interaction tests. However, it is possible that the lack of significant differences is due to the 
comparatively small number of heterosexual male participants (n=373). These results are 
depicted in Table 30a-c. 
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5.3.4 Employment and Retirement 
Many of the participants (N=1821; 49.3%) were employed, 577 (17.7%) were unemployed, 420 
(12.9%) were not working due to sickness/disability, 192 (5.9%) were retired, 99 (3.0%) were 
students, and 37 (1.1%) took care of the home. Overall, less than half (1392; 42.7%) of 
participants reported that they had enough money for basic needs all the time, while 400 
(12.4%) reported never having enough money for basic needs. Figure 25 shows the 
associations with age. 
Figure 25. Employment and money for basic needs (%) by age. 
 
While 'money for basic needs' increased (30.8% - 55.2% prevalence) with older age, being in 
employment decreased with age; and unemployment and not being in work due to 
sickness/disability increased in prevalence from the ages of 30-60 (ps<.001, for trend across 
age groups for employment status and money for basic needs). The prevalence of 
employment, unemployment and not working due to sickness/disability all decreased in 
participants over the age of 60 compared to younger age groups; as retirement became highly 
prevalent. Figure 26 shows the associations with time diagnosed with HIV. 
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Figure 26. Employment and money for basic needs (%) by time diagnosed with HIV. 
 
'Money for basic needs' remained stable across time with diagnosed HIV groups. However, 
employment was shown to decrease with increasing time with diagnosed HIV; and not working 
due to sickness/disability increased (ps<.001). Retirement was also found to increase with 
increasing time with diagnosed HIV.  
Adjusted analyses were conducted for ‘money for basic needs’. In adjusted analysis the 
association between age and 'money for basic needs' was significant, but there was no overall 
trend with age. The main difference was that adults aged 50-60 were significantly less likely to 
have money for basic needs than those aged 60 and over. There was also a nonsignificant 
association between with diagnosed HIV and ‘money for basic needs’ in adjusted analysis. This 
is depicted in Table 31. 
When analysed by separate gender/sexuality subgroup, employment was highest in MSM 
(81.1%) compared to heterosexual men (63.4%) and women (64.0%), as was money for basic 
needs (92.0%; heterosexual men = 80.2%, women = 75.4%). This trend held true in PWH over 
the age of 50, with employment highest in MSM (43.3%) compared to heterosexual men 
(31.7%) and women (33.9%). However, comparatively more MSM over the age of 50 were also 
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retired (21.0%; het. men = 20.3%, women =12.2%) and fewer were unemployed (13.7%; het. 
men = 22.0%, women =23.5%). Finally, older women were most likely to report being 
sick/disabled (20.0%; MSM = 18.3%, het. men = 15.4%). The results are depicted in Figure 27. 
Figure 27. Employment and money for basic needs (%) by gender/sexuality. 
 
When logistic regression analysis for money for basic needs was stratified by gender/sexuality, 
test for trends across age and time with diagnosed HIV remained nonsignificant, with neither 
increasing age nor increasing time diagnosed with HIV associated with higher odds of having 
money for basic needs within each gender/sexuality group. No significant interaction was 
identified between gender/sexuality and age. These results are depicted in Table 31. 
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5.3.5 The associations between physical, psychological and social factors of well-
being 
Using chi squared analysis, the associations between the social health measures and 
depression, anxiety, CD4 count, symptom prevalence and distress and problems with ADLs 
were assessed. 
 
5.3.5.1 Social support 
Social support, both overall and across all components of the social support questionnaire, was 
related to a decreased likelihood of symptom prevalence and distress (34.5% prevalence of 
symptom prevalence in adults with sufficient social support overall vs. 67.0% prevalence with 
insufficient social support, and 44.0% prevalence of distressing symptoms vs. 77.4% 
respectively). Social support was also related to roughly a 50% reduction in prevalence of 
participants reporting difficulties with ADLs (27.0% prevalence of ADLs in participants with 
sufficient social support vs. 59.3% in those without) and a 75% reduction in the odds of having 
clinically significant depression (13.4% prevalence of depression vs. 52.6%) or anxiety (10.6% 
vs. 43.1%). No association was found between social support and CD4 cell count. These 
associations were not greatly altered after adjustment for age and gender/sexuality. The 
percentages and p values are reported in Table 32.  
Using a logistic regression model, interactions between a) age and b) time with diagnosed HIV 
as grouped variables in a continuous form with social support were assessed in relation to 
physical health as the dependent variables. The models were adjusted for ethnicity and 
gender/sexuality. No significant interactions were found.  
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5.3.5.2 Relationship status 
Having a partner present was strongly related to having sufficient social support - prevalence 
of sufficient social support was 69.0% for those with a partner vs. 35.2% for those without 
(p<.001), while amongst participants with a partner, having an HIV positive partner was 
negatively related to social support (41.2% reporting sufficient social support and an HIV 
positive partner vs. 46.5% with an HIV negative partner, p=0.04). Having a child was related to 
lower levels of social support (24.8% with a child and sufficient social support, vs. 27.8% 
respectively, p=0.04). 
Having a partner present was also strongly related to all physical and mental health factors. 
More specifically, having a partner present was related to a significantly prevalence of 
participants having a CD4 count >350 cells/mm3 (82.5% for partner vs. 78.8% where no partner 
was reported), and lower physical symptom prevalence (40.6% reporting physical symptom 
prevalence vs. 50.9% respectively) or distress (50.6% vs. 61.8%), problems with ADLs (31.9% vs. 
45.9%), depression (20.0% vs. 36.3%) or anxiety (17.1% vs. 28.1%). Being in a long-term 
relationship was associated with a lower prevalence of depression (16.7% vs. 22.3%) and 
anxiety (13.0% vs. 19.9%). However, having a partner who is HIV positive was associated with 
an increase in prevalence of symptom distress (53.3% vs. 48.6%) and no other measures. 
Having a child was associated with a lower CD4 count (77.3% vs. 83.2%) and an increase in 
anxiety (24.3% vs. 21.1%). These associations were not greatly altered after adjustment for age 
and gender/sexuality. The percentages and p values are reported in Table 33.  
Using a logistic regression model, interactions between a) age and b) time with diagnosed HIV 
(grouped variables in a continuous form) with partner and parental status compared to 
physical and mental health were explored, adjusted for ethnicity and gender/sexuality. No 
significant interactions were found in relation to age.  
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When adjusted for time diagnosed with HIV, three significant interactions were found. The 
logistic model assessing an interaction between time with diagnosed HIV and relationship 
status, with a Duke–UNC FSSQ scale score of ≥20 as the dependent variable, included the 
following factors: time with diagnosed HIV (as a grouped variable in a continuous form), 
relationship status, age (categorical variable), gender/sexuality, ethnicity, and the interaction 
between time with diagnosed HIV (as a grouped variable in a continuous form) and 
relationship status. This revealed an interaction between time with diagnosed HIV and 
relationship status, in relation to social support (Odds Ratio for interaction=1.16, 95% C.I.= 
1.01-1.33, p=0.04). Table 34 shows that the association of not having a partner with sufficient 
social support, tended to decrease with time diagnosed with HIV. 
The logistic model assessing an interaction between time with diagnosed HIV and parental 
status, with GAD-7 score of ≥10 as the dependent variable revealed an interaction between 
time diagnosed with HIV by parental status, in relation to anxiety (Odds Ratio for interaction 
=0.74, 95% C.I.= 0.59-0.94, p=0.01). Table 35 shows that the association of not having a child 
present with anxiety symptom prevalence tended to increase with increasing time diagnosed 
with HIV. Finally, the logistic model assessing an interaction between time with diagnosed HIV 
and relationship length, with 'having a partner with a positive HIV status' as the dependent 
variable revealed an interaction between time diagnosed with HIV by relationship length, in 
relation to partner's HIV status (Odds Ratio for interaction =1.27, 95% C.I.=1.06-1.53, p=0.01). 
Table 36 shows that the association of partner's HIV-positive status with relationship length 
tended to increase with increasing time diagnosed with HIV. 
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Table 34. The relationship between time with diagnosed HIV, relationship status and social 
support prevalence. 
Time in 
years 
Relationship 
status 
Sufficient social support present* 
No Yes 
0-2 
No partner 78 (45.6%) 93 (54.4%) 
Partner 34 (18.1%) 154 (81.9%) 
2-5 
No partner 76 (42.7%) 102 (57.3%) 
Partner 60 (21.1%) 224 (78.9%) 
5-10 
No partner 186 (55.4%) 150 (44.6%) 
Partner 108 (22.6%) 370 (77.4%) 
10-20 
No partner 261 (56.7%) 199 (43.3%) 
Partner 146 (24.6%) 447 (75.4%) 
≥20 
No partner 104 (66.2%) 53 (33.8%) 
Partner 34 (20.6%) 131 (79.4%) 
*Duke–UNC FSSQ scale score of ≥20 
 
Table 35. The relationship between time with diagnosed HIV, parental status and anxiety 
symptoms. 
Time in 
years 
Child present 
Anxiety symptoms present* 
No Yes 
0-2 
No 241 (87.3%) 35 (12.7%) 
Yes 103 (79.8%) 26 (20.2%) 
2-5 
No 310 (83.3%) 62 (16.7%) 
Yes 99 (81.1%) 23 (18.9%) 
5-10 
No 454 (77.5%) 132 (22.5%) 
Yes 212 (74.1%) 74 (25.9%) 
10-20 
No 649 (77.9%) 184 (22.1%) 
Yes 215 (74.1%) 75 (25.9%) 
≥20 
No 200 (70.9%) 82 (29.1%) 
Yes 39 (69.6%) 17 (30.4%) 
*GAD-7 score ≥10 
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Table 36. The relationship between time with diagnosed HIV, partner's HIV status and 
relationship length. 
Time in 
years 
Partner's HIV 
status 
Relationship length 
0-9 years ≥10 years 
0-2 
HIV negative 59 (57.3%) 44 (42.7%) 
HIV positive 47 (70.1%) 20 (29.9%) 
2-5 
HIV negative 98 (64.9%) 53 (35.1%) 
HIV positive 77 (70.6%) 32 (29.4%) 
5-10 
HIV negative 145 (62.5%) 87 (37.5%) 
HIV positive 138 (65.1%) 74 (34.9%) 
10-20 
HIV negative 169 (51.8%) 157 (48.2%) 
HIV positive 108 (43.4%) 141 (56.6%) 
≥20 
HIV negative 42 (42.9%) 56 (57.1%) 
HIV positive 23 (37.1%) 39 (62.9%) 
 
 
5.3.5.3 Disclosure 
Disclosure of HIV status to one or more persons other than health-care staff was positively 
associated with social support rates (94.0% reporting sufficient support in disclosed 
participants vs. 89.7% in non-disclosed, p<.001) and reports of having a partner present (58.3% 
vs. 34.2%, p<.001). Having a child was related to lower disclosure rates (25.1% of participants 
who had disclosed vs. 50.2% of those who hadn't, p<.001). 
Disclosure was related to a higher chance of participants having a CD4 count >350 cells/mm3 
(82.1% vs. 74.2%) and a greater likelihood of reporting symptom prevalence (46.0% vs. 37.3%) 
and distress (56.3% vs. 47.6%). Disclosure of HIV status to a partner was related to greater 
likelihood of CD4 count >350 cells/mm3 (83.8% vs. 78.6%) and a decrease in reports of 
symptom prevalence (42.0% vs. 48.9%), symptom distress (52.4% vs. 59.3%), difficulty with 
ADLs (33.4% vs. 43.5%), depression (22.0% vs. 33.2%) or anxiety (18.5% vs. 26.1%). However, 
disclosure to family members was also related to an increase in reports of symptom 
prevalence (49.6% vs. 40.7%) and distress (60.8% vs. 50.4%), problems with ADLs (44.1%vs. 
32.0%), depression (30.0% vs. 24.3%) and anxiety (24.0% vs. 19.9%). Similarly, disclosure to 
friends was related with higher symptom prevalence and distress and problems with ADLs - 
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but not depression or anxiety - and disclosure to colleagues was related to higher symptom 
prevalence and distress but lower prevalence of depression and anxiety. These associations 
were not greatly altered after adjustment for age and gender/sexuality. The percentages and p 
values are reported in Table 37.  
Using a logistic regression model, interactions between a) age and b) time with diagnosed HIV 
(grouped variables in a continuous form), with HIV status disclosure were assessed in relation 
to physical and mental health as the dependent variables. The models were adjusted for 
ethnicity and gender/sexuality. Only two significant interactions were found. The logistic 
model assessing an interaction between age and disclosure, with ≥10 physical symptoms as 
the dependent variable, included the following factors: age (as a grouped variable in a 
continuous form), disclosure to one or more persons, time with diagnosed HIV (categorical 
variable), gender/sexuality, ethnicity, and the interaction between age (as a grouped variable 
in a continuous form) and disclosure. This revealed an interaction between age by disclosure, 
in relation to physical symptom prevalence (Odds Ratio for interaction=1.35, 95% C.I.= 1.03-
1.75, p=0.03). Table 38 shows that the association of disclosure with prevalence of ten or more 
physical symptoms, while present across all age groups, tended to be lower in participants 
aged 30-40 than other age groups.  
The logistic model assessing an interaction between time with diagnosed HIV and disclosure, 
with a Duke–UNC FSSQ scale score of ≥20 as the dependent variable revealed an interaction 
between time diagnosed with HIV by disclosure, in relation to social support (Odds Ratio 
interaction =0.77, 95% C.I.= 0.61-0.98, p=0.04). Table 39 shows that the association of 
disclosure with sufficient social support, while present across all time with diagnosed HIV 
groups, tended to decrease with increased time diagnosed with HIV. 
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Table 38. The relationship between age, disclosure, and physical symptom prevalence. 
Age in years Disclosure* 
Physical symptom prevalence 
0-9 symptoms 10 or more symptoms 
<30 
No 8 (57.1%) 6 (42.9%) 
Yes 92 (58.2%) 66 (41.8%) 
30-40 
No 32 (56.1%) 25 (43.9%) 
Yes 428 (63.0%) 251 (37.0%) 
40-50 
No 68 (61.8%) 42 (38.2%) 
Yes 645 (51.9%) 598 (48.1%) 
50-60 
No 31 (62.0%) 19 (38.0%) 
Yes 294 (46.6%) 337 (53.4%) 
60+ 
No 21 (75.0%) 7 (25.0%) 
Yes 101 (54.3%) 85 (45.7%) 
* Disclosed to one or more person other than healthcare staff 
 
Table 39. The relationship between time diagnosed with HIV, disclosure and social support. 
Time in 
years 
Disclosure 
Social Support 
Less than desired Acceptable level* 
0-2 
No 25 (54.3%) 21 (45.7%) 
Yes 85 (27.2%) 227 (72.8%) 
2-5 
No 17 (37.8%) 28 (62.2%) 
Yes 119 (28.4%) 300 (71.6%) 
5-10 
No 38 (53.5%) 33 (46.5%) 
Yes 258 (34.5%) 490 (65.5%) 
10-20 
No 29 (50.9%) 28 (49.1%) 
Yes 380 (38.0%) 620 (62.0%) 
20+ 
No 3 (37.5%) 5 (62.5%) 
Yes 134 (42.7%) 180 (57.3%) 
*
Duke–UNC FSSQ scale score of ≥20     
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5.3.5.4 Employment and money for basic needs 
Social support was higher in adults who were employed, rather than unemployed (73.1% 
reporting sufficient social support in employed participants vs. 49.2% in unemployed, p<.001), 
and in those who always had money for basic needs (67.2% reporting sufficient social support 
vs. 38.3% respectively, p<.001). Having a partner was also associated with higher rates of 
employment (62.3% with a partner vs. 37.7% without, p<.001), as was having a child (37.2% 
with a child vs. 21.8% without, p<.001). Employment was positively associated with always 
having money for basic needs (90.0% employed with money for basic needs vs. 84.2% 
unemployed, p<.001), but having a child was negatively associated (23.9% with a child and 
money for basic needs vs. 48.6% without, p<.001). Finally, disclosure was also positively 
related to having money for basic needs (88.6% disclosed vs. 76.4% undisclosed, p<.001).  
In PWH over the age of 50, being unemployed was related to the highest levels of anxiety 
(28%) and depression (44%) and the lowest satisfaction with social support (48% with 
sufficient social support) compared to all other employment groups (ps<.01). Retired OPWH 
showed the highest physical symptom distress and second highest rates of depression and 
anxiety, compared to other employment groups (employed, unemployed, unemployed due to 
sickness/disability) but the second lowest reports of social support. Employment was still 
related to low levels of depression, anxiety and physical symptom distress and high social 
support when compared to other employment groups. 
CD4 count was high across employment groups, but was highest in those employed (83.2%) 
and retired (83.2%) and lowest in those who were sick/disabled (77.3%). This difference was 
statistically significant. Symptom prevalence was lowest in the employed group (32.7%) and 
highest in the sick/disabled group (81.2%), as were symptom distress (44.4% and 88.1% 
respectively), problems with ADLs (19.7% and 87.9%), depression (14.9% and 59.5%) and 
anxiety (12.4% and 45.0%).  
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Compared to unemployed PWH, employed PWH were more likely to have a high CD4 count 
and less likely to show symptom prevalence, distress, depression, anxiety or problems with 
ADLs. Similar results were found for 'money for basic needs', with those 'always having money 
for basic needs' showing higher CD4 count and lower odds of symptom prevalence, distress, 
mental illness and ADL problems. In OPWH, being employed was related to lower odds of 
physical and mental symptoms, but no difference in CD4 count when compared to 
unemployment. In comparison to retirement, employed OPWH were less likely to report 
symptom prevalence, distress, depression or problems with ADLs. Unemployed OPWH were 
more likely than retired OPWH to report physical and mental problems. These associations 
were not greatly altered after adjustment for age and gender/sexuality. The percentages and p 
values are reported in Table 40a-b. 
Using a logistic regression model, interactions between a) age and b) time with diagnosed HIV 
(grouped variables in a continuous form) with employment status were assessed in relation to 
physical and mental health as the dependent variables. The models were adjusted for ethnicity 
and gender/sexuality. Only one significant interaction was found in relation to money for basic 
needs. The logistic model assessing an interaction between time with diagnosed HIV and 
money or basic needs, with a GAD-7 score of ≥10 as the dependent variable, included the 
following factors: time with diagnosed HIV (as a grouped variable in a continuous form), 
money for basic needs, age (categorical variable), gender/sexuality, ethnicity, and the 
interaction between time with diagnosed HIV (as a grouped variable in a continuous form), and 
money for basic needs. This revealed an interaction between time with diagnosed HIV by 
money for basic needs, in relation to anxiety (Odds Ratio for interaction =1.25, 95% C.I.= 1.02-
1.52, p=0.03) which increased in strength with increasing time.  
However, employment - compared to any other employment status – did show interactional 
differences in relation to age and time with diagnosed HIV. Specifically, the logistic models 
assessing an interaction between age and employment revealed interactions between age by 
188 
 
employment, in relation to anxiety (Odds Ratio for interaction =1.27, 95% C.I.= 1.04-1.55, 
p=0.02), which increased in strength with increasing age as did the relationship to having a 
child present (Odds Ratio for interaction=1.36, 95% C.I.= 1.14-1.61, p=0.001), while the 
relationship to relationship length weakened (Odds Ratio for interaction =0.68, 95% C.I.= 0.52-
0.88, p=0.003). The logistic models assessing an interaction between time with diagnosed HIV 
and employment revealed interactions between 'time with diagnosed HIV by employment', in 
relation to physical symptom prevalence, which became weaker (Odds Ratio for interaction 
=0.72, 95% C.I.= 0.63-0.82, p<.001). The relationship to symptom distress also became weaker 
(Odds Ratio for interaction =0.77, 95% C.I.= 0.67-0.88, p<.001), as did the relationship to 
problems with ADLs (Odds Ratio for interaction =0.75, 95% C.I.= 0.65-0.86, p<.001), depression 
(Odds Ratio for interaction =0.77, 95% C.I.= 0.66-0.90, p=0.001), and disclosure of HIV status 
(Odds Ratio for interaction =0.78, 95% C.I.= 0.62-0.98, p=0.03). The relationship to ‘having a 
child present’ became stronger (Odds Ratio for interaction =1.17, 95% C.I.= 1.01-1.35, p=0.04).
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5.4 Discussion 
The aim of this chapter was to assess the association of age with a) social support, b) 
relationship and parental status, c) disclosure and d) employment and financial hardship, 
taking into account time since HIV diagnosis and other demographic factors. It also explored 
the relationship between these social factors and CD4 count, physical and mental symptom 
distress.  
Insufficient social support was apparent in 36.1% of the ASTRA population: that is, they 
reported moderately less support than desired on one or more of the Duke–UNC FSSQ 
domains. In adjusted analysis, the number of participants with sufficient social support 
decreased with age until the 50-60 year age group, becoming lowest in participants aged 50-60 
and then increasing slightly in the 60 and over age group. However, the declining trend with 
age was not statistically significant. OPWH were found to be less likely to be in a relationship, 
but where they were they were more likely to have been in the relationship for ten or more 
years. Older OPWH were also more likely to be a parent and less likely to have disclosed their 
HIV status to their partner, family, friends or work colleagues.  
Good social support has previously been found to be related to better physical and mental 
health in the general population272-274 and older adults70;7218;2074, strongly suggesting that social 
engagement is an important determinant of health and well-being. These results are reiterated 
here. Sufficient social support was related to lower levels of depression, anxiety and physical 
symptom distress. Disclosure of HIV status and being in a relationship were also associated 
with higher levels of overall social support. These associations did not differ greatly between 
age groups. Finally, rates of unemployment and 'not working due to sickness/disability’ 
increased with age and, in comparison to participants over the age of 60 who were employed, 
retired OPWH showed higher physical symptom distress, depression and anxiety and lower 
levels of social support.  
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5.4.1 Social Support 
In older adults, levels of social support are generally found to be lower than in younger 
adults64-66, due to retirement, illness, loss of friends and family through bereavement64;97;117;271. 
As physical health declines with age, it is likely that social support becomes an increasingly 
important factor in the maintenance of physical and mental health and the possibility of 
‘successful ageing’. In older adults with HIV, social support may be doubly important; both to 
maintain acceptable levels of health and medication adherence and to buffer against stigma. 
However, very few quantitative studies have explored social support in this population, fewer 
still have made age comparisons and none have utilised UK populations. Previously, no 
difference has been found in social support by age in relation to PWH148, but dissatisfaction 
with levels of support were commonly identified in older PWH94;96;307;310;312, as was social 
isolation due to a loss of friends over time and difficulties in creating new social connections 
due to old age, HIV-related stigma, fatigue and illness96;98;99;261;308;309. This social isolation was, 
in turn, related to increased prevalence of depression261;308 and illness310, with one study 
reporting a stronger relationship between social support and distress with increasing age308. 
However, in the present HIV-positive population the association between social support and 
physical and mental health did not differ with age. This suggests that, for PWH, social support 
does not become increasingly important with age. This could be due to the relatively low levels 
of social support reported in all PWH, or possibly due to illness burden and medication 
management causing variations in health regardless of social support. 
Other than this, the presented results mirror those of the international literature; social 
support decreased (nonsignificantly) with age in PWH, and higher levels of social support were 
related to lower probabilities of depression, anxiety and physical symptom distress. This 
suggests that PWH overall may not be receiving the levels of informal support that they 
require to maintain their overall well-being. 
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The association between low social support and poorer mental health among PWH may affect 
mental health by limiting the self-worth available to them through friendship which, in turn, 
reduces wellbeing and health maintenance65;268. Lower social support may also affect physical 
health directly by preventing the development of health-seeking behaviours, such as exercise 
and medication adherence72;268;269. In PWH 'HIV health maintenance' - the action of monitoring 
ill health, creating and keeping hospital appointments and adhering to medication - is 
especially important for physical health and to prevent virological failure of ART and, 
ultimately, progression to AIDS. Without acceptable levels of social support, PWH may not 
receive the levels of psychological and physical support269;270 required to maintain these health 
behaviours, or to respond appropriately to ill health and medication side-effects.  
 
5.4.2 Relationship and parental status 
Partners are often reported as a source of emotional and physical support; with the benefits 
accumulating with increasing length of relationship277. Relative to their unmarried 
counterparts, married older adults often have lower rates of chronic illness278 and mortality70 
and those in 'positive' relationships show low levels of anxiety and depression74. In the ASTRA 
population almost half of the participants did not have a partner, with the likelihood of being 
single increasing with age in women and relationship length decreasing with age in MSM. 
Being in a relationship was found to be related to sufficient social support, which may explain 
the lower levels of social support reported in older adults. However, unlike social support, 
relationship status and length were not found to be strongly associated with mental or 
physical health. It is possible that, as found in the qualitative literature, the feelings of being a 
burden to loved ones310 may decrease mental health and balance out the positive effects of 
long-term relationships . Alternatively, the stress and anxieties related to preventing the 
transmission of HIV to their partner may create an HIV-specific effect wherein being in a 
relationship causes as much physical and mental stress as it removes. This may be especially 
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true in cases where the partner has not been disclosed to. Finally, it is possible that being in a 
long-term MSM relationship brings its own challenges which reduce the positive effects of 
having a partner present. Gender/sexuality-based differences in relationship status were not 
explored, but such differences are worthy of investigation in other studies; especially in 
relation to recent legislative changes in relation to same-sex marriage. 
Interestingly, having a child was related to lower levels of social support and disclosure, 
regardless of participant age. In other words, older PWH do appear to disclose their HIV status 
to their children, but may not rely on adult children for support. This would cut older PWH off 
from a very important line of financial, emotional and physical support, which is commonly 
utilised in older adults in the general population295-298;314, and may detrimentally affect their 
ability to cope with age-related changes in physical well-being. 
 
5.4.3 Disclosure 
Disclosure prevalence was very high in the study population overall, with over 90% having 
disclosed their HIV status to someone other than health-care staff. Friends were the most 
likely group to have been disclosed to across all ages and, while the HIV status of adults 
disclosed to was not measured, it seems likely from the literature that that a significant 
number of confidants may also be HIV positive94;96;315 due to the lower levels of expected 
stigma from other HIV positive adults and the ability to share HIV-specific stories, advice and 
emotions94. 
Disclosure prevalence decreased with age both overall and within each individual social group 
(partner, family, friends, colleagues). In agreement with a previous study, disclosure was 
related to increased social support307, and this may at least partially explain the reduction in 
social support identified amongst older population study participants. Previous qualitative 
work has identified that older PWH are hindered in disclosing their HIV status for three 
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primary reasons: a) fear of consequences, b) protection of loved ones and c) not knowing how 
to disclose their status94;95;309;311. As, with older age, HIV-positive friends decline in numbers 
due to illness and reduced mobility94 the 'friends' available for disclosure and social support 
also decrease. If older adults feel the need to protect younger family members from their 
illness and/or are not equipped with the necessary skills to broach the subject of HIV then the 
likelihood of disclosure will decrease; as will the available social support. Furthermore, 
disclosure was found to be increasingly strongly related to physical symptom prevalence with 
age, which suggests that family members may have a positive effect on health-related 
behaviours when disclosed to. However, this could equally suggest that PWH do not disclose 
their status until forced to by ill health. Either way, disclosure appears to be important to well-
being in PWH and, since the prevalence decreased with age, is of concern for OPWH. 
 
5.4.4 Retirement  
In the study population overall, retirement was found to be related to higher prevalence of 
depression, anxiety, physical distress and insufficient social support when compared to 
employment, but the prevalence of these symptoms was lower among retired participants 
than among those who were unemployment or not working due to sickness/disability. An 
identical pattern was found when looking at adults over the age of 50 only and, when adjusted 
for age, the relationships between employment and mental and physical health became 
stronger. This suggests that employment is as central to identity in older adults as younger 
adults. It also implies that, for PWH, retirement may well be forced by ill health, and is related 
to overall well-being.  
In the literature, it has been suggested that retirement causes positive effects on mental and 
physical health through lowered stress61;316 and increased time for social and physical 
activity300;301 unless it is forced due to ill health300;303;304. In ASTRA the reasons behind 
retirement were not collected, but it seems possible that ill health and fear of HIV stigma may 
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dampen the positive effects of retirement by reducing opportunities for social or physical 
activity - thus causing the apparent negative effects of retirement on health measures shown 
in this analysis. It also seems possible that, on average, people with HIV may take retirement 
earlier than planned due to ill health or as a care-giver for family members and therefore feel 
'cheated' of the sense of achievement attained through work. This is partially supported by the 
average age of the 'retired' group, which was 62.3 years; meaning that many PWH retired early 
(assuming a traditional retirement age of 65). However, the information necessary to confirm 
this is not available. 
While retirement was related to worse overall well-being in comparison to employment, 
retirement was related to improved well-being compared to unemployment and those not 
working due to sickness/disability; both overall and in participants over the age of 50s only. As 
such, it does appear possible that retirement does have some positive effects on levels of 
stress and physical health (as found in the gerontological literature)when compared to adults 
who cannot afford to stop working, despite physical illness. This is supported by the evidence 
that not having 'money for basic needs' was strongly related to lower levels of physical and 
mental well-being. 
 
5.4.5 Time with diagnosed HIV 
With longer time diagnosed with HIV, social support decreased and disclosure prevalence 
increased. It is not surprising that prevalence of disclosure increased with longer time HIV 
since diagnosis, but the steady increase in prevalence across the time since diagnosis 
categories suggests that many PWH take a number of years to disclose their status to another 
person. In addition, disclosure may be higher with longer time since diagnosis through 
necessity; in previous qualitative analysis PWH mentioned disclosing their HIV status due to a 
need for support and an inability to hide their status because of ill health and medication317. 
For PWH who have lived through a time when the outcome of HIV was far less certain, 
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moreover, it is likely that family or friends were necessary for emotional and physical support, 
and so non-disclosure was less available. This is corroborated by the finding that, with 
increasing time with diagnosed HIV, the relationship between social support and having a 
partner increased, as did the relationship between being in a long-term relationship and 
reporting fewer problems with ADLs.  
Relationship status did not differ by time diagnosed with HIV. The implication of this is unclear, 
but as low prevalence of relationships were reported in the participants aged under 30 years, 
it is possible that this reflects a difficulty in maintaining or starting a relationship in individuals 
with a positive diagnosed HIV status; meaning that the odds of being in a relationship remain 
relatively low across the HIV lifespan. This is especially problematic in light of the strengthened 
relationship between relationship status and social support with longer time diagnosed with 
HIV. Furthermore, with increasing time diagnosed with HIV, being in a long-term relationship 
was more strongly related to having an HIV positive partner. This may limit the support 
possible from partners in this sub-population due to their partner's own limited health277 and 
increased care needs and contribute to the lower levels of social support reported with 
increased time diagnosed. 
The fact that low levels of social support were reported, despite the positive association 
previously found between disclosure and social support, suggests that bereavement of HIV-
positive friends and partners from earlier in the epidemic may cause a retraction in available 
social support over time, even with disclosure. This would also explain why, with increasing 
time diagnosed with HIV, social support became less related to disclosure. However, the 
evidence may not support this, as the decrease in social support was continuous across time 
and did not show particular prevalence in participants who were diagnosed early in the 
epidemic. As such, it is also possible that the decline in satisfactory social support with 
increasing time diagnosed with HIV is related to decreased physical and mental health. More 
specifically, it is possible that as physical and mental health declines the need for social 
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support increases318 and the ability to engage in social situations declines319, leading PWH to 
be less satisfied with the levels that they receive. Therefore, PWH who have been diagnosed 
with HIV for longer may be at an even greater disadvantage when it comes to informal care-
givers, and overall physical and mental support. 
 
Due to the absence of available literature on ageing with HIV, the meanings behind these 
results can only be surmised, based on overall OPWH literature and the information gathered 
in the previous chapters of this thesis. As such, the information provided here, while a broad 
image of the social impact of ageing with HIV, is scarce in regards to the factors driving these 
changes. Further research needs to be developed to explore the causes and effects of lower 
social support with time diagnosed with HIV. 
 
5.4.6 Limitations 
As previously mentioned, mental, physical and social health are inextricably interlinked. Due to 
the cross-sectional nature of the ASTRA study it is not possible to attribute any causation 
between the social support measures and mental and physical distress (e.g. whether lower 
social support causes depression or vice versa) and it is likely that the correlations observed 
are bi-directional. The reasons suggested for the links between the variables examined in this 
chapter are based on the evidence available from the HIV-positive and ageing literature but do 
not exclude the possibility of other explanations.  
Satisfaction with social support was measured, but not the size of social networks or the 
isolation experienced by the participants; although it is assumed that they are related. As such 
it is not possible to say with certainty whether the observed reductions in prevalence of 
satisfaction with social support and of disclosure with older age are related to decreasing 
social network size; only that this appears likely from the limited literature. Similarly, we can 
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only make conjecture on HIV-related ill health being the cause of lower mental health in 
retired older PWH. However, the conclusions are informed by the ageing literature from the 
general population and the conclusions remain justifiable. 
 
5.4.7 Conclusions and Implications 
Our results reveal that in a UK HIV-positive population rates of 'sufficient' social support 
appeared low and tended to decrease with increasing time with diagnosed HIV; making it an 
important factor to consider when measuring well-being in older adults with HIV. Sufficient 
social support was, further, related to lower levels of depression, anxiety and physical 
symptom distress; making social support an important factor for development of well-being in 
OPWH. Relationship status and disclosure were both found to be related to the level of social 
support available, and both reduced with age suggesting that they may in part be responsible 
for the low levels of social support available to OPWH. Finally, unlike much gerontological 
literature, retirement was also found to be related to a decrease in mental and physical health 
and social support in the ageing HIV-positive population. This may be due to HIV-related illness 
reducing the availability of the social and physical leisure usually associated with retirement. 
Support groups appear to be particularly important to OPWH and could be utilised by clinicians 
to improve well-being, by increasing the availability of age-matched HIV-positive networks. 
Similarly, sessions into counteracting HIV stigma or 'ways to disclose' to family members 
appear likely to be beneficial in improving the social support available to this population, as 
well as support in coping with feelings of 'being a burden'. 
However, while social support alone is a factor of well-being worthy of intervention, it is worth 
noting that in the previous chapter no significant difference was found in relation to overall 
physical symptom distress was found with age, and there was a decrease with age in the 
prevalence of depression and anxiety. It appears that despite the potential detrimental effects 
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of lower prevalence of having a current partner, higher prevalence of HIV status non-
disclosure, and retirement among older adults with HIV, they manage to maintain positive 
physical and mental health in comparison to younger PWH; if not in comparison to the general 
population. It is likely that resilience is responsible for these improvements in well-being; 
especially as the results in this chapter do not suggest that improved 'social support' is 
responsible. This will be explored further in the following chapters. 
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6 The Resilience study - Methodology 
6.1 Background 
Resilience is a multidimensional concept which seeks to explain how some individuals can 
achieve, maintain or regain well-being in the face of hardship111. It encompasses an individual's 
current coping mechanisms in response to stressors and their ability to adapt these 
mechanisms to combat new stressful situations320-324. More specifically, Vance and colleagues' 
review identified that individuals with high resilience were likely to use problem-focused 
coping mechanisms - transforming stressors into experiences to be overcome, while those with 
low resilience tend towards distancing coping mechanisms such as withdrawal, repression and 
denial152. Often, definitions of resilience also rely on the premise that the individual has 
experienced stressful life events before and can utilise these life experiences to effectively 
adapt their behaviours325-327.  
This would suggest that resilience can be learnt in response to adversity, should the individual 
be in a position to accept the possibility of behavioural change. Therefore, such behavioural 
change could be the focus of interventions to improve well-being. However, achieving high 
levels of resilience is likely reliant on several intrinsic and extrinsic factors. Commonly, 
resilience is broken down into five intrinsic characteristics: purpose/meaning in life112;328-331, 
perseverance328, equanimity (balance in life)328;329, self-reliance111;112;328;329;332 and 'authenticity' 
(self-acceptance, autonomy)112. Extrinsic factors related to resilience include hardship 
experience112;333, access to care112;328 and social support from professionals, the community 
and family/friends112;328;329;333;334. As such, the definition could be amended to: 'resilience is a 
series of responses to adversity which can, in the presence of an acceptable support network, 
be learnt in response to repeated stressful circumstances'. As the importance of social support 
was discussed in Chapter 5, the resilience study will focused on the intrinsic characteristics of 
resilience. 
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6.1.1 The relationship between resilience and health 
Resilience has been consistently linked to mental and physical health in the general 
population. This has been found in relation to chronic illness, health-care behaviours and 
disability. For example, a study of 185 Native Americans over the age of 55 found, using the 
Connor-Davidson Resilience Scale (CD-RISC335), that low levels of resilience were associated 
with low mental health (Mental health Component Summary (MCS-8) scores of the SF-36336) 
and physical health (Physical Component Summary (PCS-8) scores of the SF-36336) as well as 
higher prevalence of depression and chronic pain337. A small, cross-sectional, Argentinean 
study (N=53) also reported higher risk of hypertension in adults with low resilience (CD-RISC 
scale)338. 
In relation to health-care behaviour, a cross-sectional Taiwanese study found that high 
resilience (using the RS scale) was related to an increase in health-promoting behaviours and 
lower risk of end-stage renal disease in 150 participants with kidney disease (p<.001)339. 
Finally, 3,942 people over the age of 65 were studied in Germany in 2012340. Using the RS scale 
the researchers found that highly resilient participants were more likely to consume five or 
more servings of fruit or vegetables each day and to perform physical activity than participants 
with low resilience340. This occurred irrespective of socioeconomic status340. Since no studies 
were identified showing improved health or health-related behaviours in participants with 
lower resilience scores, these results suggest a strong relationship between high levels of 
resilience and favourable health behaviour outcomes. 
While these associations are interesting, where relationships are found in cross-sectional 
studies it is difficult to rule out reverse causality. For example, it is possible that low levels of 
health decrease an individual's ability to develop or maintain resilience, rather than low 
resilience resulting in poorer health outcomes. As such, evidence from longitudinal data were 
also explored in order to suggest causal evidence for the relationship between resilience and 
health.  
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A longitudinal study from China (2002-2005) of adults over 65 years old (N=11,112) related 
higher resilience at base-line to a lower risk of developing ADL disabilities at three-year follow-
up, independent of sociodemographic factors, family support, and base-line health341. A 
similarly large American longitudinal study (the Health and Retirement Study, N=10,753) of 
adults aged over 50 from 2006-2010 reported that high resilience at baseline - assessed via the 
RS - was a protective factor against the development of problems with ADLs, chronic illness 
and subsequent disability342. A smaller (N=1,594) longitudinal American study of disabled 
adults reported that greater baseline resilience (CD-RISC scale) predicted decreases in 
depressive symptoms and increases in social functioning three years later113. A 2008 
prospective American study of 111 people with diabetes found that low resilience at base-line 
was associated with fewer self-care behaviours (Pearson’s correlation coefficient r= -0.55), 
high levels of diabetes-related emotional distress, and worsening blood sugar levels at one-
year follow-up (r = 0.57 and r= 0.56, respectively)343. Finally, two American studies (Ns=1,150 
and 1,238) explored 'purpose in life' specifically. They found that higher purpose in life at base-
line was related to a substantially reduced risk of developing disability (Hazard ratio = 0.61, 
95% Confidence Interval = 0.44, 0.84) or problems with ADLs (HR= 0.60, 95% CI= 0.45, 0.81) in 
older adults344 and lower mortality rates at five-year follow-up (Hazard ratio = 0.60, 95% CI = 
0.42, 0.87) when adjusted for age, sex, education, and race - although not to pre-existing poor 
health345.  
This information provides evidence that resilience is related to better mental and physical 
health and may be a protective factor against health decline. The consistent results across 
different study populations suggest that this effect operates across the lifespan, irrespective of 
original health status (e.g. disability113), sociodemographic characteristics or geographical 
location. A possible reason for this is that resilient individuals are more 'self-
reliant'111;112;328;329;332 and perseverant328 and may be more likely to engage in health-promoting 
behaviours such as healthy eating and exercise340 which, in turn, improves overall mental and 
physical health. However, it is also possible that improved access to care and social support are 
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related to the improvements in health regardless of levels of resilience. It is also worth noting 
that many of these studies focused on individuals with chronic illness and found both high and 
low resilience in these populations. This implies that it is possible to develop or maintain 
resilience despite a reduced health status. 
 
6.1.2 The relationship between resilience and age 
As people age, purpose in life changes260, especially in relation to retirement and adult 
children, and the opportunities for self-reliance may increase while social support may 
decrease260. However, for similar reasons, the opportunity for leisure activities and equanimity 
may increase. Resilience may be especially important to older adults as it may allow for 
psychosocial adjustment in compensation for physical decline51.  
The majority of resilience research has focused on the development of children111;333, but 
recently the field has begun to evolve and acknowledge age-related changes in adults. Overall, 
current research suggests that resilience may be higher in older – than younger - adults112-
114;346;347. This was found, for example, in a comparative study of 60 older (>64) and 60 younger 
(<26) adults in the UK in 2011347. The British Household Panel Survey (N=3581) also found that 
resilience continued to increase with age amongst older adults346, as did an American study of 
adults over and under the age of 65 years (N=1,594)113, and one of disabled adults 
(N=1,862)114. 
However, a longitudinal study in China (CLHLS, 1998-2009, N=1,528) reported increases in 
resilience with age up until the age of 65, after which resilience began to decrease348. Similarly, 
the KORA-Age study (Germany, N=3,942) reported that high resilience was more prevalent in 
participants under the age of 75 than those over this age (35.8 vs. 27.9%)340 and a five-year 
longitudinal American study (N=1,238) exploring 'purpose in life' (Ryff scale) reported a 
negative correlation with age (r = −0.34, p < .001)345. This highlights, again, the importance of 
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studying changing patterns with age across the full older age range when assessing age 
associations. 
The evidence for an increase in resilience with age may be due to accrued experiences with 
adversity in older adults - such as bereavement, physical changes and adaptive life roles115 - 
giving them an effective skill-set for dealing with hardship. It is also possible, however, that 
these changes are responsible for the reduction in 'purpose in life' in older age, found in the 
American study345. Interestingly, in the one study that explored disability, the duration of 
disability was not associated with resilience scores114. This suggests that resilience may be 
more related to lifespan development than the length of experience with a single stressor. 
 
6.1.3 The relationship between resilience and HIV 
Only two quantitative studies were identified in relation to HIV and resilience, and neither 
looked at age-related differences. The first compared resilience in people with and without HIV 
(N=60) using the CD-RISC scale349. They found a near significant decrease in resilience in PWH 
when compared to the controls (mean score = 27.0 v.31.0, p = 0.06)349. The second included 
138 women with HIV on ART in the USA, and found that high resilience was associated with an 
increase in cART adherence and a greater likelihood of undetectable viral load (p<.05), when 
controlled for age, race, income, substance use, and depressive symptoms350.  
As previously mentioned, high levels of resilience have been identified in chronically ill 
populations, suggesting that resilience is also likely to be possible in relation to HIV. However, 
the effects of time with chronic illness have not been explored. It is possible that, with time 
with diagnosed HIV, adults learn and hone coping strategies such that resilience is able to 
increase. It is also possible that, while some individuals may maintain or develop resilience, 
unrelenting illness-related stress reduces the population’s potential for high resilience overall. 
205 
 
For example, similar to the model of toxic stress in children351, prolonged stress and illness may 
inhibit the time and resources necessary for positive mental development.  
As such, very little is known about the relationship of resilience with physical, psychological or 
social health in PWH and the existing studies are greatly limited by small sample sizes. It could 
be hypothesised that resilience in PWH is associated with improved biopsychosocial health, as 
found in other populations, but no studies have looked at changes in resilience with age or 
time diagnosed with HIV in HIV positive adults. Vance, Struzick and Masten152 do note, 
however, that due to the continued hardship of living with HIV for a comparatively long time, 
older adults with HIV may develop higher resilience than HIV-negative individuals.  
The resilience study was conceived, developed and conducted specifically as part of this PhD 
and is novel in regards to the population, geographical origin and factors studied. The study 
methodology and results are described in this and the next chapter. This chapter (Chapter 6) 
will cover the development and methodology of the study and present the demographics of 
the study sample. Chapter 7 will describe the measures utilised to analyse the effects of 
resilience on mental and physical health, present the results of these analyses and draw 
conclusions. 
 
6.1.4 Aims of the resilience study 
The resilience study was an exploratory study which was designed to assess differences in 
levels of resilience between older and younger adults with and without HIV, and to assess the 
association between resilience and time with diagnosed HIV, mental, and physical health. It 
was a cross sectional self-administered questionnaire study that included an HIV-positive 
sample and an HIV-negative sample. The resilience study questions were an addition to a 
larger questionnaire which aimed to investigate smoking and respiratory health in HIV-positive 
and negative populations. The questionnaire therefore included inquiry on smoking habits and 
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lung health and participants were also asked to complete spirometry readings. Only the 
information relevant to the resilience study is detailed below.  
 
The primary aims of this study were: 
1. To assess age-related differences in resilience in adults with and without HIV. 
2. To assess 'time with diagnosed HIV'-related differences in resilience in adults with HIV. 
3. To assess the association of resilience, if any, with depression, anxiety, problems with 
ADLs and physical activity in adults with and without HIV. 
Secondary aims involved comparison of prevalence of depression, anxiety, problems with ADLs 
and physical activity in adults with and without HIV. This allows us to build on the ASTRA data 
further by assessing whether age associations with well-being differ among those with and 
without HIV. 
 
6.2 Data collection and management 
6.2.1 Development of study questionnaire 
An initial draft questionnaire and other participant documents (information sheet, consent 
form) were produced. Following feedback from research staff, a small number of minor 
revisions were made to the questionnaire, the participant information sheet and consent form 
(Appendix B). These changes were submitted as amendments for ethical approval and were 
incorporated into the final versions employed during the main recruitment period, which 
commenced in March 2015. The final questionnaire consisted of a printed A5 booklet, with 
two versions available: one for HIV-positive and one for HIV-negative participants. The 
questions included in each version were identical, except that HIV positive participants were 
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asked whether they were currently taking HIV treatment and their date of HIV diagnosis. The 
HIV positive booklet is available in Appendix C. 
 
6.2.2 Study recruitment 
Patients attending out-patient appointments or accessing the drop-in service at the Ian 
Charleson Centre (ICC) HIV clinic or Marlborough Sexual Health Clinic in Hampstead were 
invited to participate on arrival between March 2015 and August 2015. Both clinics are 
situated at the Royal Free London NHS Foundation Trust in London. The Ian Charleson Centre 
was selected for recruitment of the HIV-diagnosed sample based on previously successful 
research collaborations with UCL, while the Marlborough Sexual Health Clinic was chosen for 
recruitment of HIV-negative participants due to its geographical similarity to the Ian Charleson 
Centre.  
A sexual health clinic was chosen for recruitment of the HIV-negative sample as it was 
considered to include a population with similar risk characteristics (e.g. smoking rates, sexual 
behaviour) to those of an HIV clinic, which was beneficial for the smoking study occurring in 
tandem, and would include individuals from the major demographic groups affected by HIV, 
therefore providing a suitable control group. A six-month time period was used for recruitment 
as the majority of participants at the HIV clinic had an appointment scheduled every six 
months or less, meaning that this was the shortest amount of time in which the majority of the 
clinic population would be seen in the clinic and would potentially be eligible to be recruited 
into the study. 
The recruitment team involved two doctoral students who had undertaken General Clinical 
Practise training and the clinic nurses. The recruitment schedule was based on the clinic times, 
identified by the nursing staff, in which the most patients would be available to discuss 
participation. The recruitment team then contacted participants while they were waiting for 
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their appointments. Specifically, in the Ian Charleson Centre, participants were approached 
during blood pressure recordings. This area was chosen to maintain privacy, but participants 
were also made aware that they could ask for a private area if necessary. In the Marlborough 
clinic the reception staff asked participants whether they would like to participate on entry to 
the clinic. With confirmation, patients were directed to a private room where the study was 
explained to them in more detail. At each site, participants were given details of the study 
(including a patient information sheet) and those agreeing to participate completed a patient 
consent form. As part of the main consent process, participants were given the option to allow 
us access to their clinical information. Individuals were allowed to be involved in the study 
regardless of consent to view clinical data. They were told that the research team would use 
this information to confirm their HIV status and age. 
 
6.2.3 Sample size 
The aim was to recruit 165 HIV-positive and 165 HIV-negative participants, giving a total of 330 
participants. This was based on a power calculation from the co-occurring smoking study in 
order to compare the health of adults with and without HIV. Specifically, based on an 80% 
power, and two-sided 5% significance level, to detect the minimal clinically important 
difference (4 points on the SGRQ scale) between these two groups, a samples size of 165 
individuals per group was required. It was calculated that a total sample size of 330 
participants was needed to detect a moderate difference (0.3 of a standard deviation) in 
resilience between older and younger PWH, using a two-sided 5% significance level. As such 
this sample was expected to include a large enough percentage of older adults to form a 
statistically meaningful comparison between older and younger PWH. 
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6.2.4 Participant eligibility and recruitment process 
Patients were eligible if they met the inclusion criteria. In order to participate individuals were 
to: a) be over 18 years of age, b) have sufficient English fluency to be able to understand the 
information sheet, questionnaire and provide informed consent and c) not too ill or distressed 
to participate, as judged by the clinic staff. In addition to this, as the HIV-negative group was 
expected to be younger than the HIV positive group, HIV-negative participants were further 
required to be a) aged 30 or over, to allow for more direct age comparisons with the HIV 
positive population, and b) not known to be HIV positive.  
Participants were asked their diagnosed HIV status at enrolment and given the appropriate 
questionnaire. Participants' HIV status was based on self-report, where no clinical data was 
available. Where permission to view clinical records was given, HIV status was checked during 
data cleaning and participants moved group accordingly. 
Participants who were eligible and expressed interest were given a participant information 
sheet that contained full details of the research project, including contact details for the 
research team (Appendix B). The research staff explained the purpose of the study and its 
potential benefits and answered any questions or concerns. Participants were told that the 
self-completed questionnaire would take between ten and 20 minutes to complete. If the 
participant agreed to participate they were required to sign the study consent form (Appendix 
B). Recruiters kept a log of the number of patients approached who declined to participate 
such that a response rate could be calculated. 
Participants completed the self-administered pen-and-paper questionnaire on a range of 
demographic, health, and lifestyle issues. They were encouraged to complete the 
questionnaire at the clinic (either before or after their appointment, or while waiting for tests 
or prescriptions), but were also allowed to take the questionnaires home and bring them back 
to the clinic and a time convenient to them. Names and clinic numbers were not recorded on 
the questionnaire. Completed questionnaires were collected in the clinic, directly from the 
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participants, and transferred regularly to the study management centre, where they were kept 
locked in a secure area. During the questionnaire, participants were asked for their height and 
weight. If they were unsure then they were offered a measurement within the clinic. This data 
was using to create a Body Mass Index (BMI). 
Details of all the clinic attendees approached for the study were collected in a study log which 
was maintained securely and updated at the study management centre at UCL. The study log 
contained study numbers, clinic identifiers and details of consent status for all participants 
who agreed to participate in the study. A checking process using clinical data identified four 
cases where participants filled out a questionnaire more than once. In these cases only the 
first completed questionnaire was included in the analysis. All the questionnaires which were 
returned to the researchers were digitised by the recruitment team through manual data 
entry, with each booklet being entered once and checked once, each time by different 
researcher.  
During the study period, 439 participants were invited to take part in the study, of which 327 
completed the questionnaire; a response rate of 74.5% invited participants. In regards to HIV 
status, the response rate was 75.5% for HIV positive patients and 73% for HIV negative 
patients.  
 
6.2.5 Ethics statement 
The research protocol and all versions of the study documents (information sheet, consent 
form and questionnaire) were approved by the local Ethics Committee and Hospital R&D 
department (ref 14.LO.1646, NRES committee London, Camden & Islington). The study is 
sponsored by University College London (UCL Sponsor reference 13/0639). A summary of the 
measures taken to ensure the confidentiality and security of participant information is as 
follows: 
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1. Care was taken to ensure the privacy of participants during questionnaire completion. 
2. Participants were assured, via the information sheet, that their questionnaire 
responses would not be seen by clinic staff or recorded in clinic notes. 
3. The participant information sheet made participants aware that they could withdraw 
at any stage without affecting their care. 
4. The participant information sheet informed participants that their data would be kept 
anonymous. 
5. The questionnaire noted that participants could leave out any of the questions. 
6. Paper copies of participant responses were kept in a secure area of the hospital, inside 
a locked room and cabinet. Questionnaires were identified only by a unique study 
number and were not linked to clinic number on any document. 
7. Where clinical data was taken, this data was linked to the survey responses using only 
a personalised study ID. No personal information (names, address, and clinic number) 
was kept in the database. 
8. Data were stored on a secure database. It was anonymised at data entry and files kept 
in an encrypted form on computers at the Royal Free Hospital and University College 
London (Royal Free Campus). 
9. Data was identified only by an anonymous study number and did not contain sufficient 
detail to allow personal identification of responses during the data processing stage. 
 
6.3 Subject characteristics  
6.3.1 Statistical methods 
In this chapter subject characteristics and health-related behaviours are compared across HIV 
status group using demographic data. The relationships between age group and demographic 
and health-related factors are then assessed separately amongst HIV positive and HIV negative 
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groups. Due to the small number of older adults in the HIV negative sample, participants aged 
over 50 years were grouped together. The differences in demographic data by HIV status 
group are then given. 
 
6.3.2 Demographic variables by HIV status 
The final HIV positive sample included 195 participants. The HIV negative sample included 126 
participants. In the HIV positive population, the mean age was 48 years (SD=10.5, range=19-82 
years), with 40 (20.5%) participants aged under 40, 72 (36.9%) aged 40-50, 61 (31.3%) aged 50-
60 and 22 (11.3%) aged 60 and over. The mean age for the HIV negative population was 42 
(SD=11.2, range=19-81), with 68 (54.0%) participants aged under 40, 31 (24.6%) aged 40-50, 17 
(13.5%) aged 50-60 and 10 (7.9%) aged 60 and over. As such, the HIV positive population was 
significantly older than the HIV negative population, despite the recruitment measures used. 
There were more HIV-positive MSM (66.5% vs. 24.2%) than HIV negative MSM, and fewer HIV-
positive than HIV-negative heterosexual men (13.7% vs. 46.8%) and women (19.8% vs. 29.0%). 
PWH were more likely to be Black African (16.3% vs. 6.3%) than HIV negative participants, but 
there was no significant difference in the likelihood of being UK born (61.7% vs. 56.7%). No 
difference was observed in terms of levels of education, with a similar proportion of HIV-
positive and negative participants attaining a university qualification (54.4% vs. 60.7%) and no 
qualification (12.3% vs. 11.5%). However, PWH were less likely to be employed (58.1% vs. 
81.6%), and more likely to be retired (9.2% vs. 3.2%) or sick/disabled (14.2% vs. 4.0%) than 
HIV-negative participants. Despite this there was no substantial difference in the number of 
participants who always had money for basic needs (57.9% vs. 66.4%).  
There was also no significant difference between the HIV-positive and HIV-negative samples in 
relation to recreational drug use (29.6% vs. 21.5% respectively) or smoking habits in relation to 
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current smokers (30.1% vs. 36.0%), ex-smokers (28.1% vs. 18.4%) or non-smokers (41.7% vs. 
45.6%). These differences are shown in table 41 below. 
Of the participants with HIV only, the mean time since diagnosis was 14 years (S.D.=8.6, 
range=0-32 years). By group, 32 (18.1%) participants had been diagnosed with HIV for 0-5 
years, 32 (18.1%) for 5-10 years, 61 (34.5%) for 10-20 years and 52 (29.4%) for more than 20 
years. The majority of HIV-positive participants were currently on ART (N=171, 94.5%).  
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Table 41. Demographic and health-related risk factors in the HIV positive and negative 
samples (n & percentage of group). 
Characteristics 
HIV positive 
population 
(N=195) 
HIV negative 
population 
(N=126) 
Age 
<40 
40-50 
                                                         50-60 
                                                            60+ 
 
40 (20.5%) 
72 (36.9%) 
61 (31.3%) 
22 (11.3%) 
 
68 (54.0%) 
31 (24.6%) 
17 (13.5%) 
10 (7.9%) 
Gender/Sexuality 
MSM 
Het. Male 
Female 
 
131 (66.5%) 
27 (13.7%) 
39 (19.8%) 
 
30 (24.2%) 
58 (46.8%) 
36 (29.0%) 
Ethnicity 
Born in the UK  
White British 
Black African 
 
121 (61.7%) 
106 (54.1%) 
32 (16.3%) 
 
72 (56.7%) 
49 (38.9%) 
8 (6.3%) 
Work status 
Employed 
Unemployed 
Sick/disabled 
Retired 
 
114 (58.1%) 
25 (12.8%) 
28 (14.2%) 
18 (9.2%) 
 
102 (81.6%) 
5 (4.0%) 
5 (4.0%) 
4 (3.2%) 
Highest education level 
University or above 
A levels 
GCSE/O-level 
None 
 
106 (54.4%) 
31 (15.9%) 
28 (14.4%) 
24 (12.3%) 
 
74 (60.7%) 
18 (14.8%) 
11 (9.0%) 
14 (11.5%) 
Money for basic needs 
Always 
Never 
 
114 (57.9%) 
16 (8.1%) 
 
83 (66.4%) 
3 (2.4%) 
Smoking status 
Current 
Ex-smoker 
Non-smoker 
 
58 (30.2%) 
54 (28.1%) 
80 (41.7%) 
 
45 (36.0%) 
23 (18.4%) 
57 (45.6%) 
Recreational drug use  58 (29.6%) 26 (21.5%) 
 
Next, age-related differences in demographic factors were assessed.  
 
6.3.3 Age-related demographic differences: HIV positive population sample 
Demographic differences by age group were assessed. Unsurprisingly, as age increased so did 
time with diagnosed HIV (χ2, N=176 (9)=46.21, p<.001, test for trend). As shown in figure 28 
below, adults under the age of 40 had primarily been diagnosed for less than five years, with 
none diagnosed for more than twenty years; while participants aged 40-50 were diagnosed for 
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ten or more years. The proportion of adult diagnosed for ten or more years was greatest for 
those aged 50 and over.  
Figure 28. Time with diagnosed HIV by age group (N=176). 
 
In terms of ethnicity/country of origin, the number of participants born in the UK increased 
with age (52.5% vs. 72.7%). For gender/sexuality, MSM were more likely to be older (52.5% of 
MSM under the age of 40 vs. 86.4% over the age of 60) and heterosexual men and women 
were more likely to be younger (22.5% aged <40 vs. 4.5% aged >60, and 25.0% vs. 9.1% 
respectively). This is shown in table 42. 
Levels of education were similar across all ages, with 55.0% aged <40 - 63.6% aged >60 being 
university educated. Employment was highest among participants aged <40 and 50-50 years, 
while unemployment was highest in the < 40s group and decreased with age (15.0% aged <40 - 
4.5% aged >60). The proportion of people who were not working due to sickness/disability was 
highest in the 40-50 years age group while retirement was highest in those 60 and over years 
of age (54.5%). Always having money for basic needs was highest in the >60s age group 
(81.8%) and lowest between ages 40-50 (50.0%). 
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Recreational drug use decreased with age (45.0% aged <40 - 4.5% aged >60), but the 
prevalence of being overweight, as specified by a BMI score of >25kg/m3, increased with age 
(40.6-61.5% respectively). The proportion of current smokers decreased with age (42.5% - 
13.6%), as the proportion of non-smokers (52.5% - 45.5%) while the proportion of ex-smokers 
increased (5.0 - 40.9%). These differences are reported in table 42 below. The percentage of 
participants on ART increased with age (80.6-100%). 
Table 42. The demographic and health-related risk factors by age group among of the HIV 
positive sample (n & percentage of age group). 
Characteristic  
(N=195) 
<40 
(N=40) 
40-50 
(N=72) 
50-60 
(N=61) 
>60 
(N=22) 
Gender/Sexuality 
MSM 
Het. Male 
Female 
 
21 (52.5%) 
9 (22.5%) 
10 (25.0%) 
 
52 (72.2%) 
7 (9.7%) 
13 (18.1%) 
 
39 (63.9%) 
8 (13.1%) 
14 (23.0%) 
 
19 (86.4%) 
1 (4.5%) 
2 (9.1%) 
Ethnicity 
Born in the UK  
White British 
Black African 
 
21 (52.5%) 
15 (37.5%) 
1 (2.5%) 
 
43 (59.7%) 
38 (52.8%) 
1 (1.4%) 
 
41 (68.3%) 
38 (63.3%) 
4 (6.7%) 
 
16 (72.7%) 
15 (68.2%) 
0 (0.0%) 
Work status 
Employed 
Unemployed 
Sick/disabled 
Retired 
 
27 (67.5%) 
6 (15.0%) 
3 (7.5%) 
0 (0.0%) 
 
49 (68.0%) 
10 (13.9%) 
9 (12.5%) 
0 (0.0%) 
 
29 (48.3%) 
7 (11.7%) 
3 (5.0%) 
6 (10.0%) 
 
8 (36.3%) 
1 (4.5%) 
1 (4.5%) 
12 (54.5%) 
Highest education level 
University or above 
A levels 
GCSE/O-level 
None 
 
22 (55.0%) 
8 (20.0%) 
1 (2.5%) 
8 (20.0%) 
 
38 (53.5%) 
16 (22.5%) 
9 (12.7%) 
4 (5.6%) 
 
30 (50.0%) 
6 (10.0%) 
16 (26.7%) 
7 (11.7%) 
 
14 (63.6%) 
1 (4.5%) 
2 (9.1%) 
5 (22.7%) 
Money for basic needs 
Always 
Never 
 
27 (67.5%) 
3 (7.5%) 
 
36 (50.0%) 
8 (11.1%) 
 
32 (52.5%) 
4 (6.6%) 
 
18 (81.8%) 
0 (0.0%) 
Smoking status 
Current 
Ex-smoker 
Non-smoker 
 
17 (42.5%) 
2 (5.0%) 
21 (52.5%) 
 
21 (30.0%) 
20 (28.6%) 
29 (41.4%) 
 
17 (29.3%) 
22 (37.9%) 
19 (32.8%) 
 
3 (13.6%) 
9 (40.9%) 
10 (45.5%) 
Recreational drug use  18 (45.0%) 21 (29.6%) 18 (29.5%) 1 (4.5%) 
BMI 
Underweight (0-18.4) 
Healthy weight (18.5-24.9) 
Overweight (25+) 
 
1 (3.1%) 
18 (56.3%) 
13 (40.6%) 
 
3 (5.1%) 
34 (57.6%) 
22 (37.3%) 
 
1 (2.0%) 
18 (36.0%) 
31 (62.0%) 
 
1 (7.7%) 
4 (30.8%) 
8 (61.5%) 
Years since diagnosis  
0-5 
5-10 
10-20 
20+ 
 
16 (45.7%) 
10 (28.6%) 
9 (25.7%) 
0 (0.0%) 
 
11 (16.9%) 
7 (10.8%) 
30 (46.2%) 
17 (26.2%) 
 
4 (7.0%) 
11 (19.3%) 
16 (28.1%) 
6 (45.6%) 
 
1 (5.3%) 
3 (15.8%) 
6 (31.6%) 
9 (47.4%) 
ART status  
Currently on ART 
 
29 (80.6%) 
 
63 (95.5%) 
 
58 (100%) 
 
20 (100%) 
217 
 
6.3.4 Age-related demographic differences: HIV negative population sample 
In terms of ethnicity, the number of participants who were 'White British' increased with age 
(36.4% of participants aged <40 – 61.5% aged >50). In relation to gender/sexuality, the 
proportion of heterosexual men did not differ much with age (49.2% aged <40 - 50.0% aged 
>50), but MSM and women were more likely to be younger (67.2% MSM aged < 40 years, 
30.8% aged >50, and 35.4% - 19.2% respectively).  
Levels of education were highest in the <40s age group (63.6% university educated, 12.1% with 
no qualifications) and lowest in the >50s (53.8% university educated, 11.5% with no 
qualifications). Employment was also highest in the <40s age group (89.4%) while 
unemployment remained relatively stable with age. Being sick/disabled increased with age 
(0.0% - 19.2%), as did retirement (0.0% - 11.5%). ‘Always having money for basic needs’ was 
highest in the 40-50s age group (77.4%) and lowest in participant aged over 50 (61.5%). 
The proportion of current smokers remained relatively stable across age (40.3% - 34.6%), while 
the proportion of non-smokers decreased (48.5% aged <40 - 34.6% aged >50). The probability 
of being an ex-smoker increased with age (12.1% - 30.8%). Recreational drug use was highest 
in adults aged under 40 (27.9%) and lowest in those aged over 50 (12.9 – 15.4%). These 
differences are reported in table 43 below. 
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Table 43. The demographic and health-related risk factors by age group of the HIV negative 
sample (n & percentage of age group). 
Characteristic 
(N=122) 
<40 
(N=65) 
40-50 
(N=31) 
>50 
(N=26) 
Gender/Sexuality 
MSM 
Het. Male 
Female 
 
10 (67.2%) 
32 (49.2%) 
23 (35.4%) 
 
12 (38.7%) 
11 (35.5%) 
8 (25.8%) 
 
8 (30.8%) 
13 (50.0%) 
5 (19.2%) 
Ethnicity 
Born in the UK  
White British 
Black African 
 
39 (58.2%) 
24 (36.4%) 
5 (7.6%) 
 
16 (51.6%) 
8 (25.8%) 
3 (9.7%) 
 
16 (61.5%) 
16 (61.5%) 
0 (0.0%) 
Work status 
Employed 
Unemployed 
Sick/disabled 
Retired 
 
59 (89.4%) 
3 (4.5%) 
0 (0.0%) 
0 (0.0%) 
 
26 (83.9%) 
1 (3.2%) 
0 (0.0%) 
0 (0.0%) 
 
16 (61.5%) 
1 (3.8%) 
5 (19.2%) 
3 (11.5%) 
Highest education level 
University or above 
A levels 
GCSE/O-level 
None 
 
42 (63.6%) 
10 (15.2%) 
3 (4.5%) 
8 (12.1%) 
 
18 (62.1%) 
3 (10.3%) 
3 (10.3%) 
3 (10.3%) 
 
14 (53.8%) 
5 (19.2%) 
3 (11.5%) 
3 (11.5%) 
Money for basic needs 
Always 
Never 
 
42 (63.6%) 
1 (1.5%) 
 
24 (77.4%) 
2 (6.5%) 
 
16 (61.5%) 
0 (0.0%) 
Smoking status 
Current 
Ex-smoker 
Non-smoker 
 
26 (40.3%) 
8 (12.1%) 
32 (48.5%) 
 
10 (33.3%) 
7 (23.3%) 
13 (43.3%) 
 
9 (34.6%) 
8 (30.8%) 
9 (34.6%) 
Recreational drug use  17 (27.9%) 4 (12.9%) 4 (15.4%) 
 
Demographic differences of older adults by HIV status were also compared. In older adults 
(participants over the age of 50) PWH were more likely to be MSM (69.4 vs. 31.0%). No 
significant difference was found in relation to ethnicity, employment, education, money for 
basic needs, smoking habits or recreational drug use.  
 
6.4 Conclusions 
The Resilience study population are predominantly white, UK-born, MSM who are well-
educated and employed. However, only 61.2% always had money for basic needs, 26.5% 
currently used recreational drugs, 32% were current smokers and 48.7% were overweight. As 
219 
 
such they are at risk of lifestyle factors affecting their biopsychosocial health. The HIV-positive 
and -negative populations were comparable in birth country, education, money for basic 
needs, recreational drug use or smoking behaviour. However, PWH were more likely to be 
older, MSM and unemployed or sick/disabled. As such, these differences are important to bear 
in mind in the main analyses. 
In relation to age, overall, older participants were more likely to be British, male, always have 
money for basic needs and be ex-smokers. They were less likely to use recreational drugs, be 
educated to university level or employed. In relation to PWH, older adults were more likely to 
have been diagnosed with HIV for longer and be on ART. No difference was found by age in 
relation to birth country or BMI. This pattern of results according to age is comparable to those 
found in the ASTRA study.  
There was a substantial difference in age between the HIV positive and negative populations. 
This reflects the difference in age between the respective clinic populations and could not be 
completely addressed by recruitment strategies without excluding older adults with HIV. This 
does, however, highlight the important of adjusting for age when comparing clinic samples.  
 
6.4.1 Contributions 
This project was designed and implemented in tandem with research into the effects of 
smoking on health in people with and without HIV. The inclusion of the measures identified 
here and the research questions are the work of the author, with the exception of the measure 
of physical activity. Study design, protocol, management, participant recruitment, data 
collection, data input and cleaning were the joint responsibilities of the author and Dr James 
Brown, the designer of the conjoined project82. The work shown here and in the following 
chapter - including background research, analysis and interpretation of results -are the sole 
work of the author.  
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7 The effects of age, ageing with HIV and HIV status on 
resilience 
7.1 Aims 
The primary aim of this research was to explore differences in resilience according to age and 
time diagnosed with HIV, and the association between resilience and mental and physical 
health (ADLs and physical activity) in adults with HIV.  
A secondary aim was to compare resilience, mental and physical health by HIV status ('HIV 
positive' or 'HIV negative'). Measures of resilience, symptoms and physical function are 
described below.  
 
7.2 Methods 
7.2.1 Symptom measures 
7.2.1.1 Resilience 
The RS-14320, a shortened version of the Resilience Scale, was used to measure resilience 
(Appendix C). This is a 14-item, 7-point Likert scale. According to a recent systematic review of 
the psychometric rigour of resilience measurement scales there is no 'gold standard' scale, but 
the Connor-Davidson Resilience Scale (CD-RISC), the Resilience Scale for Adults and the 
Resilience Scale (RS) have the best psychometric ratings352. Of these, the CD-RISC329;353 and the 
Resilience scale51;115;264 have been used in the older adult and HIV/AIDS literature but only the 
RS320 was specifically developed to measure resilience in older adults - albeit only among 
women115. As such it was chosen for this particular project. 
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The RS-14 scores are summed (range=14-98) to create a resilience reading. Specifically, a 
summated score of ≥82 indicates moderately high-to-high resilience; 74-81 indicates 
moderately low to moderately high levels of resilience; and ≤73 indicating very low- low 
resilience320. For the purpose of logistic regression analysis participants reporting 'high' (scores 
≥82) were compared to those reporting 'moderate - low' resilience scores (scores <82). As 
before, this was also considered to be a more clinically useful analysis than including resilience 
in the regression as a continuous scale.  
 
7.2.1.2 Depression and Anxiety  
Mental health was assessed using clinically standard validated questionnaire measures of 
depression and anxiety. Specifically, depression and anxiety symptoms were assessed via self-
report, using the PHQ-9156 and GAD-7 scales157 respectively. As previously described in Chapter 
2 (section 2.2.2), these scales are validated diagnostic instruments, based on the DSM-IV 
criteria for depression156 and generalised anxiety disorder (GAD)157, for measuring the 
prevalence and severity of depression and anxiety. Use of the GAD-7157 and PHQ-9156 also 
allowed for ease of direct comparison to the results of the ASTRA study164.  
For both the PHQ-9 and GAD-7, participants were asked to respond to the question "Over the 
past 2 weeks, how often have you been bothered by any of the following problems?". 
Participants could respond with one of four options: 'not at all', 'several days', 'more than half 
the days' or 'nearly every day' to each of the symptoms. For each scale, these responses were 
scored from 0-3 respectively and added to create a 'total score' (possible range of 0-27 for the 
PHQ-9 and 0-21 for the GAD-7) which is used to measure the participant's level of 
depression/GAD. For the purpose of this analysis participants were also categorised into two 
groups using the standard score-based definitions for anxiety and depression with scores ≥10 
taken to indicate depression and anxiety in each case.  
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7.2.1.3 Activities of Daily Living and Physical activity 
Difficulty with ADLs was identified using the EQ-5D155, a five-item quality of life instrument. 
This instrument asks participants to report their 'status of health today' in relation to Mobility, 
Self-care, 'Usual activities' (e.g. work, study, housework, family or leisure activities), 
Pain/discomfort and Anxiety/Depression. Response options comprise a five-point Likert scale. 
Participants can report no problems, slight problems, moderate problems, severe problems or 
being unable to perform each activity. Difficulty with ADLs was assessed through the first three 
domains only. Responses for each of the three remaining domains were divided into 
participants having no problems compared to those with problems (from slight problems to 
being unable to perform each activity). An overall measure of problems with physical function 
was used, where participants who reported problems with at least one of the three activities 
were compared to those showing no difficulties. In addition the three individual domains were 
considered separately. 
Participants were also asked to report whether they undertook "regular physical activity (at 
least once a week)"; to which they could respond 'yes' or 'no'. If so, they were asked to specify 
the type of physical activity which they undertook, with the possible options of: running, 
cycling, swimming, gym-use or 'other'. 
 
7.2.1.4 Demographic factors 
Other demographic factors included in the analysis were age group, gender/sexuality (MSM, 
heterosexual men, women) and country of birth (UK-born or other). 
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7.2.2 Missing values 
Missing values for individual questions on symptom questionnaires (PHQ-9, GAD-7, Euroqol) 
were counted as the absence of symptoms (coded as '0'). For the RS-14, if at least one 
question had a valid response, missing values for the other questions were coded as '5.5'; the 
resilience score that corresponded to the mid-point of the scoring chart. 
 
7.3 Statistical analysis 
Chi squared, chi squared test for trend, and logistic regression were used to assess the 
association between age group and each of the well-being measures (dependent variables: 
high resilience, depression, anxiety, problems with physical function and regular physical 
activity) separately among the HIV-positive and HIV-negative groups. The participants were 
grouped according to their age into: <40, 40-49, ≥50 years of age. An age group of <30 was not 
used for analysis as this was an exclusion criteria for HIV-negative participants. In the main 
analysis, age was categorised into groups rather than used as a continuous variable to allow 
the exploration of non-linear age differences. However a sensitivity analysis also considered 
age as a continuous variables. Although I have previously stressed the importance of analysing 
older age groups individually, unfortunately the age dispersion of the sample populations did 
not allow this and all adults over the age of 50 were, by necessity, grouped together.  
For analysis within the HIV-positive group, the effect of age on each of the above factors was 
assessed, adjusting for gender/sexuality (MSM; heterosexual man; woman), country of birth 
(UK-born; other) and time since diagnosis of HIV (<5 years; 5-10 years; 10-20 years and >20 
years). For the HIV-negative group, the effect of age was assessed adjusting for 
gender/sexuality and Country of birth only. 
 Age and time since diagnosis of HIV (where appropriate) were fitted as categorical variables in 
logistic regression models; tests for trend across age and time with diagnosed HIV were also 
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performed. In addition, the association between resilience and depression, anxiety, problems 
with ADLs and physical activity was assessed using chi squared tests and logistic regression 
model with adjustment for age group, gender/sexuality and country of origin. Finally, the 
association between HIV-status and each of the well-being measures was assessed in a logistic 
regression model with adjustment for age group, gender/sexuality and country of origin.  
The results are presented below, as odds ratios (OR) with 95% confidence intervals (CI). 
 
7.4 Results 
7.4.1 Resilience 
Using the entire sample population (HIV-positive and HIV-negative, N=321), the mean 
resilience score was 76.9 (S.D. = 17.7); corresponding to a rating of 'moderate’ resilience on 
average. The range was 14-98; the entire range of the RS-14 scale. By group, 107 (33.3%) 
participants showed low resilience (score ≤64), 64 (19.9%) showed moderate resilience (score 
65-81) and 150 (46.7%) showed high resilience (score ≥82). 
 
7.4.1.1 Resilience by HIV status and age 
When looking at average resilience scores by age group, for each age group the average score 
corresponded to a 'moderate' level of resilience. In each age group, HIV negative participants 
showed higher mean resilience scores, but differences were comparatively small. Table 44 
reports the mean and median RS-14 scores by age and HIV status and Table 45 reports the 
prevalence of resilience categories by HIV status.  
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Table 44. The average resilience score by age group and HIV status. 
 HIV positive (N=195) HIV negative (N=126) 
Age in years Mean S.D. Median Mean S.D. Median 
<40 (N=108) 72.8 17.7 74.5 78.0 16.9 80.5 
40-50 (N=103) 76.5 18.2 82.0 79.5 18.0 79.0 
≥50 (N=100) 77.0 18.3 77.0 78.9 13.8 82.0 
TOTAL 76.00 18.1 78.0 78.5 16.5 80.5 
 
Table 45. Prevalence of resilience (RS-14 groupings) by age group and HIV status. 
 HIV positive (N=195) HIV negative (N=126) 
Age in years Low (≤64) 
Average 
(65-81) 
High (≥82) Low (≤64) 
Average 
(65-81) 
High (≥82) 
<40 (N=108) 20 (50.0%) 6 (15.0%) 14 (35.0%) 20 (29.4%) 16 (23.5%) 32 (47.1%) 
40-50 (N=103) 24(33.3%) 11 (15.3%) 37 (51.4%) 7 (22.6%) 9 (29.0%) 15 (48.4%) 
≥50 (N=110) 29 (34.9%) 16 (19.3%) 38 (45.8%) 7 (25.9%) 6 (22.2%) 14 (51.9%) 
 
In unadjusted analysis, age group was not significantly associated with high resilience in either 
the HIV positive (χ2 test for trend, (N=195) = 4.93, p=0.55) or HIV negative groups (χ2, 
(N=126)=.96, p=0.99). HIV status (χ2, (N=327)=4.65, p=0.10) was not significantly associated 
with resilience.  
The adjusted association of age with high resilience is presented in Table 46, for HIV positive 
and HIV-negative participants separately. Among HIV-positive participants (after adjustment 
for gender/sexuality, time diagnosed with HIV and country of birth) the prevalence of high 
resilience increased with age: a trend nearing significance. Longer time diagnosed with HIV, on 
the other hand, was related to a strong and statistically significant decrease in the prevalence 
of resilience. Among HIV-negative participants, resilience also tended to increase with age but 
this association was not statistically significant. 
In analysis including all participants (HIV-positive and HIV-negative) adjusted for age, gender 
and country of birth, HIV status was not significantly related to high resilience (Odds 
Ratio=1.51, 95% C.I.=0.68-1.95, p=0.61 for comparison of HIV-negative with HIV-positive 
group).   
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Table 46. Adjusted association of age, time with diagnosed HIV, gender/sexuality and 
country of birth with resilience in HIV positive and negative adults (logistic regression 
analysis). 
 High resilience (score ≥82) 
Adults with HIV (N=197) 
High resilience (score ≥82) 
Adults without HIV (N=130) 
Independent Variable p. value Odds ratio 95% C.I. p. value Odds ratio 95% C.I. 
Age  0.11   0.78   
Test for trend 0.08 1.52 (0.95, 2.41) 0.48 1.18 (0.75, 1.87) 
<40 0.05 0.37 (0.14, 0.98) 0.48 0.71 (0.28, 1.82) 
40-50 0.82 0.92 (0.45, 1.88) 0.68 0.80 (0.27, 2.32) 
50+*  1   1  
Years with diagnosed HIV  0.22      
Test for trend 0.05 0.37 (0.14, 0.98)    
0-5*  1     
5-10 0.89 0.93 (0.32, 2.65)    
10-20 0.36 0.65 (0.26, 1.65)    
20+ 0.07 0.38 (0.13, 1.08)    
Sex 0.64   0.54   
MSM*  1   1  
Hetero male 0.51 1.39 (0.51, 3.79) 0.30 1.64 (0.65, 4.13) 
female 0.41 1.41 (0.63, 3.15) 0.35 1.63 (0.59, 4.57) 
Country of birth                Other*  1   1  
UK 0.92 0.96 (0.49, 1.89) 0.26 0.65 (0.31, 1.37) 
    * reference group 
 
 
    
 
 
 
7.4.1.2 The relationship between resilience and mental and physical health 
Using chi squared analysis, the unadjusted associations of resilience with depression, anxiety, 
ADL problems and physical activity was assessed for adults with and without HIV. In adults 
with HIV, high levels of resilience were found to be significantly related to lower prevalence of 
depression (6.7% vs. 36.5% for prevalence of depression among participants with high vs. 
moderate - low resilience), anxiety (3.4% vs. 29.7% respectively) and problems with ADLs 
(19.1% vs. 52.7% respectively; ps<.001 for all chi squared test for trend). The percentages and 
p values are reported in table 47. 
  
227 
 
Table 47. Physical and mental symptom prevalence in relation to resilience in adults with 
HIV. 
 Resilience 
 
Low (score ≤73) 
(N=74) 
Average (74-81) 
(N=34) 
High (score ≥82) 
N=89) 
p. value 
Depression present 27 (36.5%) 6 (17.6%) 6 (6.7%) p<.001 
Anxiety present 22 (29.7%) 7 (20.6%) 3 (3.4%) p<.001 
ADL problems 39 (52.7%) 13 (38.2%) 17 (19.1%) p<.001 
Physically active 38 (51.4%) 19 (57.6%) 58 (65.2%) p=0.20 
x RS-14 score ≥82 
p values by chi-squared test for trend 
 
In adults without HIV, high levels of resilience were, similarly, found to be significantly related 
to lower prevalence of depression (7.8% vs. 25.7%; for depression prevalence for high vs. low 
resilience p=0.02). No significant relationship was found between resilience and anxiety, 
problems with ADLs or physical activity. The percentages and p values are reported in table 48. 
Table 48. Physical and mental symptom prevalence in relation to resilience in adults without 
HIV. 
 Resilience 
 
Low (score ≤73) 
(N=35) 
Average (74-81) 
(N=27) 
High (score ≥82) 
N=64) 
p. value 
Depression present 9 (25.7%) 3 (9.7%) 5 (7.8%) p=0.03 
Anxiety present 4 (11.4%) 2 (6.5%) 3 (4.7%) p=0.45 
ADL problems 9 (25.7%) 5 (16.1%) 7 (10.9%) p=0.16 
Physically active 28 (80.0%) 19 (70.4%) 44 (68.8%) p=0.47 
   x RS-14 score ≥82 
 
 
7.4.2 The effects of HIV status on mental and physical health 
7.4.2.1 Depression and Anxiety symptoms 
Depression and anxiety symptoms were highly prevalent in the sample. Specifically, depression 
prevalence occurred at 19.8% of PWH and 13.1% of HIV negative participants and anxiety 
symptoms in 16.2% and 6.9% respectively. When looking at PHQ-9 scores (range=0-27) by age 
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group, the mean scores and prevalence were highest in those aged under 40 years of age and 
lowest in those aged ≥60 in the HIV positive participants. Depression prevalence was highest in 
those aged 40-50 years of age and lowest in those aged ≥60 in HIV negative participants. For all 
age groups, HIV negative participants showed lower mean depression scores than participants 
with HIV. Similar results were found for anxiety. Table 49 reports the prevalence (PHQ-9 score 
≥10), mean and median PHQ-9 scores by age and HIV status. Table 50 reports the same for 
anxiety.  
Table 49. The average depression score and number (n and %) of participants showing 
depressive symptoms by age group and HIV status. 
 HIV positive (N=195) HIV negative (N=126) 
Age in years Mean S.D. Median N (%) Mean S.D. Median N (%) 
<40 (N=108) 6.7 5.7 5.5 11 (27.5%) 3.9 4.3 3 6 (8.8%) 
40-50 (N=103) 5.7 6.1 3 15 (20.8%) 4.4 4.7 3 6 (19.4%) 
≥50 (N=110) 5.2 5.5 4 13 (15.7%) 3.7 6.0 1 5 (18.5%) 
TOTAL 5.7 5.8 4 39 (20.0%) 3.0 4.8 3 17 (13.5%) 
 
Table 50. The average anxiety score and number (n and %) of participants showing 
depressive symptoms by age group and HIV status. 
 HIV positive (N=195) HIV negative (N=126) 
Age in years Mean S.D. Median N (%) Mean S.D. Median N (%) 
<40 (N=108) 5.9 4.8 5.5 8 (20.0%) 3.7 3.9 3.5 5 (7.4%) 
40-50 (N=103) 4.9 5.1 4 13 (18.1%) 4.0 3.8 4 1 (3.2%) 
≥50 (N=110) 4.4 5.1 3 11 (13.3%) 3.2 4.5 1 3 (11.1%) 
TOTAL 4.9 5.0 4 32 (16.4%) 3.7 4.0 3 9 (7.1%) 
 
In unadjusted analysis, the prevalence of depression was not significantly different by age in 
either the HIV positive ((χ2, (N=195)=2.49, p=0.48, test for trend) or HIV negative groups ((χ2, 
(N=126)=3.76, p=0.29). Anxiety prevalence was not significantly different by age in either the 
HIV positive ((χ2, (N=195)=1.12, p=0.77) or HIV negative groups ((χ2, (N=126)=1.39, p=0.67).  
The adjusted associations of age with depression and anxiety among the HIV-positive and HIV-
negative groups are presented in Table 51. After adjustment for gender/sexuality, country of 
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birth, and time diagnosed with HIV (where applicable), there was evidence of associations 
between age and depression and anxiety among HIV positive participants, with a trend of 
lower depression and anxiety with older age. The trends were nearing statistical significance. 
Time diagnosed with HIV was not significantly related to depression or anxiety in this sample, 
although symptom prevalence tended to increase with longer time with diagnosed HIV; the 
relationship between longer time with diagnosed HIV and higher prevalence of anxiety neared 
significance. Among the HIV- negative sample, there was no significant associations of age with 
depression and anxiety.  
In a model including all participants (HIV-positive and HIV-negative) with adjustment for age, 
gender/sexuality and country of origin, a positive HIV status was not significantly related to 
depression (Exp(B)=0.56, 95% C.I.=0.27-1.14, p=0.11), but was associated with a higher 
prevalence of anxiety (Exp(B)=0.41, 95% C.I.=0.17-1.01, p=0.05).  
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7.4.2.2 Activities of Daily Living 
In response to all ADL domains, problems with ADLs were more prevalent in PWH than HIV 
negative participants, with 34.9% of PWH reporting one or more problem with ADLs, 
compared to 15.9% of HIV negative participants. In particular, PWH under the age of 40 
reported more than three times the number of ADL problems as their HIV-negative 
counterparts. Mobility was the most common problem reported in both groups. However, it is 
worth noting the small number of HIV negative adults with problems with ADLs. Table 52 
reports the prevalence of problems with ADL in relation to age and HIV status.  
Table 52. Prevalence of problems with ADLs (n and %) by age group and HIV status. p values 
are provided for age-related differences. 
 HIV positive (N=195) HIV negative (N=126) 
Age in 
years 
ADL 
problems 
Mobility Self-care 
Usual 
activity 
ADL 
problems 
Mobility Self-care 
Usual 
activity 
<40 
(N=108) 
11 (27.5%) 8 (20.5%) 4 (10.3%) 10 (25.0%) 6 (8.8%) 6 (9.1%) 1 (1.5%) 3 (4.5%) 
40-50 
(N=103) 
19 (26.4%) 15 (20.8%) 10 (14.1%) 15 (21.1%) 9 (29.0%) 6 (20.0%) 5 (16.7%) 6 (19.4%) 
≥50 
(N=110) 
38 (45.8%) 36 (43.4%) 13 (15.7%) 31 (37.3%) 5 (18.5%) 4 (14.8%) 2 (7.4%) 4 (14.8%) 
TOTAL 68 (34.9%) 59 (30.4%) 27 (14.1%) 56 (29.0%) 20 (15.9%) 15 (13.2%) 8 (6.7%) 13(10.7%) 
 
In unadjusted analysis, ADLs were not significantly different by age in either the HIV positive 
((χ2, (N=195) = 4.93, p=0.55, chi squared test for trend) or HIV negative groups ((χ2, (N=126) = 
.96, p=0.99). HIV status was related to a significant increase in ADL problems overall ((χ2, 
(N=327) = 13.98, p<.001) and in relation to each individual domain (ps<.05).  
The adjusted association of age and HIV status with ADLs is presented in Tables 53 and 54, 
separately for the HIV positive and negative participants. After adjustment for 
gender/sexuality, time diagnosed with HIV (for the HIV-positive group ) and ethnicity, ADLs 
rates did not differ by age among the HIV-positive or HIV-negative samples. However longer 
time with HIV diagnosis was strongly associated with increasing ADL prevalence overall and for 
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each domain. This trend held true across the subgroups. In a model including all participants, 
and adjusted for age, gender/sexuality and country of origin, HIV-positive status was related to 
a significant increase in problems with ADLs (Odds Ratio=2.72, 95% C.I.=1.42-5.23, p=0.003, for 
comparison of HIV-negative with HIV-positive group).
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7.4.2.3 Physical activity 
When looking at raw regular physical activity prevalence by age group, among HIV-positive 
participants the likelihood of participants partaking in any regular physical activity was not 
associated with age. In HIV negative participants, physical activity also tended to decrease with 
age, except that adults under the age of 40 were less likely to participate in running, cycling or 
gym use when compared to older participants.  
In terms of the overall proportion reporting regular physical activity, HIV negative participants 
were generally more likely to be active than PWH. Table 55 reports the prevalence of each 
physical activity by age and HIV status.  
Table 55. Prevalence of physical activity (n and %) by age group and HIV status. 
 
 
 
 
 
 
 
In unadjusted analysis, the prevalence of regular physical activity was not significantly different 
by age in PWH, but decreased with age in HIV negative participants. Interestingly, free-text 
reports of 'walking' as a physical activity increased with age in this group (5.9% of <40s to 
30.0% of >60s, p=0.06). HIV status was significantly associated with regular physical activity; 
HIV positive (N=195) 
Age in years Physically active Runs Swim Cycle Gym use 
<40 (N=40) 26 (65.0%) 9 (22.5%) 5 (12.5%) 7 (17.5%) 14 (35.0%) 
40-50 (N=72) 39 (54.2%) 14 (19.4%) 6 (8.3%) 7 (9.7%) 15 (20.8%) 
≥50 (N=83) 48 (57.8%) 13 (15.7%) 7 (8.4%) 11 (13.3%) 19 (22.9%) 
TOTAL 113 (58.2%) 36 (18.6%) 18 (9.3%) 25 (12.9%) 48 (24.7%) 
p values p=0.70 p=0.82 p=0.36 p=0.59 p=036 
      
HIV negative (N=126) 
Age in years Physically active Runs Swim Cycle Gym use 
<40 (N=68) 54 (81.8%) 28 (4.4%) 14 (21.2%) 11 (16.7%) 28 (42.4%) 
40-50 (N=31) 22 (71.0%) 9 (29.0%) 4 (12.9%) 8 (25.8%) 16 (51.6%) 
≥50 (N=27) 12 (44.4%) 2 (7.4%) 3 (11.1%) 3 (11.1%) 3 (11.1%) 
TOTAL 88 (72.1%) 39 (32.0%) 22 (18.0%) 22 (18.0%) 47 (38.5%) 
p values p=0.01 p=0.02 p=0.73 p=0.58 p=0.01 
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with fewer HIV positive participants (58.7%) than HIV negative participants (72.2%) reporting 
physical activity (χ2, N=322)=6.11, p=0.01).  
 The adjusted association of age and HIV status with physical activity is presented in Table 56, 
in relation to the HIV positive and negative participants respectively.  
Table 56. Adjusted association of age, time with diagnosed HIV, gender/sexuality and 
country of birth with physical activity in HIV positive and negative adults (logistic regression 
analysis). 
Physical activity HIV positive participants 
(N=197) 
HIV negative participants 
(N=130) 
Independent Variable p. value Odds ratio 95% C.I. p. value Odds ratio 95% C.I. 
Age  0.40   0.01   
Test for trend 0.49 0.85 (0.53, 1.36) .004 0.48 (0.29, 0.79) 
<40 0.32 1.67 (0.61, 4.60) .004 4.54 (1.64, 12.59) 
40-50 0.67 0.86 (0.42, 1.76) 0.08 2.71 (0.89, 8.30) 
50+*  1   1  
Years with diagnosed HIV  0.58      
Test for trend 0.42 0.87 (0.63, 1.21)    
0-5*  1     
5-10 0.38 1.65 (0.54, 5.08)    
10-20 0.89 0.94 (0.36, 2.41)    
20+ 0.69 0.81 (0.28, 2.30)    
Sex 0.25   0.79   
MSM*  1   1  
Hetero male 0.22 0.53 (0.19, 1.46) 0.94 1.04 (0.37, 2.88) 
female 0.17 0.56 (0.25, 1.27) 0.55 1.44 (0.44, 4.67) 
Country of birth           Other*  1   1  
UK 0.29 1.44 (0.73, 2.85) 0.55 1.30 (0.55, 2.08) 
    * reference group 
 
Using the overall measure of regular physical activity, after adjustment for gender/sexuality, 
time diagnosed with HIV, and ethnicity, prevalence of regular physical activity was not related 
to age or time with diagnosed HIV in PWH. In participants without HIV, however, physical 
activity decreased with age. Spontaneous mention of walking as an activity also increased with 
age in this population (Odds Ratio=2.70, 95% C.I.=1.17-6.25, p=0.02). In a model including all 
participants, adjusted for gender/sexuality, time diagnosed with HIV (for the HIV-positive 
group ), and country of origin, HIV negative participants were more likely to report overall 
physical activity than HIV positive participants (Odds Ratio = 1.81 for HIV-negative vs. HIV-
237 
 
positive participants, 95% C.I.=1.02-3.21, p=0.04, for comparison of HIV-negative with HIV-
positive group). 
 
7.5 Discussion 
The aim of this chapter was to assess a) age-related differences in resilience in adults with and 
without HIV, b) 'time with diagnosed HIV'-related differences in resilience in adults with HIV, c) 
the association of resilience with symptoms of depression, anxiety, and physical ability in 
adults with and without HIV and d) to compare prevalence of depression, anxiety, problems 
with ADLs, and regular physical activity, by age, in adults with and without HIV. 
Comparable levels of resilience (48.4% vs. 45.6%) were found in adults with and without HIV 
respectively. In adults with HIV, resilience increased with age, although this change did not 
reach significance. Longer time with diagnosed HIV, however, was related to significantly lower 
resilience. No difference was found, by age, in HIV negative participants. High resilience was 
also found to be significantly related to lower prevalence of depression, anxiety, ADL problems 
and physical activity in PWH.  
In relation to HIV status, PWH were more likely to have depression (19.8% vs. 13.1%) and 
anxiety (16.2% vs. 6.9%) than HIV negative participants, as well as problems with ADLs 
(34.9%vs. 15.9%), and were less likely to be physically active (57.9% vs. 69.8%). In adjusted 
analysis, anxiety, ADL problems and physical activity were significantly different by HIV status, 
but the pattern of higher prevalence among the HIV-positive group was maintained for the 
other measures. Anxiety was found to decrease with age in PWH, with a non-significant 
decreasing trend for depression and no clear difference found in relation to physical activity or 
prevalence of problems with ADLs. Time diagnosed with HIV was related to an increase in 
problems with ADLs, a nonsignificant increase in anxiety prevalence and no change in 
depression or physical activity. In HIV negative participants physical activity decreased with age 
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and problems with ADLs increased nonsignificantly. No difference was found in relation to 
mental health with age.  
 
7.5.1 Resilience 
High resilience was significantly related to decreases in the reports of depression, anxiety and 
problems with ADLs in PWH, but not physical activity. Resilience has been consistently linked 
to mental113;337 and physical health338;341;342 and health-care activities339;340;343 in the general 
population, but no studies had explored the relationship between resilience and well-being in 
a HIV positive population. From the data presented here, it appears that high levels of 
resilience are possible in an HIV positive population and are related to improved well-being; as 
in the general population, but not health-related activities.  
There are two main possibilities behind the relationship between resilience and mental and 
physical well-being. Firstly, high levels of resilience may buffer adults against mental and 
physical distress by increasing health-related behaviours339-341;343 and the use of adaptive 
coping mechanisms152;320-324. While the latter of these suggestions may relate to the current 
results, no relationship between resilience and physical activity was found, so the former may 
be ruled out. Alternatively, it is possible that having poor physical and mental health prevents 
adults from developing resilience by taxing their available resources and/or reducing access to 
social support. However, based off previous longitudinal data, for which the direction of 
causality is more assured, it appears that resilience does have a positive effect on both physical 
and mental health113;341;342. Therefore, it appears that resilience may be strongly related to 
well-being in PWH and may even be a protective factor against health decline, although the 
presence of other confounding factors in this relationship (factors associated with both 
resilience and poor mental health) cannot be ruled out. 
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7.5.2 Age 
Resilience increased nonsignificantly with age in PWH. As resilience was also found to be 
related to better mental health, this may partially explain the results found in Chapter 4, which 
found improvements in mental health with age despite lower levels of physical health. While 
there was no literature available on age-related differences in resilience in PWH, resilience is 
thought to increase with age in the general population112-114;346;347 due to life experiences of 
coping with adversity - such as bereavement, physical changes and adaptive life roles115. Were 
this to be the true, one might expect to see a stronger association between resilience and age 
in PWH as they are likely to have experienced even more life stressors. This was suggested in 
the results presented here: an increase in resilience was shown for age in PWH but not in the 
HIV-negative control group. However, the lack of change among the HIV-negative group may 
also be due to the smaller number of older adults available at the sexual health clinic (27 
participants over the age of 50 vs. 83 PWH).  
As in the ASTRA data, depression and anxiety prevalence decreased with age in PWH. 
However, the relationship between age and depression was only nearing significance, and no 
relationship was found between age and problems with ADLs. The pattern of trends with age 
and time with diagnosed HIV in depression, anxiety, and ADL problems that were observed in 
the HIV-positive sample in this resilience study were very similar to those found in the HIV-
positive participants from the ASTRA study (Chapters 3 and 4), although power was reduced to 
assess differences in this smaller sample. This similarity of findings from a new study carried 
out at a later time strengthens the thesis conclusions regarding differences in physical and 
psychological health with age and time since HIV diagnosis. 
Finally, the relationship between age and physical activity was explored. In HIV-negative 
participants physical activity decreased with age, likely due to age-related reductions in 
functional ability and in the availability of age-appropriate physically active social circles. In 
PWH, however, there was no significant relationship between age and prevalence of regular 
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physical activity. Based on the results, it seems possible that this is due to the low levels of 
physical activity across all ages of PWH; that is that levels of activity are particularly low among 
younger PWH. This could be due to the significant prevalence of fatigue and other physical 
symptoms apparent in this population as shown in the ASTRA study results (Chapter 3), 
although illness and fatigue were not explicitly explored in this study. However, it is also 
possible that lack of physical activity is related to the problems with ADLs reported in ASTRA in 
older adults through sedentary behaviour. 
Finally, the number of HIV negative participants spontaneously reporting 'walking' as a physical 
activity increased with age, which marks an age-related change in physical ability resulting in 
'walking' being seen as a physically taxing exercise. It also highlights that, to older adults, 
walking appears to be an acceptable form of exercise (30% of 60 and over reporting walking as 
an exercise): information which could be utilised in future interventions. 
 
7.5.3 Time diagnosed with HIV 
Longer time with diagnosed HIV was related to a decrease in prevalence of high resilience and 
an increase in problems with ADLs, and anxiety consistent with its adverse association with all 
health measures reported in the ASTRA results (Chapters 3 and 4). Problems with ADLs, as 
already discussed, may increase with time diagnosed with HIV due to drug toxicities and the 
side effects from early ART, coupled with age-related changes in health. Resilience has not 
been previously explored in relation to 'ageing with HIV', but may decrease with increased 
ageing due to the continued accumulation of stressors related to illness, stigma and ageing 
which prevent PWH from developing adaptive coping mechanisms. In other words, similar to 
the toxic stress model351, prolonged ill health and stress appears to inhibit PWH's ability to 
develop positive mental responses. As with the increases in resilience with age, these 
decreases correlated with the high prevalence of depression and anxiety reported in this 
241 
 
population in the ASTRA study and may help to explain the problems with between mental and 
physical health reported in adults ageing with HIV. 
 
7.5.4 HIV status 
Only one previous study compared resilience by HIV status, and that reported a non-significant 
decrease in resilience in PWH349. The current results, identical to those of the previous study, 
found a non-significantly lower level of resilience in adults with HIV, when compared to HIV-
negative adults. There are several possible explanations for the non-significance of this result. 
Firstly, it is possible that as the control group is well matched to PWH in relation to risk 
behaviours and self-esteem, no difference in resilience exists. Alternatively, it is possible that 
HIV does not affect resilience in the same way as other chronic illnesses and is not related to 
lower resilience rates, although the results relating to time diagnosed with HIV do not support 
this. This could be due to the large amount of support available to PWH through their HIV 
clinic, which could create a buffer against reduced positive mental well-being.  
Anxiety and problems with ADLs were significantly higher in PWH than HIV-negative 
participants, and physical activity was lower. Indeed, anxiety and problems with ADLs were 
over twice as likely in PWH than HIV negative adults, as was naming 'walking' as a physical 
activity. This mirrors the results of the ASTRA study, which suggested higher prevalence of 
mental and physical health distress than the general UK population, and adds to their bearing 
by including direct comparisons to a clinically matched control group. Depression, however, 
was nonsignificantly higher in prevalence in PWH in adjusted analysis. The lack of significant 
difference, however, may be due to the high rates reported in both populations, which were 
far higher than those identified using the PHE statistics218. In other words, PWH appear to not 
only have higher prevalence of mental health disorders and disability to the general UK 
population, but also to age- and risk-behaviour matched adults. Alternatively it is possible that 
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the PHQ-9 and GAD-7 overestimate the prevalence of depression and anxiety - at least in 
comparison to other measures. 
 
7.5.5 Limitations 
There are two main limitations to this analysis. The first limitation is that the sample size of 
older HIV-negative participants was small due to the lack of older adults attending the clinic, 
which resulted in lack of power for age-related comparisons, as shown in the width of the 
confidence intervals reported. The small sample size also limited the power of this study and 
may have resulted in type two errors. It also meant that we were unable to perform sub-group 
analysis in relation to gender or ethnicity, or interaction tests, and that we were required to 
combine all adults over the age of 50 into one group. As such, we cannot comment on age-
related differences in resilience within the OPWH population. 
Secondly, where no response was indicated in regards to questions from the PHQ-9, GAD-7 or 
RS-14 a standardised result was input. As such, the depression, anxiety and high resilience 
rates reported here may be an underestimate of true prevalence in these populations. 
It is also important to note that the associations reported are only correlational and, while 
causal explanations have been suggested, longitudinal data is required to provide more 
evidence of causality. 
Finally, the HIV negative participants here were all recruited from sexual health clinics, which 
may have homogenised the responses. Further analysis using control participants from the 
background population may create different results. 
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7.5.6 Conclusions and Implications 
This study, while small, is the first information available on the association between resilience 
and age in PWH, and one of the first studies to explore resilience in relation to HIV. As such, 
although power was limited, the study results are integral to understanding age- and 'ageing 
with HIV'- related changes in well-being in PWH. It also confirmed earlier results in identifying 
psychological symptoms as a cause for concern amongst PWH, which requires more academic 
and clinical attention. 
The information shown suggests that resilience is strongly related to depression, anxiety, 
physical health, and health-related activities and may be a mediator between physical and 
mental health in relation to both age and time with diagnosed HIV. It should be included in 
studied assessing well-being in OPWH, and could be developed into an intervention. 
Resilience-based interventions have, for example, been piloted amongst diabetics354 with 
positive results. These interventions involve three main premises for improving resilience: 
taking responsibility, empowering the self (through education and self-management) and 
creating meaningful connections; explored across multiple support group meetings354;355. Such 
interventions could be considered for PWH, especially those who have been diagnosed with 
HIV for an extended period of time. Finally, this study also identified low levels of physical in 
PWH, compared to HIV-negative adults. As general physical fitness is an important part of 
physical and mental well-being this could also be addressed in future care. These will be 
discussed further in the next chapter. 
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8 Interventions to improve well-being in adults ageing 
with HIV 
Up until this chapter I have focused on identifying age- and 'ageing with HIV'-related 
differences in well-being in PWH in the UK. Due to the lack of previous UK literature, it was 
important to identify potential care needs of this specific population beyond routine HIV care 
as it is currently delivered. However, it is important to not only identify age-related differences 
but also to show how this information can be utilised by health-care organisations to improve 
the well-being of OPWH.  
In order to do this, I performed a second systematic review in order to identify interventions 
that have previously been found to be successful within this population. I then combined this 
information with the results of this thesis and the general gerontological literature to suggest 
measures which are most likely to improve the overall well-being of OPWH. 
 
8.1 A systematic review of interventions to improve the wellbeing of 
OPWH. 
To identify studies evaluating interventions aimed at improving well-being for older adults with 
HIV, a systematic review was conducted following Preferred Reporting Items for Systematic 
reviews and Meta-Analyses (PRISMA) standards119. All methodologies measuring well-being 
were included in the outcome, provided that they used validates measures.  
I searched 22 databases which publish articles on health, HIV, or psychology from their earliest 
recorded dates until December 2012 for all peer-reviewed publications, regardless of 
language, which contained key words within the matrix of relevant terminology. The databases 
included were: AIDS, Cochrane Database of Systematic Reviews (CDSR), database of systematic 
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and non-systematic reviews of public health interventions (DoPHER), Medline/Pubmed, JAIDS, 
SAGE, JSTOR, LILACS, Mary Ann Liebert, METALIB, Psychnet, sciencedirect, Springerlink, Taylor 
and Francis, Wiley and EBSCO in July-August 2014. This was then updated in September 2015. 
The search terms used were HIV [or] AIDS coupled with ‘50’ [or] ‘age’ [or] ‘aging’ [or] ‘elder’ 
[or] ‘elderly’ [or] ‘fifty’ [or] ‘mature’ [or] ‘old’ [or] ‘older’ [or] ‘senior'. 
 
8.1.1 Inclusion and Exclusion criteria 
Inclusion criteria incorporated the paper being (a) a peer-reviewed, original research article 
that (b) studied at least one intervention in relation to (c) physical, psychological or social 
issues associated with HIV in (d) adults over 50 with HIV (with at least 80% being over 50, or an 
indeterminate percentage with a mean of over 50) from any country. Despite the age-related 
changes found in the ASTRA study beyond the traditional '50 years of age' cut-off, the inclusion 
criteria was limited to limitations with adults over the age of 50 only so as to be clear that 
older adults were the intended recipients. These can be found in more detail in table 57. 
Studies were excluded if they did not explicitly examine interventions in psychological or social 
issues associated with HIV with a measurable outcome. Prevention interventions among 
OPWH were not included. Studies whose full text could not be retrieved were excluded. 
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Table 57. Inclusion criteria in order of use. 
No. Inclusion Criteria Status of paper and response 
  Yes Unclear No 
0 Is the study clearly outside the scope of 
the review? 
Exclude 
Go to question 
1 
Go to question 
1 
1. Are the participants HIV-positive? Go to question 2 Exclude 
Type of study  
2. Is it randomised, including cross-over, 
cluster and factorial trials? 
Go to question 4 
Go to question 
3 
3.  Is it a non-randomised intervention study 
(before and after study), cohort or case-
control observational study? 
Go to question 4 Exclude 
Participants in study  
4.  Are the participants over the age of 50 
years?  
Go to question 6 
Go to question 
5 
5. If some of the participants are under the 
age of 50, can the data be disaggregated 
to show that 80% of the sample is over 
the age of 50 or, if indeterminate, is the 
mean age over 50? 
Go to question 6 Exclude 
Interventions 
6. Does the intervention aim to improve 
biopsychosocial well-being or quality of 
life for OPWH either as a primary or 
secondary aim? 
Go to question 7 Exclude 
7. Are participants receiving the intervention 
in comparison to other adults over 50 
affected with HIV who received a) usual 
care, no care of placebo and/or b) a 
different intervention that meets the 
criteria outlined in question 6 or c) fit the 
criteria for question 3?   
Go to question 8 Exclude 
Outcomes 
8. Does the study measure physical, 
psychological and/or social factors 
measured by validated instruments? 
Include subject to clarification of 
'unclear' points 
Exclude 
 
N. Final Decision 
Include 
Unclear (more 
info) 
Exclude 
 
A total of 861 records were returned from database searches. An additional two records were 
identified through lead authors. The removal of duplicates and papers not directed at OPWH 
reduced the final count to 627 papers. A key term search was conducted through the text of 
the final list and 17 paper relevant to the review were identified, 11 of which were empirical 
studies. No further papers were identified through bibliography mining. A final four studies 
met the screening criteria and were included in the final analysis. The selection process is 
depicted in figure 29.  
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Figure 29. Preferred Reporting Items for Systematic Reviews diagram summarizing selection 
procedure for studies on interventions for OPWH.  
 
A total of 17 papers were identified, of which 10 were empirical studies. No further papers 
were identified through bibliography mining. Of the 10 studies remaining, four met the 
screening criteria listed in Table 58, Appendix E and were included in the final analysis. One 
was a pilot study356 and was excluded from analysis due to the small sample size (N=16). All 
four studies originated from the same research group.   
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8.1.2 Results 
8.1.2.1 Intervention Characteristics 
All three interventions used a randomised control trial design357-359 and involved at least one 
follow-up assessment. Two interventions357;358 involved group therapy, one of which was 
telephone administered358. Types of group therapy were a 12-session, 90-minute coping 
improvement group intervention357, a 12-session, 90-minute interpersonal support group 
intervention357, a 12-session, 90-minute telephone-administered coping effectiveness training 
(CET)358 and a 12-session, 90-minute telephone-administered supportive-expressive group 
therapy (SEGT)358. The final intervention involved telephone-delivered motivational 
interviewing, in one or four sessions lasting 50 minutes359. The coping improvement group 
interventions covered personal histories, appraisal of HIV and ageing stressors, development 
of problem-solving and emotion-focused skills and interpersonal support356;357. The 
interpersonal support group intervention discussed videos on nutrition, treatment adherence 
and sexual risk reduction, how these affected their own lives, and how to adapt them to suit 
an over-50s group357. SEGT explored feelings about aging, HIV and being an OPLWA while 
facilitating support through other members, family, health workers, and social groups, 
encouraging the expression of emotions, redefining self-image and feelings about death, 
developing activities and improving quality of life (QoL)358 and CET discussed stressor severity 
and developed and optimised coping skills, including social support358. 
The measures used to assess outcomes varied between papers, with only one appearing more 
than once. Only two interventions356-358 had psychosocial well-being of OPLWA as their primary 
objective, and both were aimed at reducing depression in OPWH with clinically relevant 
depression scores. The other primarily aimed to decrease risky sexual behaviour, with 
psychosocial well-being of participants as a secondary goal359. Finally, although length of time 
with HIV is reported in all three studies357-359, no analysis on the effect this had on treatment 
effect occurred.  
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8.1.2.2 Intervention Effects 
The coping improvement group intervention explored by Heckman and colleagues in 2011357 of 
almost 300 participants was successful in reducing depression (p<0.01) immediately post-
intervention, if not at 4 or 8-month follow-ups (although depression prevalence were still 
lower than at baseline). The support group intervention also showed successful reduction in 
depression (p<0.04), but only at 4-month follow-up: not at post-intervention or 8-month 
follow-up357.  
Lovejoy’s359 (2012) pilot telephone-delivered individual motivational interviewing intervention 
aimed at reducing sexual risk behaviour, depression, anxiety and stress in 100 PWH over the 
age of 45. For one-session interviews, no significant difference was found in depression 
(p=0.44), anxiety (p=0.99), or stress (0.85) at a 3-month follow-up compared to a control, but 
differences were found for all three at 6-month follow-up (depression: p=0.03, anxiety: p=0.04, 
stress: p=0.04)359. Similar results were found for the 4-session interviews, where at three 
months there were no significant results for depression (p=0.83), anxiety (p=0.66) or stress 
(p=0.88), but at six months all three were significantly reduced (depression: p=0.01, anxiety: 
p=0.01, stress: p=0.01)359. Although the differences in depression, anxiety, and stress showed a 
larger effect size for the 4-session interview, no significant difference was found between the 
two interview conditions, suggesting that length of the intervention is relatively irrelevant to 
the outcome359.  
Heckman and colleagues' 2013 SEGT teletherapy was successful in reducing depression in a 
sample of 361 OPWH at post-intervention (p=0.01), 4-month (p=0.01) and 8-month (p=0.01) 
follow-up compared to control358. CET teletherapy had no effect on depression at any time 
point (p=0.99, 0.25 and 0.56 respectively)358. Thorough post-hoc analysis also revealed that the 
reduction in depression was greater the more sessions were attended for both SEGT (p=0.04) 
and CET (p=0.01) and that the higher depression was pre-test, the lower it was post-test 
(p=0.01 for SEGT and CET).  
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8.1.3 Discussion 
This is the first review to systematically summarise the research available on interventions to 
improve well-being in OPWH. The most obvious finding available from this systematic review is 
that research is lacking. Three studies were found, all from the same American research group 
but each using different methodologies and measures. The lack of repeat studies and 
comparable methods makes it impossible to determine whether these interventions would be 
effective across OPWH in other geographic areas. Furthermore, the interventions were all run 
by clinicians with Masters-or-above level qualifications357-359, which are not always accessible 
for all clinics. Finally, no interventions were identified focusing on long-term HIV care. As such, 
we are reliant upon the OPWH literature to suggest strategies that may be beneficial to adults 
ageing with HIV. 
However, it is important to note that all three interventions did result in positive effects on the 
mental health of OPWH. While the methodology used was complex - making pinpointing which 
elements caused the improvement in psychosocial wellbeing difficult - what can be taken from 
this review is that well-being can indeed be improved in OPWH through interventions and that, 
regardless of content, the social contact made available through group interventions may 
improve well-being. Indeed, Heckman and colleagues357 note that the decrease in depressive 
symptoms in their interventions may come from contact with other PWH, as no significant 
difference in intervention results were found and the exchange of contact details was 
encouraged357. Furthermore, telephone-delivered interventions appear to be effective359;358, 
even after only one session359, meaning that interventions need not be in person or extensive 
to be successful. This would be useful for health-care institutions where space is an issue, as 
well as OPWH who have difficulty travelling to clinics and are therefore less likely to attend 
repeated sessions.  However, most of the interventions discussed also used 'standard of care' 
as a control, which means that the positive effects of the results are likely over-estimated and 
may not differ from those of currently available interventions.  
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9 Discussion and Implications of research 
9.1 Discussion of results 
The number of older adults with HIV in the UK is increasing, both in terms of new diagnoses 
and adults ageing with HIV19. However, there has been limited research into the physical, 
psychological, or social well-being and care needs of older adults with HIV, and even less 
research dedicated to those ageing with HIV. Research has also not tended to explore the 
possibility of 'positive' effects of age on well-being, such as resilience, and the possibility of the 
development of age-appropriate interventions to improve well-being. This has left much of the 
discussion in the literature to extrapolate information from gerontological literature and 
studies of HIV-positive populations which were predominantly composed of younger adults. In 
particular, the majority of research into OPWH originates from North America - to date only 
five studies that were specifically concerned with biological, psychological or social well-being 
were identified from the UK. 
This thesis aimed to identify the biopsychosocial problems facing older PWH in the UK, both in 
relation to biological age and 'ageing with HIV', and to explore potential avenues for an age-
appropriate intervention. Through the analysis presented, I have identified age- and ageing-
related differences in physical symptom prevalence and distress, problems with ADLs (Chapter 
3), depression, anxiety (Chapter 4), disclosure, and social support (Chapter 5) in PWH. The 
thesis results have given insight, within a large population of people with HIV in the UK, into 
the most prevalent problems limiting well-being in PWH overall and in older PWH and those 
ageing with HIV. The results presented are also among the first to assess the independent 
associations of both age and time with diagnosed HIV on indicators of well-being, together 
with the first available data on resilience in OPWH and its relationship to physical and mental 
well-being and health-related behaviours.  
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Below I discuss the evidence presented over this thesis, in relation to ASTRA'S HIV positive UK 
sample, and the factors which differ by and age time diagnosed with HIV. As physical, mental, 
and social well-being are strongly inter-related, I also report on the relationships between 
these variables, in order to identify common themes. As a large amount of data is presented, 
these associations will be depicted in visual form in Appendix E, figure 30.  
 
9.1.1 The biopsychosocial health of HIV positive people living in the UK 
The data presented, although based on a study sample, gave insight into the biopsychosocial 
well-being of HIV-positive people living in the UK in the current era of successful treatment. An 
understanding of the well-being of the HIV population in general is necessary in order to place 
age-related differences in well-being into context, and this data will therefore be presented 
below. 
In the ASTRA study of 3,258 PWH, high prevalence of symptoms and symptoms causing 
distress were identified (section 3.3), and problems with ADLs were twice as prevalent as has 
been found in the general UK population176. Almost all (92.8%) participants reported 
experiencing physical symptoms, with the majority reporting nine or more. Almost half the 
study sample reported significant distress in relation to these symptoms. The most commonly 
reported symptoms were fatigue-related, and the symptoms that, where present, were most 
likely to be distressing were 'pain', 'changes in fat in face or body' and 'difficulty sleeping'. A 
high symptom prevalence has been recorded in other studies of PWH360-362, and may occur 
both in relation to the infection itself and the medication. Fatigue, in particular, is commonly 
reported in PWH, and appears to be related to ART medication and mental stress197-199. The 
ASTRA data confirms a high burden of symptoms among people living with HIV. Symptom 
distress is less well recorded in the literature, but is not unexpected in relation to the 
symptoms common in HIV and was therefore thought to be an important focus in this study, 
which was likely to impact on well-being. 
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Compared to the general UK population, and based on a comparison study, PWH in this study 
reported higher prevalence of depression and anxiety218, across both the ASTRA and Resilience 
studies. Indeed, depression symptoms appeared to be 8-10 times more prevalent218 and 
anxiety symptoms to be 4-5 times more prevalent218 (section 4.4.1). A high psychological 
burden has been found in relation to chronic illness in general219;250;254;255;363. In chronic illness, 
depression can be related to feelings of being overwhelmed, weakness-related shame and fear 
of a slow - or non-existent - recovery221. In relation to HIV, depression has been related to 
several factors salient in older age groups, such as bereavement86, poorer physical 
function85;87;88, health-induced anxiety84;89;90 and social isolation85;91;92. As such, it may not be 
considered surprising that these rates are higher than the general population.  
Depression and anxiety have also been related to high disease burden across several chronic 
illnesses220;223;249;255 and higher rates of medication nonadherence227, making them important 
factors to consider when assessing well-being. This was also found in the ASTRA sample 
(section 4.3.3), with strong relationships found between mental and physical health symptoms. 
Similarly, social support was a commonly reported problem in the ASTRA sample (section 
5.3.1), and the availability of sufficient social support was strongly related to better overall 
well-being (section 5.3.5).  
These results highlight the detrimental relationships between HIV status and mental, physical, 
and social health. However, it is worth noting that in the study population, the vast majority 
were on ART, viral load was generally successfully controlled, and the prevalence of 
immunosuppression was low (81.5% CD4 count of ≥350 cells/mm3) (section 2.4). In fact, having 
a low CD4 count was related to few other measures of well-being. Therefore, while CD4 count 
appears to be generally successfully managed amongst this sample of UK PWH, these results 
suggest that symptom distress, depression, anxiety, and problems with ADLs are prevalent and 
consequently may not be a focus of care, and may be less well managed in adults with HIV. In 
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relation to interventions, these factors would appear to be potential intervention avenues for 
improving well-being, regardless of CD4 count. 
 
9.1.2 Age-related differences in biopsychosocial health 
9.1.2.1 Physical well-being 
Similar to PWH of all ages, the most commonly reported well-being issues in OPWH in the 
ASTRA study were symptom prevalence, symptom distress, and social support. Problems with 
ADLs were reported more frequently with age (section 3.3.3), which suggests that OPWH are 
at risk of disability and this should be addressed accordingly. Mobility and physical activity 
have also been found to reduce with increasing age in the general population26;55;175, but the 
prevalence of problems with ADLs observed in the ASTRA study data was greater than that 
found in older adults in the general population (54% vs. 45%176;215), and occurred at younger 
ages, which suggests that age and HIV may have a cumulative effect on physical health 
resulting in faster physical ageing of the body. One hypothesis may be that inflammation 
caused by HIV infection may accumulate cell damage in a similar, but faster, way to that 
described in natural physical ageing50;80;180 and thus causes earlier signs of physical ageing81. 
This could result in greater fatigue, physical frailty, and problems with activities of daily living 
(ADLs) with age26;54;55, some of which were shown here. This finding was, moreover, replicated 
in the Resilience study, which showed more prevalent problems with ADLs in an HIV positive 
sample than a demographically-matched HIV negative sample (section 7.4.2.2), although the 
sample size was small. The resilience study also identified lower levels of physical activity in 
PWH, which could be either a cause or result of increased problems with ADLs26;54;55. As such, it 
would be worth encouraging exercise in OPWH to improve overall well-being170;276;364-366. 
Differences in the prevalence of fatigue with age were not, however, identified; although this 
may be related to the high prevalence of fatigue in the ASTRA population. Similarly, in adjusted 
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analysis, there was no trend with age in relation to the majority of the physical symptoms - or 
distress - explored (section 3.3), suggesting that OPWH in the UK are not at higher risk of 
physical concerns than younger PWH, despite reporting more problems with ADLs. 
Unfortunately, while comorbidities have been well documented in OPWH55;64;79;109;130;133;141;142, 
individual symptoms have not been previously explored, and so it is unclear why symptom 
prevalence would remain stable across age. However, it is possible that this is due to the high 
levels of adherence reported overall, making HIV-medication-related symptoms similar across 
all age groups.  
In regards to the symptoms which did increase in prevalence with age, the HIV and 
gerontological literature suggest that the differences observed are likely due to a collaboration 
of age-related and HIV-related illness. Specifically, gastric symptoms were more common in 
older PWH and are common in people taking cART87, which may imply a higher toxicity in 
response to ART medication in older adults, possibly due to drug-drug interactions64;128 and/or 
age-related homeostatic loss8. Tingling in hands and feet is often related to nerve damage 
from viral infections (such as HIV), toxic exposure from medication, and systemic diseases 
(most often diabetes) while muscle ache and joint pain may be related to an age-related 
rheumatic condition54;69;173. It is also possible that the changes in reports of symptom 
prevalence and distress are related to changes in 'social comparison'201;202 with age. Older 
adults may consider some symptoms (e.g. sexual interest) to commonly decrease with age and 
others (e.g. fatigue) to commonly increase, and so find these less distressing than younger 
adults. Once again this does highlight the importance of age-specific care, as well as an 
understanding of age-related symptoms and concerns. 
Finally, CD4 count remained high across age groups (section 2.4.4). This ties in with the 
literature which suggests the possibility of a good response to cART regardless of age64;77-
79;126;128;132. It is possible that the comparable response observed in older adults to younger 
adults is due to higher levels of adherence in older PWH161-163, counteracting any age-related 
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immunological decline and contributing to the stable CD4 counts across age seen in the ASTRA 
population. CD4 count was, further, not found to be related to measures of physical, mental, 
or social well-being. As such it appears that immunological response is not a concern specific 
to the well-being of OPWH, nor an appropriate measure, when ART is administered in an 
appropriate and timely fashion. 
 
9.1.2.2 Mental well-being 
Depression and anxiety are commonly associated with chronic illness58;63;219;221 and older age56-
58 up until the age of 55, where prevalence may decrease again (according to UK statistics)218. 
In the HIV-specific literature, depression has generally not been found to differ by age 
group64;120;129;138;145-148, while anxiety has not been well researched. Somewhat in contrast to 
the previous literature, the results presented here (section 4.3) show that depression and 
anxiety symptoms decreased in prevalence with age –a finding apparent in both the ASTRA 
and Resilience studies. As depression and anxiety prevalence increased with time diagnosed 
with HIV, this suggests that previous results shown in the literature may be explained by the 
amalgamation of age and time with diagnosed HIV effects and that lack of adjustment for time 
with diagnosed HIV may obscure the declining trend with age. As such, future studies should 
adjust for time with HIV when assessing the effects of age. 
There are several possible reasons why older PWH may report lower rates of depression and 
anxiety. For example, older adults have also been found to report fewer negative emotional 
experiences than younger adults237-239 and may experience the 'positivity effect': the selective 
attention to - and recall of - positive events and situations241-244. Alternatively, it is possible that 
the results reflect better 'resilience' in older adults200, developed throughout their 
lifespan90;135;152. Higher resilience has been consistently linked to positive mental113;337 and 
physical health338;341;342 in HIV negative populations. High resilience was similarly found to be 
related to a lower prevalence of depression and anxiety rates in the Resilience study, although 
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it did not differ significantly with age. Furthermore, high levels of resilience were identified 
within the HIV positive population (section 7.4.1.1), suggesting that ‘positive’ mental health is 
possible in PWH and, in addition, are related to improved well-being. However, while 
resilience did increase in prevalence with age in PWH, this did not reach significance. While it is 
possible that this result was an artefact of the smaller sample size, the limitations of the 
methodology within this study mean that we cannot rule out alternative explanations for the 
differences in mental health seen with age in PWH. For example, depression (if not anxiety) 
were also mediated by the improved demographic variables in the older population (greater 
proportion with money for basic needs, lower alcohol dependency etc.), suggesting that age 
itself is not the only factor that needs to be taken into account when assessing depression in 
PWH. Regardless of the underlying cause, it appears the depression and anxiety - while high in 
PWH - are not of greater concern to OPWH than younger PWH, and do not need to be a 
specific focus of age-focused care. 
With increasing age, however, the association between physical and mental well-being 
became stronger, such that older adults with anxiety were more likely to report a greater 
burden of physical symptoms. Anxiety has not been researched thoroughly in relation to 
OPWH, meaning that there is little evidence to compare the current results to. It has been 
found that anxiety is higher in adults who report poor overall health249;255 and/or chronic 
illness252-254 than those without, which corresponds with the higher prevalence found in adults 
with HIV when compared to the prevalence in the general UK population, as well as to the 
relationship found between the prevalence of anxiety and of symptom prevalence and 
distress. This suggests that age-related differences in health may be of concern to OPWH and 
affect both mental and physical well-being. However it is worth noting that in general the 
relationships between physical, psychological, and social well-being did not differ by age.  
While physical symptom distress did not differ with increasing age (section 3.3.2), the stronger 
association between physical symptoms and anxiety, along with the changes in prevalence of 
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physical symptoms with age, do highlight the need, within HIV care, for an understanding of 
the effect of age-related changes in health on well-being. This may require specialised geriatric 
knowledge from HIV practitioners, or a stronger relationship between the two fields in order 
to offer appropriate care. 
 
9.1.2.3 Social well-being 
Retirement was found to be related to higher levels of physical symptom prevalence, distress, 
ADL problems, depression, and anxiety in comparison to employment both in the overall 
sample and in PWH aged over 50 (section 5.3.5.4). In the gerontological literature it has been 
suggested that retirement causes positive effects on mental and physical health through 
lowered stress61;316 and increased time for social and physical activity300;301 unless it is forced 
due to ill health300;303;304. This implies that for PWH, retirement may well be forced by ill health 
or care-giver role needs, and in these situations it is possible that individuals may feel 'cheated' 
of the sense of achievement attained through work, and not receive all the benefits of well-
being which have been related to retirement. It is also possible that ill health itself limits the 
positive effects of retirement within PWH, although this is not supported by the reported 
prevalences of physical symptoms by age group.  
Rates of 'sufficient' social support appeared to be low in PWH overall (section 5.3.1), although 
it was not possible to make a comparison with HIV-negative people or the general population.  
Social support decreased (nonsignificantly) with age and time with diagnosed HIV, making it a 
factor worth considering when measuring well-being in older adults with HIV. Social support is 
generally considered to decline with age64-66 due to reduced opportunities for social interaction 
caused by retirement97, illness64;97, loss of friends and family through bereavement64;97;117;271, 
and/or reduced mobility69;76. As such it is possible that this effect is related to general ageing, 
rather than ageing with HIV. Relationship status and disclosure were both found to be related 
to social support; both factors (being in a relationship and having disclosed HIV-status) 
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reduced in prevalence with age. This suggests that they may be linked to the lower levels of 
social support available to OPWH compared to younger people with HIV. Previous studies have 
found that OPWH reported low levels of disclosure of their HIV status to family and friends93-96. 
As older adults are reported to rely on their partners269;270;277 and family for social support295-
298, this is a concern: in particular as sufficient social support was found to be related to lower 
levels of depression, anxiety and physical symptom distress. 
Good social support has previously been found to be related to better physical and mental 
health in the general population272-274 and older adults70;7218;2074, strongly suggesting that social 
engagement is an important determinant of health and well-being. These results are reiterated 
here. Therefore, without acceptable levels of social support PWH may not receive the levels of 
psychological and physical support269;270 required to respond appropriately to ill health and/or 
strict medication regimens. As such I would suggest that, despite only moderately lower levels 
of social support in older adults, this is still an important factor to address. In particular, there 
was some evidence that being in a supportive relationship was increasingly related to social 
support and disclosure with older age, suggesting that this is an important factor for improved 
social well-being in OPWH. 
 
9.1.2.4 Variations within the age bands 
One important finding that was revealed during the analysis undertaken in this thesis was that 
consistent differences in physical, mental, and social health were apparent between PWH aged 
50-60 and those aged over 60. Specifically, adults over the age of 60 generally showed fewer 
concerns in relation to physical symptoms, depression, anxiety or levels of social support. This 
suggests that, with age, PWH may develop more adaptive coping methods and that the 
process of adaptation to illness may continue into later life. Similarly, adults aged under the 
age of 30 often reported greater biopsychosocial distress than older age groups. As such this 
underlines the need to view changes in well-being across the entire age spectrum, rather than 
260 
 
combining all adults over the age of 50, and suggests that the 'over 50' cut-off for defining 
'older adults with HIV' is likely to amalgamate important data and two (or more) subgroups 
with different care needs, or perception of need.  
Much of the previous literature on older adults with HIV has assumed that biopsychosocial 
needs are greatest in older people with HIV23;26;135;367;368. This assumption may, in part, be due 
to the lack of research comparing well-being in younger and older adults with HIV, rather than 
in older adults alone. It may also be a result of the amalgamation of age- and time with 
diagnosed HIV- effects on well-being, as already discussed. However, the results of the ASTRA 
study do not show a linear reduction in well-being with age. In fact, in regards to many of the 
well-being factors assessed, PWH aged under 30 years of age show a higher burden of 
reported symptoms and symptom distress than the other age groups. As such, this age group 
may also need to have their specific care needs explored in future research. 
 
9.1.3 'Ageing with HIV'-related differences in biopsychosocial health 
Living with HIV for a long period of time may cause HIV-specific stressors in older adults. For 
example, those who were diagnosed before the availability of effective cART are likely to have 
experienced many of their friends and partners dying from AIDS or previous HIV-related 
illnesses and conditions, and experiencing severe medication side-effects, some of which may 
have resulted in ongoing ill-health, and have lived with the fear of a poor prognosis and death. 
These experiences may well be unique enough that older adults with HIV and adults 'ageing 
with HIV' should be treated as separate groups, with separate histories, experiences, and well-
being needs101;102. However, very little information was found into the effects of 'ageing with 
HIV' in previous literature; with no previous research identified into the effects of ageing with 
HIV on mental or social health, or developing interventions specific to this sub-group. 
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One of the major findings of this thesis is that time diagnosed with HIV was revealed to have a 
much clearer and stronger relationship with well-being than age. Symptom prevalence, 
distress, ADL problems, depression, anxiety, social support, and unemployment all increased in 
prevalence with increasing time diagnosed with HIV. As such, adults with long-term diagnosed 
HIV appear to be in need of aid in improving their biopsychosocial well-being. As identified 
through symptom prevalence and distress, they have different care needs to more recently 
diagnosed adults and may require specific intervention content. Currently, adults with long-
term HIV who maintain a high CD4 count are seen by HIV clinicians only once a year and are 
not routinely measured for well-being beyond their CD4 count. As CD4 count has been shown 
here not to relate to measures of physical, mental, or social well-being, this suggests that the 
needs of adults ageing with HIV is not being assessed or habitually met. 
Symptom distress likely increases with time diagnosed with HIV due to the increase in 
symptom prevalence, which leaves participants with higher levels of distress regarding the 
progression of their HIV status. Adults who have lived with HIV for a long time may also have 
lived through HIV as a terminal illness and seen friends and peers becoming ill, before 
progressing to AIDS and eventual death. As such 'social comparisons' could be causing them 
greater levels of distress. For example, in previous research OPWH expressed fear related to 
the 'unknown' future of their health and HIV status and being hyper-aware of changes in their 
bodies106, which is likely to increase reports of symptom prevalence and distress, and could 
result in higher levels of health-related anxiety. Such concerns may be particularly prevalent 
among those diagnosed in the pre-cART era and may results in the increased distress observed 
in PWH diagnosed for twenty years or longer. The increase in symptom prevalence with time 
diagnosed with HIV may also relate to the lower reported satisfaction with social support - 
despite increased rates of disclosure. Namely, with increased physical distress and more 
problems with ADLs it is likely that this population requires a higher levels of formal - and 
informal - support which, based on the results of the ASTRA study, do not appear to be 
forthcoming. Furthermore, as the necessity of support becomes more common, PWH may feel 
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more dissatisfied with whatever support is available in terms of 1) meeting their higher level of 
needs and 2) feeling shame, or to be a 'burden'310 to their loved ones: thus reducing overall 
satisfaction. However, there is little previous literature to support this assumption. 
With longer time diagnosed with HIV, depression and anxiety prevalence also increased in 
both the ASTRA (section 4.3) and Resilience studies (section 7.4.2.1). The few studies identified 
in the literature which explored time with diagnosed HIV reported that depression is higher in 
newly diagnosed PWH88;89;258 and improves as participants develop more effective coping 
strategies and come to terms with their diagnosis. However, the results presented in this thesis 
show the opposite, which suggests that PWH may not be developing effective coping 
strategies, or are experiencing too many changes in health-related stress over time to design 
effectively adaptive strategies217. This would be especially true in the face of reduced social 
support. As longer time with diagnosed HIV was related to a decrease in the prevalence of 
resilience which, in turn, was related to higher prevalence of depression, anxiety, and 
problems with ADLs, it seems likely that the continued accumulation of stressors related 
ageing with HIV are preventing PWH from developing adaptive coping mechanisms351 and 
therefore that protective factors - such as resilience - are not apparent in this population. 
However, whether the reduction in resilience reported with increasing time diagnosed with 
HIV is a cause (and therefore a potential target of interventions), or effect, of the reduced 
biopsychosocial health is unclear and longitudinal data is required. 
Adults 'ageing with HIV' appear to be a very separate group to older adults with HIV in general 
in regards to their biopsychosocial health and report separate - and more concerning - care 
needs. Combining these two sub-groups is likely to cause misleading inferences regarding the 
effect of age, and this should be taken into account when reviewing previous literature, and 
developing further studies of well-being in OPWH or adults ageing with HIV. Indeed, I have 
suggested that the findings from previous studies which showed no significant change in 
depression prevalence with age may well be the result of an amalgamation of these two 
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groups. However, more data is needed to corroborate the findings of these two studies before 
this can be strongly defended. Similarly, due to the absence of available literature on ageing 
with HIV I can only surmise on the meanings behind these results based on overall OPWH 
literature. As such, the information provided here, while a broad image of the biopsychosocial 
impact of ageing with HIV, is scarce in regards to the factors driving these changes.  
 
9.2 Service implications 
From the results of the studies presented here it is apparent that physical health distress was 
prevalent across all age groups, problems with ADLs increased with increasing age while social 
support, the presence of close relationships, and disclosure of HIV status all decreased with 
increasing age, making these the most important measures of well-being to address in OPWH. 
Furthermore, there were age-related differences in the symptoms present and/or levels of 
distress, which suggests that age-specific physical care may be necessary. Adults ageing with 
HIV, on the other hand, report universally reduced well-being and would likely benefit from 
interventions aimed at improving physical, mental, or social well-being. Moreover, it appears 
that resilience can be utilised to improve overall well-being and may also be an important 
factor to consider when seeking to improve well-being in OPWH and adults ageing with HIV.  
In the absence of interventions identified specifically for OPWH or those ageing with HIV, 
methods which have been shown to be effective in the gerontological literature are considered 
and presented below. It is worth noting, though, that community support is currently available 
to PWH through charities such as the Terrence Higgins Trust (THT) and 'Positively UK' and well-
being may be improved in adults ageing with HIV simply through encouraging clinics to 
signpost these community services to older patients. For example, 'Positively UK' is currently 
developing 'project 100', which aims to develop social support networks in PWH. However, as 
OPWH report feeling unwelcome at support groups with younger members - which also often 
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do not address age-specific concerns76;258;312;368 - age-specific intervention groups are most 
likely to be effective when improving social support in OPWH.  
 
9.2.1 Physical symptom distress and problems with ADLs 
In relation to physical symptom distress, one previous small piece of qualitative work identified 
that OPWH (N=18) are concerned about their – and their doctor’s – ability to differentiate 
between ageing and HIV progression and would prefer more regular health screenings for 
comorbid conditions (such as cancer)369. While more frequent screenings may be useful, they 
may also fuel fear and increase hyper-awareness of bodily change in PWH. Age-specific 
changes, on the other hand, could easily be discussed in a group intervention, allowing 
participants to identify common health issues, and could be visited by a physician in one or 
more sessions to provide more in-depth information on common HIV- and ART-related 
symptoms. This could alleviate low-level anxiety about health and reassure older adults that 
their physicians understand (and have been actively made aware of) the symptoms of most 
concern to the group.  
In regards to physical activity, the THT currently advocates the use of exercise to improve 
physical and mental well-being, but suggests no age-appropriate programmes. Two types of 
physical exercise, however, have been found to be beneficial to older adults with HIV: 1) 
progressive resistance exercise, which can safely increase muscular strength, physical fitness, 
and body composition in sedentary older adults364;366, and 2) aerobic exercise, which involves 
brisk walking, running, swimming, or bicycling and is related to improved cardiovascular and 
pulmonary health in older adults366. Boundaries to physical exercise could also need to be 
assessed and set to reduce the participant’s concerns of ‘over-exerting’ themselves69;71;76 and 
adaptable schedules could be set. Such interventions could reduce frailty in adults ageing with 
HIV, as well as fatigue, and reduce the prevalence of ADL problems. However, such 
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interventions are most effective when undertaken over several days a week for six weeks, and 
require trained session leaders364;366 and so may be more difficult to implement successfully.  
 
9.2.2 Social support 
It has repeatedly been observed that OPWH have unmet social needs100;368-370. By introducing 
OPWH to other adults ageing with HIV in a group intervention setting, social support may be 
improved regardless of the intervention content. Meeting other ageing adults in a safe and HIV 
stigma-free setting can reduce feelings of isolation260 and allow them to share positive 
experiences330 and coping strategies371. It could also be an opportunity to set up support links 
between adults ageing with HIV: thus alleviating the clinic care burden.  
 Participants could also be encouraged to continue interactions outside the group, exploring 
hobbies together in order to feel more comfortable, which in turn could be beneficial to 
physical health. Once an intervention group has been established and piloted successfully, 
participants could also be invited to volunteer and speakers or mentors for future groups, 
which could increase their feelings of meaning in life, and give them a means of ‘employment’ 
even when they are unable to stay in full-time work372. This would also increase their social 
circle and support network beyond members of the initial group. 
 
9.2.3 Resilience 
While it is contentious whether resilience can be learnt350, interventions have been developed 
with the aim of improving resilience330;354;355, as mentioned in the Chapter 7 (section 
7.4.6).These interventions encourage participants to take responsibility for themselves, 
empower themselves through education and self-management and create meaningful 
connections with others354;355. Furthermore, these interventions have successfully reduced 
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depressive symptoms, negative affect, and stress, and improved self-esteem and the use of 
effective coping strategies in comparison to a wait-list control group354, and can be conducted 
by specialists or nonspecialists330, meaning that they are available for use in most health-care 
settings. However, resilience interventions in adults are not well researched - resilience has no 
operational definition as of yet and so our understanding of how to develop effective 
resilience interventions is limited - and so the potential efficacy of such treatment on PWH is, 
as of yet, still unknown. 
 
9.3 Limitations  
The data presented here is amongst the first in the UK to explore age-related differences in 
well-being in the HIV positive population, to assess the effects of ‘ageing with HIV’ on mental 
and social health and to identify resilience as a potential protective factor against declining 
biopsychosocial health. This thesis also includes information on two other under-researched 
factors of well-being: anxiety and symptom distress. As such, the results presented here add 
considerably to the literature in this area. However, it is inescapable that data is presented 
within methodological limitations. While these have been discussed in the relevant chapters, 
general limitations of this work are acknowledged below. 
 
9.3.1 Scope of research 
The work presented here displays a wide-ranging, epidemiological overview of the well-being 
of PWH in relation to several measures of physical, mental, and social health. While these 
findings will be useful for directing future research and development of interventions to 
improve well being in PWH, the quantitative nature of the questionnaire studies, including 
large sample sizes and the number of biopsychosocial factors was made possible by sacrificing 
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an in-depth exploration of any one measure. In other words, the methodology chosen in this 
thesis was based on scope rather than detailed analysis. The reasons behind the differences in 
well-being identified with age and time diagnosed with HIV was not explicitly studied in 
qualitative studies, and interpretation of the results was reliant upon the limited literature 
available. As such, although the interpretation of these results is based on the best available 
evidence, the results themselves can be used as a template only for identifying what care 
needs differ over age and time with diagnosed HIV, not why they change. 
Related to this limitation is the study design chosen. All data collected here were cross-
sectional and quantitative in design. Cross-sectional data is useful for estimating the 
prevalence of outcomes of interest and allows for many factors to be explored at once in a 
relatively short amount of time. However, as the data is collected at one point in time it is 
impossible to disentangle the direction, or temporality, of associations, and therefore to make 
causal inferences regarding the relationships between variables from this data: especially as 
physical, mental and social health are so strongly interlinked. The cross-sectional nature of this 
data also prevents the identification of whether 'time with diagnosed HIV'-related differences 
in well-being are related to calendar year of diagnosis (and the associated variations in 
prognosis and medicine) or the accumulation of HIV-related problems over time. However, it 
can be suggested that the linear relationship between time with diagnosed HIV and physical, 
mental, and social factors supports the latter conclusion. 
Due to the large number of tests conducted throughout this thesis, it is possible that type I 
errors may be apparent and the significance of p-values should be interpreted with caution. 
Therefore the data presented here can only provide a 'snapshot' of the well-being of PWH and 
the causation, and interpretation of these results are purely speculative, post-hoc, and based 
on the limited available literature. This is especially true in relation to the effects of resilience 
on physical and mental health and longitudinal analysis of these variables would be greatly 
beneficial. The issue could have been resolved with the inclusion of Bonferroni correction 
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tests. However, due to the large number of tests conducted the correction would have been so 
large as to mask significant difference in the results. This was considered to be a larger issue 
for identifying care needs than the possibility of type I errors and so no such tests were 
performed. 
Finally, as in any exploration of well-being, and any intervention development, it is important 
to include the participants themselves into the analysis of their needs. As such, qualitative 
input from PWH would greatly contribute to the discussion of potential interventions 
suggested by these findings. Such focused research can now be conducted within the detailed 
bands of information provided here. 
 
9.3.2 Generalisability 
Sampling for both studies occurred predominantly within London (73.8% of ASTRA 
participants) and within one specific hospital in the case of the resilience study. The UK HIV 
positive population is predominantly located within London19, so it is likely that these results 
are applicable to the general HIV positive population within the UK. However, it is also possible 
that outside of London well-being needs may differ. Similarly, London itself is a large and 
demographically broad location. While the clinics involved in the ASTRA study were chosen to 
allow recruitment of patients across a range of important sociodemographic variables and to 
increase generalisability of results, the population was not compared across geographic 
location it is possible that situations (e.g. money for basic needs, social support) may differ by 
area, and individual clinics may identify variation in the needs of their patients. Therefore it 
may be beneficial, in the development of targeted interventions, for this information to be 
explored. 
All participants were identified and approached during their visit to an HIV clinic. As previously 
mentioned, PWH with severe mobility problems, physical or mental illness may be less able to 
attend the clinic (although some clinics did offer free hospital transport) and so may have been 
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less likely to have been included in the study samples. As such, it is possible that the 
prevalence of physical and mental illness reported here are under-represented. This may be 
especially possible based on the decision to code missing data as 'symptom not present'. While 
I do not think that this would have unduly affected the trends in well-being seen with age or 
time diagnosed with HIV, it may affect the data on the well-being of the overall HIV positive 
population. As such the data provided here should be taken as almost a minimal estimate of 
the issues affecting PWH. However, it can be argued that this is more useful than an over-
representation of physical or mental distress. 
 
9.3.3 Replication of findings 
I have identified (and addressed) several gaps in the current literature in relation to symptom 
distress, anxiety and positive psychology (e.g. resilience, 'successful' ageing) as well as the 
effects of ‘ageing with HIV’. However, the lack of prior research limited my ability to infer the 
meaning behind the changes identified with age and time, especially as my own data was not 
longitudinal or qualitative in method. This was especially problematic in relation to the results 
exploring 'ageing with HIV', for which almost no research was identified. Many conclusions 
were, by necessity, drawn from the general ageing literature. As such the related results 
should not be taken as conclusive evidence until replicated in other research studies.  
Similarly, few interventions were found in relation to well-being in OPWH, and all were 
implemented by the same study group. As such I could only infer that group settings appear to 
be beneficial for OPWH and I was required to develop more specific methodology from the 
general gerontological literature, which is untested with this specific population. Repeat 
studies by other researchers, in other geographical locations would greatly improve the 
applicability of this research, as would explorations into the interventions suggested here and 
their acceptability to the OPWH population.  
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9.4 Conclusions and implications 
This thesis has presented work from two studies into the biopsychosocial well-being of adults 
ageing with HIV, and two reviews of the literature. I have presented the prevalence of physical, 
mental, and social problems in PWH in a UK sample. I have also presented age-related 
differences in well-being, and the relationships between these physical, social, and mental 
health in order to create a comprehensive overview of the well-being of OPWH. In doing so, I 
have identified that PWH report higher prevalence of mental and physical health distress than 
the general UK population and that, with age, social health and physical ability declines, 
physical symptoms alter in prevalence, but mental health improves. However, with time 
diagnosed with HIV, all the explored factors of biopsychosocial health worsen. While this has 
not previously been explored, this suggests that ‘ageing with HIV’ is a stronger predictor of 
well-being than biological age in PWH. 
A secondary finding of the research reported here is that CD4 count is, in the era of effective 
cART (and within a highly adherent population), not related to overall well-being. Indeed, few 
relationships were found between this indicator of health and any other variables explored - 
likely due to the high levels of clinical care available and engagement of the patients with that 
care. As such assessment of, and provision for, care needs in PWH must reach beyond viral 
suppression in order to optimise health and wellbeing in adults with HIV. 
The information provided also raises implications for the methodology used within prior and 
future research into OPWH. First and foremost, strong differences in well-being were observed 
between PWH aged 50-60 and 60 and over years. In almost every capacity, adults over the age 
of 60 reported greater well-being in comparison to younger adults. This suggests that adults 
over the age of 60 (or their generation-specific demographic) have a very different response to 
ageing with HIV than younger PWH and should be assessed as separate and distinct groups. In 
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particular studies comparing PWH over and under the age of 50 (the classically accepted cut-
off for OPWH) are likely to overlook important age-related data and may find their results 
confounded. In the systematic review alone (section 1.3), 26 studies (68%) of studies used '50 
years of age and over' as their older adults group and only five reviewed adults aged over 50 
and over 60 years of age separately. This severely limits the ability of the current literature to 
explore age-related changes in well-being in OPWH as identified here. 
Similarly, time diagnosed with HIV was identified as a far greater predictor of distress in 
relation to physical, mental, and social well-being than age. While age was related to some 
physical and social declines in well-being, increased time diagnosed with HIV was consistently 
related to worse well-being across all the variables explored. This suggests that adults ‘ageing 
with HIV’ are in need of continued monitoring and care. This needs to be addressed by 
researchers and clinicians and long-term care must be made available. It also suggests that 
time diagnosed with HIV is likely to have been a confounding factor in previous reports into 
ageing with HIV, as few were identified which took time with HIV into account. Future 
researchers wishing to explore the effects of age on well-being in this population are strongly 
encouraged to include time with diagnosed HIV as a variable. 
This thesis also highlights the dearth of research into the possibility of positive well-being 
and/or ‘successful ageing’ in PWH and shows that PWH are not only capable of achieving high 
states of resilience, but that this is likely related to their physical and mental health. While 
interventions for OPWH are currently lacking, their results conclusively support the possibility 
of improved well-being in OPWH through social group support, which could encompass the 
issues commonly identified by OPWH reported here. Therefore, taking evidence from the 
results presented here, and gerontological literature, I have suggested intervention content 
which is likely to improve well-being in adults ageing with HIV by addressing the variables most 
identified as concerning in the presented populations.  
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A. Resilience study consent form and information sheet 
Study Number: RFH 8804.  UCL 13/6039 
Participant Identification Number for this trial: ___________________________ 
CONSENT FORM 
Title of Project:  Health Perceptions, smoking and health status. 
Name of Researcher: Dr Marc Lipman,  Dr James Brown,  Ms Jennifer McGowan                                                                                    
         Please initial box 
1. I confirm that I have read the information sheet dated............. (version.........) for the 
above study. I have had the opportunity to consider the information, ask questions and 
been answered satisfactorily. 
  
   
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected. 
  
   
3. I consent to investigators accessing clinical information from my hospital records including 
the results of any HIV tests that have been performed. I understand that no blood tests 
will be performed specifically for this research study. 
  
   
4. I understand that relevant sections of my medical notes and data collected during the 
study may be looked at by individuals from regulatory authorities or from the NHS Trust, 
where it is relevant to my taking part in this research. I give permission for  these 
individuals to have access to my records.  
  
   
5. I understand that the information collected about me will be used to support other 
research in the future, and may be shared anonymously with other researchers. 
  
   
6. I agree to my General Practitioner being informed of my participation in the study.   
   
7. I agree to take part in the above study.   
       
            
Name of Participant  Date    Signature 
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We are inviting you to take part in a research study. This information is to help you understand 
why we are doing the research and what it involves. We can answer any questions that you 
have so that you can decide if you want to join the study. 
Title of study: Health Perceptions, resilience and smoking. 
What is the purpose of the study? 
We are aiming to improve our understanding of how many people smoke, what their beliefs 
about smoking are and other factors that could affect their health. We also want to obtain 
information about how frequently respiratory symptoms occur and how common 
abnormalities of lung function are. 
Why have I been chosen? 
All individuals attending this clinic can participate in this study on days when recruitment for 
the project is occurring. Your care will not be affected in any way if you don’t want to carry on 
with the study and you may opt out at any time. 
What will I have to do? 
This study involves completing a questionnaire concerning smoking and other factors that 
could influence respiratory health, some information regarding you, and any current 
respiratory symptoms. After this we would like to perform a simple measurement of lung 
function. We can give you the results of this test and/or pass them onto your GP. 
Will my taking part in this study be kept confidential? 
Yes. The results will be confidential and your results will be identifiable only by a study 
number. Some results from this study may be published but you will be anonymous in all 
results. After completion of the study we will keep the information in secure hospital 
computers and this may be used in future research projects. Results from this study may be 
used to support future research.  
What are the possible disadvantages and risks of taking part? 
Participating in this study will take some of your time. Completing the survey will take around 
15-20 minutes. Having the lung function test will take about another 10 minutes. We do not 
think that there are any other risks of taking part. 
What are the possible benefits of taking part? 
We cannot promise that there will be any benefits to you of taking part in this study. If you 
want, you can be given details of your lung function test. If you would like help to quit smoking 
then we can direct you to appropriate NHS resources. If we identify any abnormality in your 
spirometry (lung function test) then we will let you and/or you GP know.  
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Who is organising and funding the research? 
This study is organised by the Respiratory and HIV departments of the Royal Free Hospital. 
Who has reviewed the research? 
Before any research is allowed to happen it is checked by a group of people called a Research 
Ethics Committee. They make sure that the research is acceptable. Your project has been 
checked by the ___________________ Research Ethics Committee 
What if there is a problem? 
If you wish to complain or have any concerns about the way that you have been approached or 
treated by members of staff then you have access to National Health Service and Royal Free 
Hampstead NHS Trust complaints procedures. Your research doctor or nurse can provide you 
with further information regarding this.  
 
Additional information is available from:  
Participant Advice and Liaison Service, Royal Free London NHS Foundation Trust, Pond Street, 
London NW3 2QG 
Telephone: 020 7472 6446 / 6447 (020 7472 6445 – 24 hour answer phone) 
Fax:  020 7472 6463 
Email: rfh.pals@nhs.net 
This sheet is for your information and we will give you a copy of the signed consent form.  
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Name of Researcher  Date    Signature 
 
Health perceptions, smoking and health status  
 
Ian Charleson Day Centre  
Royal Free London Foundation NHS Trust  
 
We very much appreciate your help with this study.  
 
The following questionnaire has been designed to look at people’s beliefs about health and 
smoking. The results will be used to reduce the risk of heart attacks, strokes and lung disease 
and help people quit smoking.   
At the end, there are some questions about how you feel today. We would also like to check 
your breathing with a machine called a spirometer, which works out how much air you can 
blow out of your lungs and is a measure of lung function.  
The questionnaire should not take more than 20 minutes to complete, then about 5 minutes 
to do the spirometry. 
If you do not want to answer any specific questions or sections, simply leave these blank and 
move on to the next section. Your care in this clinic will not be affected in any way if you chose 
not to complete this questionnaire, or any particular questions within it.  
Please tick the boxes where appropriate.  There are no right or wrong answers so just select 
the answer that best suits you. We have also left some space for additional comments. 
 
Many thanks for taking the time to help us with our study.  
Your responses will be treated in confidence. 
Study No:  □□□   Date:  
 
Study Number: ___________________________ 
 
Date _____________ 
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B. Resilience study HIV positive participants booklet 
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C. Table 58. Papers included in the second systematic review, ranked by lead 
Author. 
Table 58. Papers included in the second systematic review, ranked by lead Author. 
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D. Figure 30: A visual representation of well-being in PWH. 
Figure 30 shows the prevalence of each variable explored in the general UK PWH population. 
The prevalence of each variable is identified as a percentage of the population, and the 
variables themselves are categorised as physical (green), mental (purple), social (blue) and 
financial (orange) factors. The associations between each variable are then identified, using 
green and red lines to show positive and negative correlations respectively. While this may 
appear overwhelming, the aim is purely to depict the inter-related nature of the variables and 
show which, if addressed in an intervention, would have the largest impact on overall well-
being. To allow for ease of identification the number of connections is also stated for each 
variable individually.  
Due to the large number of statistical tests completed (increasing the risk of type I error), only 
strong associations -those with a p value < .001 - are included in the figure. Resilience is also 
not included, as it was not analysed in relation to the full spectrum of well-being factors. 
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